BioMedLib Search Engine
[ goto HOMEPAGE ]
Find more relevant answers, faster!
Skip to content
Advanced Search
Search History
MeSH Query
Page Format
Query is expanded
Login
Skip to content
Export Citations
Search Results
RSS
Email
Articles' Details
Start new query
Reset All
Refine your query
(more in Advanced-Search):
Search all of MEDLINE
Focus on the recent 5 years
Focus on the current year
Focus on the last 30 days
More choices ...
Focus on articles with free fulltexts
More choices ...
Do simple 'keyword' search (no query expansion)
[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click
here to
RESET
all values
Click
here to
GO BACK
without resetting any value
Advanced Search
Submit one or more of the following items, and they will be searched along with your query in the search box above.
Any submit button will submit all of the items you have changed.
+
Publication-Date
Published in the last:
30 days
60 days
90 days
6 months
12 months
this year
2 years
3 years
5 years
10 years
Or published in the following date range: From (yyyy/mm/dd - month and day are optional)
to ('to' is optional)
+
Full Text
Retrieve articles with hyperlinks to:
full text (either free or subscription)
free full text
subscription full text
no full text link
+
Sort-Order
Sort the retrieved articles by:
relevance
publication date
+
Language
And with languages:
English
French
German
Italian
Japanese
Russian
Spanish
More languages:
Afrikaans
Albanian
Amharic
Arabic
Armenian
Azerbaijani
Bengali
Bosnian
Bulgarian
Catalan
Chinese
Czech
Danish
Dutch
Esperanto
Estonian
Finnish
Georgian
Scottish Gaelic
Greek, Modern
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Kinyarwanda
Korean
Latin
Latvian
Lithuanian
Macedonian
Malayalam
Maori
Malay
Multiple languages
Norwegian
Persian
Polish
Portuguese
Pushto
Romanian
Sanskrit
Serbian
Croatian
Slovak
Slovenian
Swedish
Thai
Turkish
Ukrainian
Undetermined
Urdu
Vietnamese
Welsh
+
Publication-Type
And with publication types:
Clinical Trial
Editorial
Letter
Meta-Analysis
Practice Guideline
Randomized Controlled Trial
Review
More publication types:
Addresses
Bibliography
Biography
Case Reports
Classical Article
Clinical Conference
Clinical Trial, Phase I
Clinical Trial, Phase II
Clinical Trial, Phase III
Clinical Trial, Phase IV
Comment
Comparative Study
Congresses
Consensus Development Conference
Consensus Development Conference, NIH
Controlled Clinical Trial
Corrected and Republished Article
Dictionary
Directory
Duplicate Publication
English Abstract
Evaluation Studies
Festschrift
Government Publications
Guideline
Historical Article
Interactive Tutorial
Interview
Introductory Journal Article
In Vitro
Journal Article
Lectures
Legal Cases
Legislation
Multicenter Study
News
Newspaper Article
Overall
Patient Education Handout
Periodical Index
Portraits
Published Erratum
Retracted Publication
Research Support, N.I.H., Extramural
Research Support, N.I.H., Intramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Research Support, U.S. Gov't, P.H.S.
Retraction of Publication
Scientific Integrity Review
Technical Report
Twin Study
Validation Studies
+
Species
And for:
Humans
Animals
+
Gender
And for:
Male
Female
+
Age
And for these age groups:
Newborn: birth to 1 month
Infant: 1 to 23 months
Preschool child: 2 to 5 years
Child: 6 to 12 years
Adolescent: 13 to 18 years
Adult: 19 to 44 years
Middle aged: 45 to 64 years
Aged: 65+ years
80 and over: 80+ years
+
Title
And for this query matching the titles:
+
Transliterated-Title
And for this query matching the title in original language:
+
Abstract
And for this query matching the abstratcs:
+
Major-Mesh
And for this query matching the MeSH-Major terms:
+
Mesh
And for this query matching any MeSH terms:
+
Journal
And for one or more of these journal abbreviated names:
OR
OR
(see
title abbreviations
)
+
Volume
And with journal volume number:
+
Issue
And with journal issue number:
+
Page
And with page number:
+
ISSN
And with ISSN:
+
Publication-Place
And with journal's country of publication:
+
Author
And for...
all these author names:
AND
AND
(see
help
)
one or more of these author names:
OR
OR
but not having any of these unwanted author names:
NOT
NOT
+
Affiliation
And with affiliation to:
+
Has-Abstract
Find MEDLINE records with the abstract status:
has abstract
does not have abstract
include both record types
include both record types but rank higher the records having abstract (the default BML behavior)
+
PMID
Show me only articles for these PMIDs (PubMed IDs):
+
Semantic-Type
And with semantic types:
A. Entity
A1. Physical Object
A1.1. Organism
A1.1.1. Archaeon
A1.1.2. Bacterium
A1.1.3. Eukaryote
A1.1.3.1. Animal
A1.1.3.1.1. Vertebrate
A1.1.3.1.1.1. Amphibian
A1.1.3.1.1.2. Bird
A1.1.3.1.1.3. Fish
A1.1.3.1.1.4. Mammal
A1.1.3.1.1.4.1. Human
A1.1.3.1.1.5. Reptile
A1.1.3.2. Fungus
A1.1.3.3. Plant
A1.1.4. Virus
A1.2. Anatomical Structure
A1.2.1. Embryonic Structure
A1.2.2. Anatomical Abnormality
A1.2.2.1. Congenital Abnormality
A1.2.2.2. Acquired Abnormality
A1.2.3. Fully Formed Anatomical Structure
A1.2.3.1. Body Part, Organ, or Organ Component
A1.2.3.2. Tissue
A1.2.3.3. Cell
A1.2.3.4. Cell Component
A1.2.3.5. Gene or Genome
A1.3. Manufactured Object
A1.3.1. Medical Device
A1.3.1.1. Drug Delivery Device
A1.3.2. Research Device
A1.3.3. Clinical Drug
A1.4. Substance
A1.4.1. Chemical
A1.4.1.1. Chemical Viewed Functionally
A1.4.1.1.1. Pharmacologic Substance
A1.4.1.1.1.1. Antibiotic
A1.4.1.1.2. Biomedical or Dental Material
A1.4.1.1.3. Biologically Active Substance
A1.4.1.1.3.1. Neuroreactive Substance or Biogenic Amine
A1.4.1.1.3.2. Hormone
A1.4.1.1.3.3. Enzyme
A1.4.1.1.3.4. Vitamin
A1.4.1.1.3.5. Immunologic Factor
A1.4.1.1.3.6. Receptor
A1.4.1.1.4. Indicator, Reagent, or Diagnostic Aid
A1.4.1.1.5. Hazardous or Poisonous Substance
A1.4.1.2. Chemical Viewed Structurally
A1.4.1.2.1. Organic Chemical
A1.4.1.2.1.5. Nucleic Acid, Nucleoside, or Nucleotide
A1.4.1.2.1.6. Organophosphorus Compound
A1.4.1.2.1.7. Amino Acid, Peptide, or Protein
A1.4.1.2.1.8. Carbohydrate
A1.4.1.2.1.9. Lipid
A1.4.1.2.1.9.1. Steroid
A1.4.1.2.1.9.2. Eicosanoid
A1.4.1.2.2. Inorganic Chemical
A1.4.1.2.3. Element, Ion, or Isotope
A1.4.2. Body Substance
A1.4.3. Food
A2. Conceptual Entity
A2.1. Idea or Concept
A2.1.1. Temporal Concept
A2.1.2. Qualitative Concept
A2.1.3. Quantitative Concept
A2.1.4. Functional Concept
A2.1.4.1. Body System
A2.1.5. Spatial Concept
A2.1.5.1. Body Space or Junction
A2.1.5.2. Body Location or Region
A2.1.5.3. Molecular Sequence
A2.1.5.3.1. Nucleotide Sequence
A2.1.5.3.2. Amino Acid Sequence
A2.1.5.3.3. Carbohydrate Sequence
A2.1.5.4. Geographic Area
A2.2. Finding
A2.2.1. Laboratory or Test Result
A2.2.2. Sign or Symptom
A2.3. Organism Attribute
A2.3.1. Clinical Attribute
A2.4. Intellectual Product
A2.4.1. Classification
A2.4.2. Regulation or Law
A2.5. Language
A2.6. Occupation or Discipline
A2.6.1. Biomedical Occupation or Discipline
A2.7. Organization
A2.7.1. Health Care Related Organization
A2.7.2. Professional Society
A2.7.3. Self-help or Relief Organization
A2.8. Group Attribute
A2.9. Group
A2.9.1. Professional or Occupational Group
A2.9.2. Population Group
A2.9.3. Family Group
A2.9.4. Age Group
A2.9.5. Patient or Disabled Group
B. Event
B1. Activity
B1.1. Behavior
B1.1.1. Social Behavior
B1.1.2. Individual Behavior
B1.2. Daily or Recreational Activity
B1.3. Occupational Activity
B1.3.1. Health Care Activity
B1.3.1.1. Laboratory Procedure
B1.3.1.2. Diagnostic Procedure
B1.3.1.3. Therapeutic or Preventive Procedure
B1.3.2. Research Activity
B1.3.2.1. Molecular Biology Research Technique
B1.3.3. Governmental or Regulatory Activity
B1.3.4. Educational Activity
B1.4. Machine Activity
B2. Phenomenon or Process
B2.1. Human-caused Phenomenon or Process
B2.1.1. Environmental Effect of Humans
B2.2. Natural Phenomenon or Process
B2.2.1. Biologic Function
B2.2.1.1. Physiologic Function
B2.2.1.1.1. Organism Function
B2.2.1.1.1.1. Mental Process
B2.2.1.1.2. Organ or Tissue Function
B2.2.1.1.3. Cell Function
B2.2.1.1.4. Molecular Function
B2.2.1.1.4.1. Genetic Function
B2.2.1.2. Pathologic Function
B2.2.1.2.1. Disease or Syndrome
B2.2.1.2.1.1. Mental or Behavioral Dysfunction
B2.2.1.2.1.2. Neoplastic Process
B2.2.1.2.2. Cell or Molecular Dysfunction
B2.2.1.2.3. Experimental Model of Disease
B2.3. Injury or Poisoning
Page Format
Any submit button will submit all of the items you have changed.
[theme]
Use this page design theme:
original
twenty ten
[shown]
Results per page:
5
10
20
50
100
200
500
[expand/collapse]
show these sections expanded by default:
Advanced search
MeSH query
Search history
Page format
Query expansion
Articles details
Export citations
Email
[text size]
use this font size for text:
25%
50%
75%
100%
125%
150%
200%
or enter your choice of font size:
[page width]
use this page width (relative to the default initial value):
25%
50%
75%
100%
125%
150%
200%
or enter your choice of page width:
[highlight color]
use this color to highlight query words in the articles:
red
green
blue
black
purple
yellow
orange
navy
olive
maroon
none
[query history]
maximum number of queries shown in the history section:
[annotate]
Annotate these parts of each article:
title
abstract
both
none
Reset all values
Find best MeSH terms for
Search History
1
aids related diffuse large b cell lymphoma 2005:2010[pubdate] *count=100
107 results
Searchbox
Export
PDF
RSS
Email
Delete
Email this search result to the following email address:
[X] Close
Expand the query
'
aids related diffuse large b cell lymphoma
' expanded to all its synonyms;
details
Email the results to the following email address:
Export the checked citations in RIS format (RIS format is used by RefWorks, Endnote, among others).
Items 1 to 100 of about 107
1.
Moore D, Cohen P, Malik S:
HIV-related large B-cell lymphoma confined to the bone marrow with a fulminant clinical course: a case report and literature review.
Clin Adv Hematol Oncol
; 2007 Aug;5(8):622-4; discussion 625-6
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
HIV-
related large
B-
cell lymphoma
confined to the bone marrow with a fulminant clinical course: a case report and literature review.
[MeSH-major]
Bone Marrow / pathology.
Lymphoma
,
AIDS
-
Related
/ pathology.
Lymphoma
,
Large B
-
Cell
,
Diffuse
/ pathology
Genetic Alliance.
consumer health - HIV
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 17982403.001).
[ISSN]
1543-0790
[Journal-full-title]
Clinical advances in hematology & oncology : H&O
[ISO-abbreviation]
Clin Adv Hematol Oncol
[Language]
eng
[Publication-type]
Case Reports; Journal Article
[Publication-country]
United States
2.
Navarro JT, Lloveras N, Ribera JM, Oriol A, Mate JL, Feliu E:
The prognosis of HIV-infected patients with diffuse large B-cell lymphoma treated with chemotherapy and highly active antiretroviral therapy is similar to that of HIV-negative patients receiving chemotherapy.
Haematologica
; 2005 May;90(5):704-6
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
The prognosis of HIV-infected patients with
diffuse large
B-
cell lymphoma
treated with chemotherapy and highly active antiretroviral therapy is similar to that of HIV-negative patients receiving chemotherapy.
In the era of highly active antiretroviral treatment (HAART), the prognosis of
AIDS
-
related
lymphomas might be similar to that of aggressive B-
cell
lymphomas in human immunodeficiency (HIV)-negative patients.
In this study we found that HIV-infected patients with
diffuse large
B-
cell lymphoma
treated with cyclophosphamide, hydroxydoxorubicin, vincristine and prednisone (CHOP) and HAART showed a similar response rate to chemotherapy, disease-free survival and overall survival as those of HIV-negative patients receiving CHOP.
[MeSH-major]
Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Antiretroviral Therapy, Highly Active. HIV Infections / mortality.
Lymphoma
,
AIDS
-
Related
/ mortality.
Lymphoma
,
Large B
-
Cell
,
Diffuse
/ mortality
Genetic Alliance.
consumer health - Large B cell diffuse lymphoma
.
Genetic Alliance.
consumer health - HIV
.
MedlinePlus Health Information.
consumer health - HIV/AIDS
.
MedlinePlus Health Information.
consumer health - HIV/AIDS in Women
.
MedlinePlus Health Information.
consumer health - HIV/AIDS Medicines
.
ClinicalTrials.gov.
clinical trials - ClinicalTrials.gov
.
Hazardous Substances Data Bank.
DOXORUBICIN
.
Hazardous Substances Data Bank.
CYCLOPHOSPHAMIDE
.
Hazardous Substances Data Bank.
PREDNISONE
.
Hazardous Substances Data Bank.
VINCRISTINE
.
NCI CPTC Antibody Characterization Program.
NCI CPTC Antibody Characterization Program
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 15921395.001).
[ISSN]
1592-8721
[Journal-full-title]
Haematologica
[ISO-abbreviation]
Haematologica
[Language]
eng
[Publication-type]
Letter; Research Support, Non-U.S. Gov't
[Publication-country]
Italy
[Chemical-registry-number]
143011-72-7 / Granulocyte Colony-Stimulating Factor; 5J49Q6B70F / Vincristine; 80168379AG / Doxorubicin; 8N3DW7272P / Cyclophosphamide; VB0R961HZT / Prednisone; CHOP protocol
3.
Zaragoza V, Martínez L, Pérez-Ferriols A, Alegre V:
[Cutaneous presentation of plasmablastic lymphoma in a patient with HIV Infection].
Actas Dermosifiliogr
; 2008 Dec;99(10):820-1
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
[Cutaneous presentation of plasmablastic
lymphoma
in a patient with HIV Infection].
[MeSH-major]
Lymphoma
,
AIDS
-
Related
/ diagnosis.
Lymphoma
,
Large B
-
Cell
,
Diffuse
/ diagnosis. Skin Neoplasms / diagnosis
Genetic Alliance.
consumer health - HIV
.
MedlinePlus Health Information.
consumer health - Skin Cancer
.
Hazardous Substances Data Bank.
DOXORUBICIN
.
Hazardous Substances Data Bank.
CYCLOPHOSPHAMIDE
.
Hazardous Substances Data Bank.
PREDNISONE
.
Hazardous Substances Data Bank.
VINCRISTINE
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 19091226.001).
[ISSN]
0001-7310
[Journal-full-title]
Actas dermo-sifiliográficas
[ISO-abbreviation]
Actas Dermosifiliogr
[Language]
spa
[Publication-type]
Case Reports; Letter
[Publication-country]
Spain
[Chemical-registry-number]
0 / Antigens, CD; 0 / Biomarkers, Tumor; 5J49Q6B70F / Vincristine; 80168379AG / Doxorubicin; 8N3DW7272P / Cyclophosphamide; VB0R961HZT / Prednisone; CHOP protocol
Advertisement
4.
Spina M, Gloghini A, Tirelli U, Carbone A:
Therapeutic options for HIV-associated lymphomas.
Expert Opin Pharmacother
; 2010 Oct;11(15):2471-81
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
The rarity of primary effusion lymphomas and plasmablastic lymphomas of the oral cavity type makes
large
prospective studies difficult and challenges the feasibility of defining therapy specific for a given subpopulation of patients.
However, rituximab plus chemotherapy should be offered to the majority of patients with HIV infection and
diffuse large
B-
cell
lymphomas; and the feasibility of intensive aggressive chemotherapy regimens has been successfully tested in HIV-associated Burkitt's lymphomas.
[MeSH-major]
HIV Infections / complications. HIV Infections / drug therapy.
Lymphoma
,
AIDS
-
Related
/ complications.
Lymphoma
,
AIDS
-
Related
/ drug therapy
[MeSH-minor]
Animals. Antibodies, Monoclonal / therapeutic use. Antibodies, Monoclonal, Murine-Derived / therapeutic use. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Antiretroviral Therapy, Highly Active / trends. Boronic Acids / therapeutic use. Bortezomib. Epstein-Barr Virus Infections / complications. Epstein-Barr Virus Infections / drug therapy. Humans.
Lymphoma
,
Large B
-
Cell
,
Diffuse
/ complications.
Lymphoma
,
Large B
-
Cell
,
Diffuse
/ drug therapy. Pyrazines / therapeutic use. Rituximab. Treatment Outcome
Genetic Alliance.
consumer health - HIV
.
MedlinePlus Health Information.
consumer health - HIV/AIDS
.
MedlinePlus Health Information.
consumer health - HIV/AIDS Medicines
.
Hazardous Substances Data Bank.
RITUXIMAB
.
Hazardous Substances Data Bank.
BORTEZOMIB
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 20726820.001).
[ISSN]
1744-7666
[Journal-full-title]
Expert opinion on pharmacotherapy
[ISO-abbreviation]
Expert Opin Pharmacother
[Language]
eng
[Publication-type]
Journal Article; Research Support, Non-U.S. Gov't; Review
[Publication-country]
England
[Chemical-registry-number]
0 / Antibodies, Monoclonal; 0 / Antibodies, Monoclonal, Murine-Derived; 0 / Boronic Acids; 0 / Pyrazines; 0 / ofatumumab; 4F4X42SYQ6 / Rituximab; 69G8BD63PP / Bortezomib
5.
Voigtländer C, Harrer T, Schneider L, Schulze-Koops H, Niedobitek G, Lüftl M:
Diffuse large B-cell lymphoma on the back of a patient with AIDS: successful treatment by the CD20 monoclonal antibody rituximab.
Int J Dermatol
; 2005 Nov;44(11):976-8
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Diffuse large
B-
cell lymphoma
on the back of a patient with
AIDS
: successful treatment by the CD20 monoclonal antibody rituximab.
[MeSH-major]
Antibodies, Monoclonal / therapeutic use.
Lymphoma
,
AIDS
-
Related
/ diagnosis.
Lymphoma
,
AIDS
-
Related
/ drug therapy.
Lymphoma
,
Large B
-
Cell
,
Diffuse
/ diagnosis.
Lymphoma
,
Large B
-
Cell
,
Diffuse
/ drug therapy
Genetic Alliance.
consumer health - AIDS-HIV
.
Genetic Alliance.
consumer health - Large B cell diffuse lymphoma
.
Hazardous Substances Data Bank.
RITUXIMAB
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 16336543.001).
[ISSN]
0011-9059
[Journal-full-title]
International journal of dermatology
[ISO-abbreviation]
Int. J. Dermatol.
[Language]
eng
[Publication-type]
Case Reports; Letter
[Publication-country]
United States
[Chemical-registry-number]
0 / Antibodies, Monoclonal; 0 / Antibodies, Monoclonal, Murine-Derived; 0 / Antigens, CD20; 0 / Antineoplastic Agents; 4F4X42SYQ6 / Rituximab
6.
StatBite: Lymphoma incidence in HIV patients vs. general population.
J Natl Cancer Inst
; 2010 Jul 21;102(14):1003
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
StatBite:
Lymphoma
incidence in HIV patients vs. general population.
[MeSH-major]
Lymphoma
,
AIDS
-
Related
/ epidemiology.
Lymphoma
,
AIDS
-
Related
/ virology
[MeSH-minor]
Burkitt
Lymphoma
/ epidemiology. Burkitt
Lymphoma
/ virology. Central Nervous System Neoplasms / epidemiology. Central Nervous System Neoplasms / virology. HIV Infections / complications. Hodgkin Disease / epidemiology. Hodgkin Disease / virology. Humans. Incidence.
Lymphoma
,
Large B
-
Cell
,
Diffuse
/ epidemiology.
Lymphoma
,
Large B
-
Cell
,
Diffuse
/ virology.
Lymphoma
, Non-Hodgkin / epidemiology.
Lymphoma
, Non-Hodgkin / virology
Genetic Alliance.
consumer health - HIV
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 20616355.001).
[ISSN]
1460-2105
[Journal-full-title]
Journal of the National Cancer Institute
[ISO-abbreviation]
J. Natl. Cancer Inst.
[Language]
eng
[Publication-type]
Journal Article
[Publication-country]
United States
7.
Spina M, Simonelli C, Talamini R, Tirelli U:
Patients with HIV with Burkitt's lymphoma have a worse outcome than those with diffuse large-cell lymphoma also in the highly active antiretroviral therapy era.
J Clin Oncol
; 2005 Nov 1;23(31):8132-3; author reply 8133-4
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Patients with HIV with Burkitt's
lymphoma
have a worse outcome than those with
diffuse large
-
cell lymphoma
also in the highly active antiretroviral therapy era.
[MeSH-major]
Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Antiretroviral Therapy, Highly Active. Burkitt
Lymphoma
/ mortality.
Lymphoma
,
AIDS
-
Related
/ mortality.
Lymphoma
,
Large B
-
Cell
,
Diffuse
/ mortality
Genetic Alliance.
consumer health - Lymphoma, large-cell
.
Genetic Alliance.
consumer health - HIV
.
Genetic Alliance.
consumer health - Burkitt's Lymphoma
.
MedlinePlus Health Information.
consumer health - HIV/AIDS Medicines
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[CommentOn]
J Clin Oncol. 2005 Jul 1;23(19):4430-8
[
15883411.001
]
(PMID = 16258119.001).
[ISSN]
0732-183X
[Journal-full-title]
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
[ISO-abbreviation]
J. Clin. Oncol.
[Language]
eng
[Publication-type]
Comment; Comparative Study; Letter
[Publication-country]
United States
8.
Milling DL, Lazarchick J, Chaudhary UB:
Primary mediastinal large B-cell lymphoma in an HIV-infected patient.
Am J Med Sci
; 2005 Mar;329(3):136-8
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Primary mediastinal
large B
-
cell lymphoma
in an HIV-infected patient.
HIV-
related
non-Hodgkin
lymphoma
is well documented in the literature.
We report a case of an HIV-infected patient who presents with primary mediastinal
large B
-
cell lymphoma
.
On review of the literature, this appears to be the first documented case of this subtype of
large B
-
cell
non-Hodgkin
lymphoma
seen in an HIV-infected patient.
[MeSH-major]
Lymphoma
,
AIDS
-
Related
/ diagnosis.
Lymphoma
,
Large B
-
Cell
,
Diffuse
/ diagnosis. Mediastinal Neoplasms / diagnosis
Genetic Alliance.
consumer health - HIV
.
Hazardous Substances Data Bank.
DOXORUBICIN
.
Hazardous Substances Data Bank.
CYCLOPHOSPHAMIDE
.
Hazardous Substances Data Bank.
PREDNISONE
.
Hazardous Substances Data Bank.
VINCRISTINE
.
NCI CPTC Antibody Characterization Program.
NCI CPTC Antibody Characterization Program
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 15767818.001).
[ISSN]
0002-9629
[Journal-full-title]
The American journal of the medical sciences
[ISO-abbreviation]
Am. J. Med. Sci.
[Language]
eng
[Publication-type]
Case Reports; Journal Article
[Publication-country]
United States
[Chemical-registry-number]
5J49Q6B70F / Vincristine; 80168379AG / Doxorubicin; 8N3DW7272P / Cyclophosphamide; VB0R961HZT / Prednisone; CHOP protocol
9.
Deloose ST, Smit LA, Pals FT, Kersten MJ, van Noesel CJ, Pals ST:
High incidence of Kaposi sarcoma-associated herpesvirus infection in HIV-related solid immunoblastic/plasmablastic diffuse large B-cell lymphoma.
Leukemia
; 2005 May;19(5):851-5
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
High incidence of Kaposi sarcoma-associated herpesvirus infection in HIV-
related
solid immunoblastic/plasmablastic
diffuse large
B-
cell lymphoma
.
Kaposi sarcoma-associated herpesvirus (KSHV) is known to be associated with two distinct lymphoproliferative disorders: primary effusion
lymphoma
(PEL) and multicentric Castleman disease (MCD)/MCD-associated plasmablastic
lymphoma
.
Within a cohort of 99 HIV-
related
NHLs, 10 cases were found to be KSHV positive on the basis of immunostaining for KSHV LNA-1 as well as KSHV-specific polymerase chain reaction.
Interestingly, all KSHV-positive cases belonged to a distinctive subgroup of 26
diffuse large
B-
cell
lymphomas characterized by the expression of CD138 (syndecan-1) and plasmablastic/immunoblastic morphology.
Our results indicate that KSHV infection is not restricted to PEL and MCD; it is also common (38%) in HIV-
related
solid immunoblastic/plasmablastic lymphomas.
[MeSH-major]
Giant Lymph Node Hyperplasia / virology. HIV Infections / virology. Herpesviridae Infections / virology. Herpesvirus 8, Human.
Lymphoma
,
AIDS
-
Related
/ virology.
Lymphoma
,
Large B
-
Cell
,
Diffuse
/ virology. Sarcoma, Kaposi / virology
Genetic Alliance.
consumer health - Large B cell diffuse lymphoma
.
Genetic Alliance.
consumer health - HIV
.
MedlinePlus Health Information.
consumer health - HIV/AIDS
.
MedlinePlus Health Information.
consumer health - HIV/AIDS in Women
.
MedlinePlus Health Information.
consumer health - Kaposi's Sarcoma
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 15744337.001).
[ISSN]
0887-6924
[Journal-full-title]
Leukemia
[ISO-abbreviation]
Leukemia
[Language]
eng
[Publication-type]
Journal Article
[Publication-country]
England
10.
Boy SC, van Heerden MB, Raubenheimer EJ, van Heerden WF:
Plasmablastic lymphomas with light chain restriction - plasmablastic extramedullary plasmacytomas?
J Oral Pathol Med
; 2010 May;39(5):435-9
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
BACKGROUND: It is diagnostically difficult to differentiate plasmablastic lymphomas (PBLs) from plasma
cell
neoplasms with plasmablastic differentiation.
Positivity was recorded based on the percentage of positive staining cells as focal (5-20%); intermediate (20-70%) or
diffuse
(>70%).
Diffuse
and strong positive staining was found with Ki-67 and MUM1, but variable immunoreactivity was found with CD79a, CD45, CD38 and CD138.
[MeSH-major]
Lymphoma
,
AIDS
-
Related
/ classification.
Lymphoma
,
Large
-
Cell
, Immunoblastic / classification. Mouth Mucosa / pathology. Mouth Neoplasms / classification. Plasmacytoma / classification
[MeSH-minor]
Adult.
Cell
Differentiation. Female. HIV Seropositivity / complications. Herpesvirus 4, Human / isolation & purification. Humans. Immunoglobulin Light Chains / analysis. Immunohistochemistry. In Situ Hybridization. Male. Middle Aged. RNA, Viral / analysis. Retrospective Studies. South Africa
MedlinePlus Health Information.
consumer health - Oral Cancer
.
HIV InSite.
treatment guidelines - Human Herpesvirus-8
.
NCI CPTAC Assay Portal.
NCI CPTAC Assay Portal
.
NCI CPTAC Assay Portal.
NCI CPTAC Assay Portal
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 20537055.001).
[ISSN]
1600-0714
[Journal-full-title]
Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology
[ISO-abbreviation]
J. Oral Pathol. Med.
[Language]
eng
[Publication-type]
Journal Article
[Publication-country]
Denmark
[Chemical-registry-number]
0 / Epstein-Barr virus encoded RNA 1; 0 / Epstein-Barr virus encoded RNA 2; 0 / Immunoglobulin Light Chains; 0 / RNA, Viral
11.
Vega F, Chang CC, Medeiros LJ, Udden MM, Cho-Vega JH, Lau CC, Finch CJ, Vilchez RA, McGregor D, Jorgensen JL:
Plasmablastic lymphomas and plasmablastic plasma cell myelomas have nearly identical immunophenotypic profiles.
Mod Pathol
; 2005 Jun;18(6):806-15
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Plasmablastic lymphomas and plasmablastic plasma
cell
myelomas have nearly identical immunophenotypic profiles.
Plasmablastic
lymphoma
is an aggressive neoplasm that shares many cytomorphologic and immunophenotypic features with plasmablastic plasma
cell
myeloma.
However, plasmablastic
lymphoma
is listed in the World Health Organization (WHO) classification as a variant of
diffuse large
B-
cell lymphoma
.
To characterize the relationship between plasmablastic
lymphoma
and plasmablastic plasma
cell
myeloma, we performed immunohistochemistry using a
large
panel of B-
cell
and plasma
cell
markers on nine cases of plasmablastic
lymphoma
and seven cases of plasmablastic plasma
cell
myeloma with and without HIV/
AIDS
.
All cases of plasmablastic
lymphoma
and plasmablastic plasma
cell
myeloma were positive for MUM1/IRF4, CD138, and CD38, and negative for CD20, corresponding to a plasma
cell
immunophenotype.
PAX-5 and BCL-6 were weakly positive in 2/9 and 1/5 plasmablastic lymphomas, and negative in all plasmablastic plasma
cell
myelomas.
Three markers that are often aberrantly expressed in cases of plasma
cell
myelomas, CD56, CD4 and CD10, were positive in 5/9, 2/5, and 6/9 plasmablastic lymphomas, and in 3/7, 1/5, and 2/7 plasmablastic plasma
cell
myelomas.
The only significant difference between plasmablastic
lymphoma
and plasma
cell
myeloma was the presence of EBV-encoded RNA, which was positive in all plasmablastic
lymphoma
cases tested and negative in all plasma
cell
myelomas.
In conclusion, most cases of
AIDS
-
related
plasmablastic
lymphoma
have an immunophenotype and tumor suppressor gene expression profile virtually identical to plasmablastic plasma
cell
myeloma, and unlike
diffuse large
B-
cell lymphoma
.
These results do not support the suggestion in the WHO classification that plasmablastic
lymphoma
is a variant of
diffuse large
B-
cell lymphoma
.
[MeSH-major]
Immunophenotyping.
Lymphoma
/ pathology. Multiple Myeloma / pathology. Plasma Cells / pathology
[MeSH-minor]
Adult. Aged. Antigens, CD / analysis. DNA, Viral / genetics. DNA-Binding Proteins / analysis. Epstein-Barr Virus Infections / immunology. Epstein-Barr Virus Infections / pathology. Epstein-Barr Virus Infections / virology. Female. Herpesvirus 4, Human / genetics. Herpesvirus 8, Human / genetics. Humans. Immunohistochemistry. In Situ Hybridization. Ki-67 Antigen / analysis.
Lymphoma
,
AIDS
-
Related
/ immunology.
Lymphoma
,
AIDS
-
Related
/ pathology.
Lymphoma
,
AIDS
-
Related
/ virology. Male. Middle Aged. Polymerase Chain Reaction. Proto-Oncogene Proteins / analysis. Proto-Oncogene Proteins c-bcl-2 / analysis. Proto-Oncogene Proteins c-bcl-6. Transcription Factors / analysis. Tumor Suppressor Protein p53 / analysis
MedlinePlus Health Information.
consumer health - Lymphoma
.
MedlinePlus Health Information.
consumer health - Multiple Myeloma
.
COS Scholar Universe.
author profiles
.
HIV InSite.
treatment guidelines - Cardiac Cardiac Manifestations of HIV
.
NCI CPTAC Assay Portal.
NCI CPTAC Assay Portal
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[ErratumIn]
Mod Pathol. 2005 Jun;18(6):873. Medeiros, Leonard J [corrected to Medeiros, L Jeffrey]
(PMID = 15578069.001).
[ISSN]
0893-3952
[Journal-full-title]
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
[ISO-abbreviation]
Mod. Pathol.
[Language]
eng
[Publication-type]
Comparative Study; Journal Article
[Publication-country]
United States
[Chemical-registry-number]
0 / Antigens, CD; 0 / DNA, Viral; 0 / DNA-Binding Proteins; 0 / Ki-67 Antigen; 0 / Proto-Oncogene Proteins; 0 / Proto-Oncogene Proteins c-bcl-2; 0 / Proto-Oncogene Proteins c-bcl-6; 0 / Transcription Factors; 0 / Tumor Suppressor Protein p53
12.
Fulco PP, Hynicka L, Rackley D:
Raltegravir-based HAART regimen in a patient with large B-cell lymphoma.
Ann Pharmacother
; 2010 Feb;44(2):377-82
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Raltegravir-based HAART regimen in a patient with
large B
-
cell lymphoma
.
OBJECTIVE: To describe the antiretroviral management of a patient diagnosed simultaneously with HIV/
AIDS
and
diffuse large
B-
cell lymphoma
, focusing on the drug-drug interactions between highly active antiretroviral therapy (HAART) and concomitant cancer chemotherapy.
CASE SUMMARY: A 55-year-old white man was recently diagnosed with HIV/
AIDS
and presented 1 month later with complaints of nausea, vomiting, abdominal pain, double vision, right eye discomfort/swelling, and a 3.6-kg weight loss.
An excisional biopsy of a right inguinal lymph node confirmed a new diagnosis of
diffuse large
B-
cell lymphoma
.
DISCUSSION: HAART improves the chemotherapeutic response in patients with HIV and
lymphoma
.
[MeSH-minor]
Antiretroviral Therapy, Highly Active / methods. Cyclophosphamide / therapeutic use. Doxorubicin / therapeutic use. Drug Interactions. HIV Integrase Inhibitors / therapeutic use. Humans.
Lymphoma
,
AIDS
-
Related
/ drug therapy.
Lymphoma
,
Large B
-
Cell
,
Diffuse
/ drug therapy.
Lymphoma
,
Large B
-
Cell
,
Diffuse
/ etiology. Male. Methotrexate / administration & dosage. Middle Aged. Prednisone / therapeutic use. Raltegravir Potassium. Vincristine / therapeutic use
MedlinePlus Health Information.
consumer health - HIV/AIDS
.
HIV InSite.
treatment guidelines - Ophthalmic Manifestations of HIV
.
HIV InSite.
treatment guidelines - Human Herpesvirus-8
.
Hazardous Substances Data Bank.
DOXORUBICIN
.
Hazardous Substances Data Bank.
CYCLOPHOSPHAMIDE
.
Hazardous Substances Data Bank.
Raltegravir
.
Hazardous Substances Data Bank.
PREDNISONE
.
Hazardous Substances Data Bank.
VINCRISTINE
.
Hazardous Substances Data Bank.
METHOTREXATE
.
NCI CPTC Antibody Characterization Program.
NCI CPTC Antibody Characterization Program
.
The Lens.
Cited by Patents in
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 20040700.001).
[ISSN]
1542-6270
[Journal-full-title]
The Annals of pharmacotherapy
[ISO-abbreviation]
Ann Pharmacother
[Language]
eng
[Publication-type]
Case Reports; Journal Article
[Publication-country]
United States
[Chemical-registry-number]
0 / HIV Integrase Inhibitors; 0 / Pyrrolidinones; 43Y000U234 / Raltegravir Potassium; 5J49Q6B70F / Vincristine; 80168379AG / Doxorubicin; 8N3DW7272P / Cyclophosphamide; VB0R961HZT / Prednisone; YL5FZ2Y5U1 / Methotrexate; CHOP protocol
13.
Miralles Alonso F, Ortega González LM, Oropesa González L, Francisco RD, de Paz VC:
[Behaviour of HIV/AIDS-related lymphoma in Pedro Kouri Institute. 2004-2005].
Rev Cubana Med Trop
; 2006 Sep-Dec;58(3):248-53
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
[Behaviour of HIV/
AIDS
-
related lymphoma
in Pedro Kouri Institute. 2004-2005].
A prospective and descriptive study of 20 patients infected with HIV and admitted to "Pedro Kouri" Institute of Tropical Disease after a diagnosis of
lymphoma
was conducted.
Of this number, 85% presented with CD4+ count under 350
cell
/mm3 at the time of diagnosis; however, only 55% showed viral loads exceeding 50,000 copies/mL.
The predominant histological subtype was
large diffuse
cells and the most frequent location was the extrapulmonary site in 70% of cases.
It called our attention that high levels of lactic acid dehydrogenase and extrapulmonary location of tumors were
related
.
Statistically significant association was found (p < 0.05) between immunosuppresion condition of the patients given by CD4+ count below 350
cell
/mm3 and advanced staging of the tumoral disease (stages III and IV).
[MeSH-major]
Lymphoma
,
AIDS
-
Related
/ epidemiology
Genetic Alliance.
consumer health - AIDS-HIV
.
Genetic Alliance.
consumer health - HIV
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 23424794.001).
[ISSN]
0375-0760
[Journal-full-title]
Revista cubana de medicina tropical
[ISO-abbreviation]
Rev Cubana Med Trop
[Language]
spa
[Publication-type]
English Abstract; Journal Article
[Publication-country]
Cuba
[Chemical-registry-number]
0 / Biomarkers, Tumor; EC 1.1.1.27 / L-Lactate Dehydrogenase
14.
Kaaya EE, Castaños-Velez E, Ekman M, Mwakigonja A, Carneiro P, Lema L, Kitinya J, Linde A, Biberfeld P:
AIDS and non AIDS-related malignant lymphoma in Tanzania.
Afr Health Sci
; 2006 Jun;6(2):69-75
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
AIDS
and non
AIDS
-
related
malignant
lymphoma
in Tanzania.
BACKGROUND: Malignant
lymphoma
(ML) in HIV patients, are second in frequency to Kaposi's sarcoma (AKS) as
AIDS
-defining tumors.
In Africa the frequency of
AIDS
-
related lymphoma
(ARL) is rare and the findings are controversial.
Both retrospective and prospective
lymphoma
cases were classified according to the revised European-American (REAL) classification.
OBJECTIVES: To determine the frequency and type of
AIDS
and non-
AIDS related
malignant
lymphoma
in Tanzania and a possible co-association with KSHV/HHV-8 and EBV.
The tumors were classified as Burkitt's (6),
diffuse large cell
(10), precursor-B lymphoblastic (1) and Hodgkin's disease (5) from HIV positive and negative patients.
Ten (40%) high grade ML and three Hodgkin's
lymphoma
from HIV patients had HHV-8 DNA.
These findings were not
related
to age, sex or type of
lymphoma
.
There was no association of HHV-8 with the
lymphoma
cells.
CONCLUSIONS: This study suggests an overall increased frequency of ML patients infected with HHV-8 in Tanzania particularly in HIV patients which may result from the well established high HHV-8 prevalence in the general population, but HHV-8 was not associated with ARL pathogenesis as reflected by lack of tumor
cell
infection.
[MeSH-major]
Lymphoma
/ epidemiology.
Lymphoma
/ pathology.
Lymphoma
,
AIDS
-
Related
/ epidemiology
[MeSH-minor]
Adolescent. Adult. Aged. Biopsy, Needle. Burkitt
Lymphoma
/ epidemiology. Burkitt
Lymphoma
/ pathology. Child. Child, Preschool. Developing Countries. Female. Herpesvirus 4, Human / isolation & purification. Herpesvirus 8, Human / isolation & purification. Hodgkin Disease / epidemiology. Hodgkin Disease / pathology. Humans. Immunohistochemistry. In Situ Hybridization. Incidence.
Lymphoma
, Non-Hodgkin / epidemiology.
Lymphoma
, Non-Hodgkin / pathology. Male. Middle Aged. Polymerase Chain Reaction. Registries. Retrospective Studies. Risk Assessment. Sarcoma, Kaposi / epidemiology. Sarcoma, Kaposi / pathology. Sarcoma, Kaposi / virology. Survival Analysis. Tanzania / epidemiology. Young Adult
Genetic Alliance.
consumer health - AIDS-HIV
.
MedlinePlus Health Information.
consumer health - Lymphoma
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Cites]
J Natl Cancer Inst Monogr. 1998;(23):79-88
[
9709308.001
]
[Cites]
Br J Cancer. 1997;75(11):1704-7
[
9184191.001
]
[Cites]
CA Cancer J Clin. 2005 Jul-Aug;55(4):229-41; 260-1, 264
[
16020424.001
]
[Cites]
Curr HIV/AIDS Rep. 2004 Apr;1(1):5-11
[
16091217.001
]
[Cites]
Br J Haematol. 2005 Sep;130(5):662-70
[
16115121.001
]
[Cites]
Scand J Infect Dis. 1994;26(6):749-52
[
7747100.001
]
[Cites]
Int J Cancer. 1995 May 16;61(4):574-9
[
7759163.001
]
[Cites]
Blood. 1995 Aug 15;86(4):1276-80
[
7632932.001
]
[Cites]
Blood. 1995 Oct 1;86(7):2708-14
[
7670109.001
]
[Cites]
Lancet. 1995 Sep 23;346(8978):799-802
[
7674745.001
]
[Cites]
J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Nov 1;10(3):295-305
[
7552491.001
]
[Cites]
AIDS. 2002 Mar 8;16(4):597-603
[
11873003.001
]
[Cites]
J Med Virol. 2002 Oct;68(2):264-7
[
12210417.001
]
[Cites]
Lancet Oncol. 2003 Feb;4(2):110-9
[
12573353.001
]
[Cites]
Rev Clin Exp Hematol. 2003 Dec;7(4):375-405
[
15129649.001
]
[Cites]
MMWR Morb Mortal Wkly Rep. 1985 Jun 28;34(25):373-5
[
2989677.001
]
[Cites]
N Engl J Med. 1985 Dec 19;313(25):1564-71
[
2999595.001
]
[Cites]
Lancet. 1991 Apr 6;337(8745):805-9
[
1672911.001
]
[Cites]
J Histochem Cytochem. 1991 Jun;39(6):741-8
[
1709656.001
]
[Cites]
Blood. 1994 Sep 1;84(5):1361-92
[
8068936.001
]
[Cites]
Science. 1994 Dec 16;266(5192):1865-9
[
7997879.001
]
[Cites]
N Engl J Med. 1995 May 4;332(18):1186-91
[
7700311.001
]
[Cites]
Science. 1995 Apr 28;268(5210):582-3
[
7725108.001
]
[Cites]
Nat Med. 1995 Jul;1(7):707-8
[
7585156.001
]
[Cites]
Nat Med. 1995 Dec;1(12):1274-8
[
7489408.001
]
[Cites]
J Virol. 1996 Jan;70(1):549-58
[
8523568.001
]
[Cites]
N Engl J Med. 1996 Jan 25;334(4):272-3
[
8532016.001
]
[Cites]
Arch Intern Med. 1996 Jan 22;156(2):202-4
[
8546554.001
]
[Cites]
Br J Haematol. 1995 Dec;91(4):918-20
[
8547139.001
]
[Cites]
Am J Clin Pathol. 1996 Feb;105(2):221-9
[
8607449.001
]
[Cites]
Blood. 1996 May 1;87(9):3903-9
[
8611719.001
]
[Cites]
Nat Med. 1996 Aug;2(8):918-24
[
8705863.001
]
[Cites]
Nat Med. 1996 Aug;2(8):925-8
[
8705864.001
]
[Cites]
J Mol Med (Berl). 1995 Dec;73(12):603-9
[
8825757.001
]
[Cites]
AIDS. 1996 Aug;10(9):951-8
[
8853727.001
]
[Cites]
J Virol. 1997 Mar;71(3):2505-11
[
9032391.001
]
[Cites]
J Mol Diagn. 2005 Feb;7(1):17-27
[
15681470.001
]
(PMID = 16916294.001).
[ISSN]
1729-0503
[Journal-full-title]
African health sciences
[ISO-abbreviation]
Afr Health Sci
[Language]
eng
[Publication-type]
Journal Article; Research Support, Non-U.S. Gov't
[Publication-country]
Uganda
[Other-IDs]
NLM/ PMC1831982
15.
Noy A:
Update in HIV lymphoma.
Curr Opin Oncol
; 2006 Sep;18(5):449-55
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Update in HIV
lymphoma
.
Lymphoma
is the most common HIV-associated malignancy in these countries.
RECENT FINDINGS: Investigators continue to demonstrate that HIV-associated non-Hodgkin's
lymphoma
remains a significant problem, even in the era of highly active antiretroviral therapy.
The majority of work has been in
diffuse large
B-
cell lymphoma
, with infusional therapy remaining promising, and rituximab an area of investigation.
Biological insights have been gained into the spectrum of HIV-associated non-Hodgkin's
lymphoma
and Hodgkin's disease, and include further work on virological co-infections.
SUMMARY: The outcome for individuals infected with HIV and developing non-Hodgkin's
lymphoma
and Hodgkin's disease continues to improve as insights into the pathophysiology and treatment advance.
[MeSH-major]
Anti-Retroviral Agents / therapeutic use. Antineoplastic Combined Chemotherapy Protocols / therapeutic use.
Lymphoma
,
AIDS
-
Related
/ drug therapy
Genetic Alliance.
consumer health - HIV
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 16894292.001).
[ISSN]
1040-8746
[Journal-full-title]
Current opinion in oncology
[ISO-abbreviation]
Curr Opin Oncol
[Language]
eng
[Publication-type]
Journal Article; Review
[Publication-country]
United States
[Chemical-registry-number]
0 / Anti-Retroviral Agents
[Number-of-references]
45
16.
Costa H, Franco M, Hahn MD:
Primary lymphoma of the central nervous system: a clinical-pathological and immunohistochemical study of ten autopsy cases.
Arq Neuropsiquiatr
; 2006 Dec;64(4):976-82
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Primary
lymphoma
of the central nervous system: a clinical-pathological and immunohistochemical study of ten autopsy cases.
METHOD: The clinical, histological and immunohistochemical data of ten cases of PCNSL, eight cases from patients with
AIDS
, identified among 265 autopsies of these patients were analyzed.
Most patients had
diffuse large B cell
non-Hodgkins
lymphoma
.
CONCLUSION: In the present series, PCNSL presented with focal symptoms, with unifocal or multifocal lesions, with a predominant B-
cell
CD20 positive phenotype, rarely associated with EBV.
[MeSH-major]
Central Nervous System Neoplasms / pathology.
Lymphoma
/ pathology
[MeSH-minor]
Adult. Autopsy. Epstein-Barr Virus Infections / pathology. Epstein-Barr Virus Infections / virology. Female. Humans. Immunohistochemistry.
Lymphoma
,
AIDS
-
Related
/ pathology.
Lymphoma
,
AIDS
-
Related
/ virology. Male. Middle Aged
Genetic Alliance.
consumer health - Central Nervous System Lymphoma, Primary
.
Genetic Alliance.
consumer health - TEN
.
MedlinePlus Health Information.
consumer health - Lymphoma
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 17221007.001).
[ISSN]
0004-282X
[Journal-full-title]
Arquivos de neuro-psiquiatria
[ISO-abbreviation]
Arq Neuropsiquiatr
[Language]
eng
[Publication-type]
Journal Article; Research Support, Non-U.S. Gov't
[Publication-country]
Brazil
17.
Sawka CA, Shepherd FA, Franssen E, Brandwein J, Dotten DA, Routy JP, Walker IR, St-Louis J, Taylor M, Arts K, Crump M, Foote M:
A prospective, non-randomised phase 1-2 trial of VACOP-B with filgrastim support for HIV-related non-Hodgkin's lymphoma.
Biotechnol Annu Rev
; 2005;11:381-9
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
A prospective, non-randomised phase 1-2 trial of VACOP-B with filgrastim support for HIV-
related
non-Hodgkin's
lymphoma
.
Non-Hodgkin's
lymphoma
(NHL) remains an important complication of associated HIV infection despite advances in antiretroviral therapy (ART), and the optimum chemotherapy regimen for this disease remains to be defined.
Patients with aggressive histology HIV-
related
NHL who were previously untreated with chemotherapy, and who had no active opportunistic infection were eligible for the study.
Forty-seven patients were enrolled, most with
diffuse large
-
cell
or immunoblastic NHL.
[MeSH-major]
Antineoplastic Combined Chemotherapy Protocols / therapeutic use.
Lymphoma
,
AIDS
-
Related
/ drug therapy.
Lymphoma
, Non-Hodgkin / drug therapy
Genetic Alliance.
consumer health - HIV
.
COS Scholar Universe.
author profiles
.
Hazardous Substances Data Bank.
BLEOMYCIN
.
Hazardous Substances Data Bank.
Filgrastim
.
Hazardous Substances Data Bank.
DOXORUBICIN
.
Hazardous Substances Data Bank.
ETOPOSIDE
.
Hazardous Substances Data Bank.
CYCLOPHOSPHAMIDE
.
Hazardous Substances Data Bank.
PREDNISONE
.
Hazardous Substances Data Bank.
VINCRISTINE
.
The Lens.
Cited by Patents in
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 16216784.001).
[ISSN]
1387-2656
[Journal-full-title]
Biotechnology annual review
[ISO-abbreviation]
Biotechnol Annu Rev
[Language]
eng
[Publication-type]
Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study
[Publication-country]
Netherlands
[Chemical-registry-number]
0 / Recombinant Proteins; 11056-06-7 / Bleomycin; 143011-72-7 / Granulocyte Colony-Stimulating Factor; 5J49Q6B70F / Vincristine; 6PLQ3CP4P3 / Etoposide; 80168379AG / Doxorubicin; 8N3DW7272P / Cyclophosphamide; PVI5M0M1GW / Filgrastim; VB0R961HZT / Prednisone; VACOP-B protocol
18.
Ribera JM, Oriol A, Morgades M, González-Barca E, Miralles P, López-Guillermo A, Gardella S, López A, Abella E, García M, PETHEMA, GELTAMO, GELCAB and GESIDA Groups:
Safety and efficacy of cyclophosphamide, adriamycin, vincristine, prednisone and rituximab in patients with human immunodeficiency virus-associated diffuse large B-cell lymphoma: results of a phase II trial.
Br J Haematol
; 2008 Feb;140(4):411-9
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Safety and efficacy of cyclophosphamide, adriamycin, vincristine, prednisone and rituximab in patients with human immunodeficiency virus-associated
diffuse large
B-
cell lymphoma
: results of a phase II trial.
Immunochemotherapy with cyclophosphamide, adriamycin, vincristine, prednisone and rituximab (R-CHOP) is the standard treatment in non-immunosuppressed patients with
diffuse large
B-
cell lymphoma
(DLBCL), but its adequacy has not been definitively established in patients with human immunodeficiency virus (HIV)-
related lymphoma
.
This phase II trial aimed to evaluate the safety and efficacy of six cycles of R-CHOP in patients with HIV-
related
DLBCL and to determine whether response to highly active antiretroviral therapy (HAART) had prognostic impact.
In HIV-
related
DLBCL R-CHOP is feasible, safe and effective.
The prognosis depends on
lymphoma
-
related
parameters and on the response to HAART.
[MeSH-major]
Antineoplastic Combined Chemotherapy Protocols / adverse effects.
Lymphoma
,
AIDS
-
Related
/ drug therapy.
Lymphoma
,
Large B
-
Cell
,
Diffuse
/ drug therapy
Genetic Alliance.
consumer health - Large B cell diffuse lymphoma
.
Hazardous Substances Data Bank.
RITUXIMAB
.
Hazardous Substances Data Bank.
DOXORUBICIN
.
Hazardous Substances Data Bank.
CYCLOPHOSPHAMIDE
.
Hazardous Substances Data Bank.
PREDNISONE
.
Hazardous Substances Data Bank.
VINCRISTINE
.
NCI CPTC Antibody Characterization Program.
NCI CPTC Antibody Characterization Program
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 18162120.001).
[ISSN]
1365-2141
[Journal-full-title]
British journal of haematology
[ISO-abbreviation]
Br. J. Haematol.
[Language]
eng
[Publication-type]
Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
[Publication-country]
England
[Chemical-registry-number]
0 / Antibodies, Monoclonal; 0 / Antibodies, Monoclonal, Murine-Derived; 4F4X42SYQ6 / Rituximab; 5J49Q6B70F / Vincristine; 80168379AG / Doxorubicin; 8N3DW7272P / Cyclophosphamide; VB0R961HZT / Prednisone; CHOP protocol
19.
Panos G, Karveli EA, Nikolatou O, Falagas ME:
Prolonged survival of an HIV-infected patient with plasmablastic lymphoma of the oral cavity.
Am J Hematol
; 2007 Aug;82(8):761-5
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Prolonged survival of an HIV-infected patient with plasmablastic
lymphoma
of the oral cavity.
Plasmablastic
lymphoma
is an aggressive subtype of
diffuse large
B-
cell lymphoma
that is mainly observed in patients with the human immunodeficiency virus (HIV) infection, and it tends to arise in the oral cavity.
We present a case of an HIV-infected patient with plasmablastic
lymphoma
with prolonged survival.
Histological and immunochemical examination of biopsy of the oral lesion showed plasmablastic
lymphoma
(CD138+).
The patient remains in complete remission 61 months after the diagnosis of plasmablastic
lymphoma
.
[MeSH-major]
Acquired Immunodeficiency Syndrome / complications. Acquired Immunodeficiency Syndrome / pathology.
Lymphoma
,
AIDS
-
Related
/ etiology.
Lymphoma
,
AIDS
-
Related
/ pathology. Mouth / pathology
Genetic Alliance.
consumer health - HIV
.
MedlinePlus Health Information.
consumer health - HIV/AIDS
.
COS Scholar Universe.
author profiles
.
HIV InSite.
treatment guidelines - Women and HIV
.
HIV InSite.
treatment guidelines - Human Herpesvirus-8
.
NCI CPTC Antibody Characterization Program.
NCI CPTC Antibody Characterization Program
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 17094093.001).
[ISSN]
0361-8609
[Journal-full-title]
American journal of hematology
[ISO-abbreviation]
Am. J. Hematol.
[Language]
eng
[Publication-type]
Case Reports; Journal Article
[Publication-country]
United States
20.
Castillo JJ, Winer ES, Stachurski D, Perez K, Jabbour M, Milani C, Colvin G, Butera JN:
Prognostic factors in chemotherapy-treated patients with HIV-associated Plasmablastic lymphoma.
Oncologist
; 2010;15(3):293-9
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Prognostic factors in chemotherapy-treated patients with HIV-associated Plasmablastic
lymphoma
.
BACKGROUND: Plasmablastic
lymphoma
(PBL) is a variant of
diffuse large
B-
cell lymphoma
commonly seen in the oral cavity of HIV-infected individuals.
[MeSH-major]
Antineoplastic Combined Chemotherapy Protocols / therapeutic use. HIV Infections / complications.
Lymphoma
,
AIDS
-
Related
/ drug therapy.
Lymphoma
,
Large
-
Cell
, Immunoblastic / drug therapy.
Lymphoma
,
Large
-
Cell
, Immunoblastic / virology
Genetic Alliance.
consumer health - HIV
.
MedlinePlus Health Information.
consumer health - HIV/AIDS
.
MedlinePlus Health Information.
consumer health - HIV/AIDS in Women
.
Hazardous Substances Data Bank.
DOXORUBICIN
.
Hazardous Substances Data Bank.
CYCLOPHOSPHAMIDE
.
Hazardous Substances Data Bank.
PREDNISONE
.
Hazardous Substances Data Bank.
VINCRISTINE
.
NCI CPTC Antibody Characterization Program.
NCI CPTC Antibody Characterization Program
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Cites]
Clin Oncol (R Coll Radiol). 2000;12(3):194
[
10942339.001
]
[Cites]
J Hematol Oncol. 2009;2:47
[
19909553.001
]
[Cites]
Leuk Lymphoma. 2002 Feb;43(2):423-6
[
11999580.001
]
[Cites]
Br J Haematol. 2002 Dec;119(3):622-8
[
12437635.001
]
[Cites]
AIDS. 2003 Jul 4;17(10):1582-4
[
12824797.001
]
[Cites]
Am J Surg Pathol. 2003 Nov;27(11):1473-6
[
14576483.001
]
[Cites]
Leuk Lymphoma. 2004 Sep;45(9):1881-5
[
15223650.001
]
[Cites]
Blood. 1997 Feb 15;89(4):1413-20
[
9028965.001
]
[Cites]
Ann Intern Med. 2005 Aug 16;143(4):265-73
[
16103470.001
]
[Cites]
Blood. 2005 Sep 1;106(5):1538-43
[
15914552.001
]
[Cites]
Br J Dermatol. 2005 Oct;153(4):828-32
[
16181470.001
]
[Cites]
Blood. 2006 May 15;107(10):3832-40
[
16410446.001
]
[Cites]
J Clin Oncol. 2006 Sep 1;24(25):4123-8
[
16896005.001
]
[Cites]
J Acquir Immune Defic Syndr. 2007 Feb 1;44(2):167-73
[
17117144.001
]
[Cites]
Haematologica. 2007 Jan;92(1):e11-2
[
17405744.001
]
[Cites]
J Oral Maxillofac Surg. 2007 Jul;65(7):1361-4
[
17577503.001
]
[Cites]
Am J Hematol. 2007 Aug;82(8):761-5
[
17094093.001
]
[Cites]
Am J Hematol. 2008 Oct;83(10):804-9
[
18756521.001
]
[Cites]
Oral Dis. 2009 Jan;15(1):38-45
[
18939960.001
]
[Cites]
Intern Med. 2009;48(7):559-62
[
19336959.001
]
[Cites]
Eur J Haematol. 2009 Jun;82(6):490-2
[
19220417.001
]
[Cites]
Blood. 2009 Jun 11;113(24):6069-76
[
19380866.001
]
[Cites]
AIDS. 2009 Sep 24;23(15):2029-37
[
19531926.001
]
[Cites]
Am J Clin Pathol. 2009 Oct;132(4):597-605
[
19762538.001
]
[Cites]
Blood. 2009 Oct 22;114(17):3533-7
[
19704118.001
]
[Cites]
Oral Oncol. 2002 Jan;38(1):96-102
[
11755827.001
]
(PMID = 20167839.001).
[ISSN]
1549-490X
[Journal-full-title]
The oncologist
[ISO-abbreviation]
Oncologist
[Language]
eng
[Publication-type]
Journal Article
[Publication-country]
United States
[Chemical-registry-number]
5J49Q6B70F / Vincristine; 80168379AG / Doxorubicin; 8N3DW7272P / Cyclophosphamide; VB0R961HZT / Prednisone; CHOP protocol
[Other-IDs]
NLM/ PMC3227958
21.
Miralles P, Berenguer J, Ribera JM, Rubio R, Mahillo B, Téllez MJ, Lacruz J, Valencia E, Santos J, Rodríguez-Arrondo F, Pintado V, Grupo de Estudio del SIDA Register of Systemic AIDS-Related Lymphomas:
Prognosis of AIDS-related systemic non-Hodgkin lymphoma treated with chemotherapy and highly active antiretroviral therapy depends exclusively on tumor-related factors.
J Acquir Immune Defic Syndr
; 2007 Feb 1;44(2):167-73
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Prognosis of
AIDS
-
related
systemic non-Hodgkin
lymphoma
treated with chemotherapy and highly active antiretroviral therapy depends exclusively on tumor-
related
factors.
OBJECTIVES: To assess complete remission (CR) and survival in patients with systemic
AIDS
-
related
non-Hodgkin
lymphoma
(ARL) receiving highly active antiretroviral therapy (HAART).
Histologic subtypes were
diffuse large
B-
cell lymphoma
(DLCL; n = 153 [72.9%]), Burkitt and atypical Burkitt/Burkitt-like
lymphoma
(BL; n = 40 [19.0%]), T-
cell lymphoma
(TC; n = 8 [3.8%]), and miscellaneous (n = 9 [4.3%]).
CONCLUSIONS: In patients with ARL treated with HAART, CR was associated exclusively with tumor-
related
factors.
[MeSH-major]
Anti-HIV Agents / therapeutic use. Antineoplastic Combined Chemotherapy Protocols. Antiretroviral Therapy, Highly Active.
Lymphoma
,
AIDS
-
Related
/ drug therapy.
Lymphoma
,
AIDS
-
Related
/ pathology
[MeSH-minor]
Adult. Burkitt
Lymphoma
/ drug therapy. Burkitt
Lymphoma
/ pathology. Combined Modality Therapy. Disease-Free Survival. Female. Humans. Longitudinal Studies.
Lymphoma
, B-
Cell
/ drug therapy.
Lymphoma
, B-
Cell
/ pathology.
Lymphoma
, T-
Cell
/ drug therapy.
Lymphoma
, T-
Cell
/ pathology. Male. Middle Aged. Prognosis. Remission Induction. Statistics as Topic. Survival Analysis
Genetic Alliance.
consumer health - AIDS-HIV
.
Genetic Alliance.
consumer health - Hodgkin lymphoma
.
Genetic Alliance.
consumer health - Non-Hodgkin Lymphoma
.
MedlinePlus Health Information.
consumer health - HIV/AIDS Medicines
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 17117144.001).
[ISSN]
1525-4135
[Journal-full-title]
Journal of acquired immune deficiency syndromes (1999)
[ISO-abbreviation]
J. Acquir. Immune Defic. Syndr.
[Language]
eng
[Publication-type]
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
[Publication-country]
United States
[Chemical-registry-number]
0 / Anti-HIV Agents
22.
Chahin N, Temesgen Z, Kurtin PJ, Spinner RJ, Dyck PJ:
HIV lumbosacral radiculoplexus neuropathy mimicking lymphoma: diffuse infiltrative lymphocytosis syndrome (DILS) restricted to nerve?
Muscle Nerve
; 2010 Feb;41(2):276-82
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
HIV lumbosacral radiculoplexus neuropathy mimicking
lymphoma
:
diffuse
infiltrative lymphocytosis syndrome (DILS) restricted to nerve?
Diffuse
infiltrative lymphocytosis syndrome (DILS) is a hyperimmune reaction against HIV.
It leads to MHC-restricted clonal expansion of CD8 T cells characterized by circulating CD8 hyperlymphocytosis and CD8 T-
cell
infiltration in organs.
Nerve biopsy showed
large
collections of CD8 lymphocytes suspicious for
lymphoma
.
[MeSH-major]
AIDS
-Associated Nephropathy / diagnosis. Lymphocytosis / diagnosis.
Lymphoma
,
AIDS
-
Related
/ diagnosis. Radiculopathy / diagnosis
Genetic Alliance.
consumer health - HIV
.
COS Scholar Universe.
author profiles
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Cites]
Muscle Nerve. 2002 Apr;25(4):477-91
[
11932965.001
]
[Cites]
J Neuropathol Exp Neurol. 2008 Aug;67(8):819-27
[
18648321.001
]
[Cites]
Mayo Clin Proc. 1975 Nov;50(11):621-37
[
1186294.001
]
[Cites]
Ann Neurol. 1980 Dec;8(6):590-6
[
7212646.001
]
[Cites]
Ann Neurol. 1987 Jan;21(1):32-40
[
3030188.001
]
[Cites]
Cancer. 1988 Jun 1;61(11):2318-24
[
3365659.001
]
[Cites]
Lancet. 1989 Aug 26;2(8661):466-8
[
2570184.001
]
[Cites]
Ann Intern Med. 1990 Jan 1;112(1):3-10
[
2136714.001
]
[Cites]
Rheum Dis Clin North Am. 1992 Aug;18(3):683-97
[
1496168.001
]
[Cites]
J Clin Invest. 1993 Jul;92(1):495-502
[
8392093.001
]
[Cites]
Ann Neurol. 1994 Jan;35(1):53-8
[
8285593.001
]
[Cites]
AIDS. 1996 Apr;10(4):385-91
[
8728042.001
]
[Cites]
Ann Neurol. 1997 Apr;41(4):438-45
[
9124800.001
]
[Cites]
Neurology. 1998 Apr;50(4):855-7
[
9566362.001
]
[Cites]
Neurology. 1998 Apr;50(4):1041-4
[
9566392.001
]
[Cites]
Mayo Clin Proc. 2006 Feb;81(2):213-9
[
16471077.001
]
[Cites]
Neuromuscul Disord. 2004 Nov;14(11):740-3
[
15482959.001
]
(PMID = 19882634.001).
[ISSN]
1097-4598
[Journal-full-title]
Muscle & nerve
[ISO-abbreviation]
Muscle Nerve
[Language]
eng
[Grant]
United States / NINDS NIH HHS / NS / R01 NS036797; United States / NINDS NIH HHS / NS / R01 NS036797-12
[Publication-type]
Case Reports; Journal Article
[Publication-country]
United States
[Other-IDs]
NLM/ NIHMS235321; NLM/ PMC2965045
23.
Nyagol J, De Falco G, Lazzi S, Luzzi A, Cerino G, Shaheen S, Palummo N, Bellan C, Spina D, Leoncini L:
HIV-1 Tat mimetic of VEGF correlates with increased microvessels density in AIDS-related diffuse large B-cell and Burkitt lymphomas.
J Hematop
; 2008 Jul;1(1):3-10
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
HIV-1 Tat mimetic of VEGF correlates with increased microvessels density in
AIDS
-
related diffuse large B
-
cell
and Burkitt lymphomas.
We evaluated the role of HIV-1 Tat in regulating the level of VEGF expression and microvessel density in the
AIDS
-
related diffuse large B
-
cell
(DLBCL) and Burkitt lymphomas (BL).
Reduced VEGF protein expression in primary HIV-1 positive BL and DLBCL, compared to the negative cases, supported the findings of promoter downregulation from the
cell
lines.
Thus, targeting Tat protein itself and stabilizing transient silencing of VEGF expression or use of monoclonal antibodies against their receptors in the
AIDS
-associated tumors will open a window for future explorable pathways in the management of angiogenic phenotypes in the
AIDS
-associated non-Hodgkin's lymphomas.
COS Scholar Universe.
author profiles
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Cites]
Nat Med. 1996 Dec;2(12):1371-5
[
8946838.001
]
[Cites]
Oncogene. 2000 Jan 20;19(3):373-9
[
10656684.001
]
[Cites]
Oncogene. 1996 Jan 18;12(2):289-97
[
8570206.001
]
[Cites]
Nature. 1995 Jul 6;376(6535):66-70
[
7596436.001
]
[Cites]
Leuk Lymphoma. 2007 Oct;48(10):2014-21
[
17917969.001
]
[Cites]
Br J Cancer. 2007 Jul 16;97(2):223-30
[
17595666.001
]
[Cites]
Exp Cell Res. 2007 May 1;313(8):1561-74
[
17382929.001
]
[Cites]
Am J Pathol. 2007 Apr;170(4):1362-9
[
17392174.001
]
[Cites]
Proc Natl Acad Sci U S A. 2007 Mar 13;104(11):4647-52
[
17360578.001
]
[Cites]
Biochem Biophys Res Commun. 2007 Apr 13;355(3):693-9
[
17320821.001
]
[Cites]
Nat Struct Mol Biol. 2007 Mar;14(3):249-50
[
17293873.001
]
[Cites]
J Cell Biochem. 2007 Feb 15;100(3):727-37
[
17115409.001
]
[Cites]
Curr Med Chem. 2006;13(16):1845-57
[
16842197.001
]
[Cites]
FEBS J. 2005 Nov;272(22):5723-41
[
16279938.001
]
[Cites]
Folia Histochem Cytobiol. 2004;42(4):241-3
[
15704651.001
]
[Cites]
Biochem Pharmacol. 2004 Dec 15;68(12):2359-66
[
15548382.001
]
[Cites]
Circulation. 1997 Dec 2;96(11):4083-94
[
9403634.001
]
[Cites]
J Biol Chem. 1998 Nov 20;273(47):31119-24
[
9813014.001
]
[Cites]
Science. 1998 Dec 4;282(5395):1837-9
[
9874635.001
]
[Cites]
Proc Natl Acad Sci U S A. 1998 Mar 31;95(7):3851-6
[
9520456.001
]
[Cites]
J Clin Pathol. 1997 Jun;50(6):481-4
[
9378813.001
]
[Cites]
Int Arch Allergy Immunol. 1995 May-Jun;107(1-3):233-5
[
7542074.001
]
[Cites]
Cancer Res. 1995 Sep 15;55(18):3964-8
[
7664263.001
]
[Cites]
Nature. 1994 Oct 20;371(6499):674-80
[
7935812.001
]
[Cites]
Arch Orthop Trauma Surg. 2003 Nov;123(9):475-80
[
12750926.001
]
[Cites]
Angiogenesis. 2002;5(3):141-51
[
12831055.001
]
[Cites]
Cell Prolif. 2003 Jun;36(3):131-49
[
12814430.001
]
[Cites]
Nat Rev Cancer. 2003 Jun;3(6):401-10
[
12778130.001
]
[Cites]
Curr Drug Targets Infect Disord. 2003 Jun;3(2):115-28
[
12769789.001
]
[Cites]
J Rheumatol. 2003 Feb;30(2):260-8
[
12563678.001
]
[Cites]
J Clin Oncol. 2002 Nov 1;20(21):4368-80
[
12409337.001
]
[Cites]
Hum Pathol. 2002 Jul;33(7):723-31
[
12196924.001
]
[Cites]
Cancer Control. 2002 Mar-Apr;9(2 Suppl):36-44
[
11965229.001
]
[Cites]
Clin Microbiol Rev. 2002 Apr;15(2):310-26
[
11932235.001
]
[Cites]
Am J Clin Pathol. 2001 Dec;116(6):838-45
[
11764072.001
]
[Cites]
Biochem J. 2001 Feb 1;353(Pt 3):569-78
[
11171054.001
]
[Cites]
Cancer Res. 2001 Jan 15;61(2):462-8
[
11212232.001
]
[Cites]
Curr Opin Oncol. 2000 Sep;12(5):445-9
[
10975552.001
]
[Cites]
Biochem Biophys Res Commun. 2000 Jun 24;273(1):267-71
[
10873597.001
]
[Cites]
Oncologist. 2000;5 Suppl 1:3-10
[
10804084.001
]
[Cites]
Am J Pathol. 1996 Apr;148(4):1065-74
[
8644848.001
]
(PMID = 19669199.001).
[ISSN]
1868-9256
[Journal-full-title]
Journal of hematopathology
[ISO-abbreviation]
J Hematop
[Language]
eng
[Publication-type]
Journal Article
[Publication-country]
Germany
[Other-IDs]
NLM/ PMC2712328
24.
Jabr FI:
Recurrent lymphoma presenting as a penile ulcer in a patient with AIDS.
Dermatol Online J
; 2005;11(2):29
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Recurrent
lymphoma
presenting as a penile ulcer in a patient with
AIDS
.
Penile
lymphoma
is a rare neoplasm.
We report a 45-year-old man with history of
AIDS
and previous retroperitoneal
lymphoma
who presented with painless penile ulceration and multiple inguinal lymphadenopathy.
Fine needle biopsy showed
diffuse
,
large B
-
cell lymphoma
.
We review the literature and discuss this uncommon presentation of
lymphoma
.
[MeSH-major]
Lymphoma
,
AIDS
-
Related
/ pathology. Neoplasm Recurrence, Local / pathology. Penile Diseases / etiology. Penile Diseases / pathology. Penile Neoplasms / etiology. Penile Neoplasms / pathology. Ulcer / etiology. Ulcer / pathology
Genetic Alliance.
consumer health - AIDS-HIV
.
MedlinePlus Health Information.
consumer health - Penis Disorders
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 16150237.001).
[ISSN]
1087-2108
[Journal-full-title]
Dermatology online journal
[ISO-abbreviation]
Dermatol. Online J.
[Language]
eng
[Publication-type]
Case Reports; Journal Article; Review
[Publication-country]
United States
[Number-of-references]
13
25.
Corti M, Solari R, Cangelosi D, De Carolis L, Schtirbu R, Lewi D:
Oral cavity lymphoma as secondary AIDS-defining neoplasm in a patient on HAART with immune reconstitution.
Rev Soc Bras Med Trop
; 2007 Sep-Oct;40(5):582-4
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Oral cavity
lymphoma
as secondary
AIDS
-defining neoplasm in a patient on HAART with immune reconstitution.
Lymphomas of the oral cavity are a rare complication of advanced HIV/
AIDS
disease.
We report the case of a patient with
AIDS
who developed
diffuse large
B-
cell
non-Hodgkins
lymphoma
of the oral cavity during highly active antiretroviral therapy, with undetectable plasma viral load and immune reconstitution.
[MeSH-major]
Antineoplastic Combined Chemotherapy Protocols. Antiretroviral Therapy, Highly Active.
Lymphoma
,
AIDS
-
Related
/ diagnosis.
Lymphoma
,
Large B
-
Cell
,
Diffuse
/ diagnosis. Mouth Neoplasms / diagnosis
Genetic Alliance.
consumer health - AIDS-HIV
.
MedlinePlus Health Information.
consumer health - HIV/AIDS Medicines
.
MedlinePlus Health Information.
consumer health - Oral Cancer
.
HIV InSite.
treatment guidelines - Clinical Implications of Immune Reconstitution in AIDS
.
Hazardous Substances Data Bank.
DOXORUBICIN
.
Hazardous Substances Data Bank.
CYCLOPHOSPHAMIDE
.
Hazardous Substances Data Bank.
PREDNISONE
.
Hazardous Substances Data Bank.
VINCRISTINE
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 17992417.001).
[ISSN]
0037-8682
[Journal-full-title]
Revista da Sociedade Brasileira de Medicina Tropical
[ISO-abbreviation]
Rev. Soc. Bras. Med. Trop.
[Language]
eng
[Publication-type]
Case Reports; Journal Article
[Publication-country]
Brazil
[Chemical-registry-number]
5J49Q6B70F / Vincristine; 80168379AG / Doxorubicin; 8N3DW7272P / Cyclophosphamide; VB0R961HZT / Prednisone; CHOP protocol
26.
Lim ST, Karim R, Tulpule A, Nathwani BN, Levine AM:
Prognostic factors in HIV-related diffuse large-cell lymphoma: before versus after highly active antiretroviral therapy.
J Clin Oncol
; 2005 Nov 20;23(33):8477-82
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Prognostic factors in HIV-
related diffuse large
-
cell lymphoma
: before versus after highly active antiretroviral therapy.
PURPOSE: To compare the prognostic factors for survival and the validity of the International Prognostic Index (IPI) in patients with HIV-
related diffuse large
-
cell lymphoma
(HIV-DLCL) treated with curative intent in the pre-highly active antiretroviral therapy (HAART) era versus the HAART era.
RESULTS: There were no statistically significant differences in terms of either
lymphoma
or HIV-
related
characteristics in the two time periods.
Clinical outcomes in patients with HIV-DLCL are now approaching the outcomes of patients with de novo
lymphoma
.
[MeSH-major]
Antiretroviral Therapy, Highly Active. Health Status Indicators.
Lymphoma
,
AIDS
-
Related
/ diagnosis.
Lymphoma
,
AIDS
-
Related
/ drug therapy.
Lymphoma
,
Large B
-
Cell
,
Diffuse
/ diagnosis.
Lymphoma
,
Large B
-
Cell
,
Diffuse
/ drug therapy
Genetic Alliance.
consumer health - Lymphoma, large-cell
.
Genetic Alliance.
consumer health - HIV
.
MedlinePlus Health Information.
consumer health - HIV/AIDS Medicines
.
COS Scholar Universe.
author profiles
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 16230675.001).
[ISSN]
0732-183X
[Journal-full-title]
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
[ISO-abbreviation]
J. Clin. Oncol.
[Language]
eng
[Publication-type]
Comparative Study; Journal Article
[Publication-country]
United States
27.
Capello D, Scandurra M, Poretti G, Rancoita PM, Mian M, Gloghini A, Deambrogi C, Martini M, Rossi D, Greiner TC, Chan WC, Ponzoni M, Moreno SM, Piris MA, Canzonieri V, Spina M, Tirelli U, Inghirami G, Rinaldi A, Zucca E, Favera RD, Cavalli F, Larocca LM, Kwee I, Carbone A, Gaidano G, Bertoni F:
Genome wide DNA-profiling of HIV-related B-cell lymphomas.
Br J Haematol
; 2010 Jan;148(2):245-55
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Genome wide DNA-profiling of HIV-
related B
-
cell
lymphomas.
To elucidate HIV-NHL pathogenesis, we performed a genome-wide DNA profiling based on a single nucleotide polymorphism-based microarray comparative genomic hybridization in 57 HIV-lymphomas and, for comparison, in 105 immunocompetent
diffuse large
B-
cell
lymphomas (IC-DLBCL).
HIV-Burkitt
lymphoma
showed a significantly lower number of lesions than HIV-DLBCL (P = 0.032), whereas the median number of copy number changes was significantly higher in Epstein-Barr virus negative (EBV-) HIV-DLBCL (42.5, range 8-153) compared to EBV+ cases (22; range 3-41; P = 0.029).
[MeSH-major]
Lymphoma
,
AIDS
-
Related
/ genetics.
Lymphoma
,
Large B
-
Cell
,
Diffuse
/ genetics. Polymorphism, Single Nucleotide
[MeSH-minor]
Burkitt
Lymphoma
/ genetics. Chromosome Aberrations. DNA Methylation. Gene Frequency. Humans. Microarray Analysis. Polymerase Chain Reaction / methods
Genetic Alliance.
consumer health - B-Cell Lymphomas
.
Genetic Alliance.
consumer health - HIV
.
COS Scholar Universe.
author profiles
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Cites]
Oncogene. 2004 Dec 2;23(56):9148-54
[
15480422.001
]
[Cites]
Br J Haematol. 2006 Jul;134(1):27-36
[
16803564.001
]
[Cites]
Cancer Lett. 2006 Jan 28;232(1):37-47
[
16242840.001
]
[Cites]
Blood. 2006 Jan 1;107(1):13-20
[
16099881.001
]
[Cites]
Semin Cancer Biol. 2007 Feb;17(1):31-41
[
17140807.001
]
[Cites]
Cancer Lett. 2007 Jul 18;252(2):157-70
[
17188425.001
]
[Cites]
Blood. 2003 Nov 15;102(10):3775-85
[
12907442.001
]
[Cites]
Blood. 2008 Feb 15;111(4):2347-53
[
18079361.001
]
[Cites]
Cancer Lett. 2006 Jan 28;232(1):48-57
[
16221525.001
]
[Cites]
Am J Hum Genet. 1992 Jun;50(6):1243-51
[
1317992.001
]
[Cites]
Haematologica. 2008 Aug;93(8):1178-85
[
18556404.001
]
[Cites]
J Biol Chem. 2006 Mar 31;281(13):8591-9
[
16455660.001
]
[Cites]
Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):3615-20
[
11891319.001
]
[Cites]
AIDS. 2006 Nov 28;20(18):2285-91
[
17117014.001
]
[Cites]
Int J Cancer. 2005 Sep 1;116(3):407-14
[
15818620.001
]
[Cites]
Blood. 2005 Nov 1;106(9):3183-90
[
16046532.001
]
[Cites]
J Cell Physiol. 2007 Aug;212(2):307-10
[
17458891.001
]
[Cites]
Oncogene. 2003 Feb 27;22(8):1225-37
[
12606949.001
]
[Cites]
Mol Cancer Res. 2003 Nov;1(13):940-7
[
14638866.001
]
[Cites]
N Engl J Med. 2008 Nov 27;359(22):2313-23
[
19038878.001
]
[Cites]
Blood. 2003 May 15;101(10):4115-21
[
12531789.001
]
[Cites]
Front Biosci. 2007 Sep 01;12:4911-24
[
17569619.001
]
[Cites]
Blood. 2006 Mar 15;107(6):2477-85
[
16317097.001
]
[Cites]
Cancer Res. 2004 Sep 1;64(17):5948-55
[
15342373.001
]
[Cites]
J Clin Pathol. 2007 Dec;60(12):1365-72
[
18042692.001
]
[Cites]
Nat Cell Biol. 2003 Mar;5(3):216-23
[
12598906.001
]
[Cites]
Nature. 2009 Jun 4;459(7247):717-21
[
19412164.001
]
[Cites]
Blood. 2001 Feb 1;97(3):744-51
[
11157493.001
]
[Cites]
N Engl J Med. 2006 Jun 8;354(23):2419-30
[
16760442.001
]
[Cites]
PLoS Comput Biol. 2006 May;2(5):e41
[
16699594.001
]
[Cites]
Nat Rev Cancer. 2004 Dec;4(12):978-87
[
15573119.001
]
[Cites]
Eur J Cancer. 2001 Jul;37(10):1270-5
[
11423258.001
]
[Cites]
Genes Chromosomes Cancer. 2007 Dec;46(12):1129-36
[
17823927.001
]
[Cites]
Proc Natl Acad Sci U S A. 2008 Sep 9;105(36):13520-5
[
18765795.001
]
[Cites]
Cancer Res. 2008 Apr 15;68(8):2610-21
[
18375840.001
]
[Cites]
Cell Cycle. 2007 May 2;6(9):1044-8
[
17457056.001
]
[Cites]
BMC Bioinformatics. 2009 Jan 08;10:10
[
19133123.001
]
[Cites]
Int J Cancer. 2006 Apr 15;118(8):1945-53
[
16287063.001
]
[Cites]
Cancer Res. 2001 Nov 15;61(22):8068-73
[
11719429.001
]
[Cites]
Proc Natl Acad Sci U S A. 2003 Sep 2;100(18):10399-404
[
12925741.001
]
[Cites]
Biochem Biophys Res Commun. 2001 May 25;283(5):1031-6
[
11355876.001
]
[Cites]
Genes Chromosomes Cancer. 2004 Dec;41(4):321-9
[
15384174.001
]
[Cites]
Proc Natl Acad Sci U S A. 2003 May 13;100(10 ):5956-61
[
12719539.001
]
[Cites]
Nat Rev Immunol. 2009 Apr;9(4):235-45
[
19319142.001
]
[Cites]
Br J Haematol. 2008 May;141(5):622-30
[
18397341.001
]
[Cites]
Oncogene. 2005 Feb 24;24(9):1625-33
[
15674328.001
]
[Cites]
Blood. 2009 Feb 5;113(6):1213-24
[
18955561.001
]
[Cites]
Lab Invest. 2004 Sep;84(9):1193-9
[
15241441.001
]
[Cites]
Cell Death Differ. 2005 Aug;12(8):1031-43
[
16015380.001
]
[Cites]
Proc Natl Acad Sci U S A. 2007 Mar 6;104(10):3949-54
[
17360458.001
]
[Cites]
Cancer Cell. 2006 Apr;9(4):313-25
[
16616336.001
]
[Cites]
Cancer Genet Cytogenet. 2006 Dec;171(2):119-21
[
17116491.001
]
[Cites]
J Neurochem. 2008 Jun;105(5):1806-19
[
18248624.001
]
(PMID = 19832807.001).
[ISSN]
1365-2141
[Journal-full-title]
British journal of haematology
[ISO-abbreviation]
Br. J. Haematol.
[Language]
eng
[Grant]
United States / NCI NIH HHS / CA / U01 CA114778; United States / NCI NIH HHS / CA / U01 CA114778-05; United States / NCI NIH HHS / CA / UO1 CA 114778
[Publication-type]
Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
[Publication-country]
England
28.
Marotta D, Sgambato A, Cerciello S, Magarelli N, Martini M, Larocca LM, Maccauro G:
Soft tissue non-Hodgkin lymphoma of shoulder in a HIV patient: a report of a case and review of the literature.
World J Surg Oncol
; 2008;6:111
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Soft tissue non-Hodgkin
lymphoma
of shoulder in a HIV patient: a report of a case and review of the literature.
BACKGROUND: The risk of developing
lymphoma
is greatly increased in HIV infection.
HIV-
related
neoplastic processes that affect the musculoskeletal system include Kaposi's sarcoma and non-Hodgkin's
lymphoma
, the latter being mainly localized at lower extremities, spine and skull.
A final diagnosis of
diffuse large
B-
cell lymphoma
was made.
CONCLUSION: In this report, we present a case of
diffuse large
B-
cell lymphoma
localized in the soft tissue of the shoulder in a HIV infected patient.
[MeSH-major]
Lymphoma
,
AIDS
-
Related
/ pathology.
Lymphoma
,
Large B
-
Cell
,
Diffuse
/ pathology. Pregnancy Complications, Neoplastic / pathology. Pregnancy Outcome. Soft Tissue Neoplasms / pathology
Genetic Alliance.
consumer health - Hodgkin lymphoma
.
Genetic Alliance.
consumer health - Non-Hodgkin Lymphoma
.
Genetic Alliance.
consumer health - HIV
.
MedlinePlus Health Information.
consumer health - Tumors and Pregnancy
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Cites]
Ann Med Interne (Paris). 2003 Dec;154(8):523-8
[
15037828.001
]
[Cites]
J Am Acad Dermatol. 2003 May;48(5 Suppl):S82-5
[
12734486.001
]
[Cites]
Radiology. 1980 Feb;134(2):521-3
[
7352243.001
]
[Cites]
Am J Surg Pathol. 1987 May;11(5):359-66
[
3578646.001
]
[Cites]
Br J Radiol. 1989 Jan;62(733):81
[
2914198.001
]
[Cites]
J Comput Assist Tomogr. 1995 May-Jun;19(3):455-9
[
7790558.001
]
[Cites]
Bol Asoc Med P R. 1995 Oct-Dec;87(10-12):158-61
[
8924158.001
]
[Cites]
Crit Rev Diagn Imaging. 1996 Sep;37(4):305-47
[
8894398.001
]
[Cites]
Clin Radiol. 1997 Mar;52(3):203-12
[
9091255.001
]
[Cites]
Radiol Clin North Am. 1997 Sep;35(5):1167-89
[
9298091.001
]
[Cites]
Am J Orthop (Belle Mead NJ). 1998 Feb;27(2):128-34
[
9506198.001
]
[Cites]
Semin Ultrasound CT MR. 1998 Apr;19(2):200-8
[
9567324.001
]
[Cites]
Blood. 1998 Aug 1;92(3):1011-9
[
9680371.001
]
[Cites]
Am J Surg Pathol. 1999 Jan;23(1):88-96
[
9888708.001
]
[Cites]
Clin Orthop Relat Res. 1999 Mar;(360):221-30
[
10101328.001
]
[Cites]
Leuk Lymphoma. 2006 Feb;47(2):329-32
[
16321866.001
]
[Cites]
Blood. 2006 Jan 1;107(1):13-20
[
16099881.001
]
[Cites]
Leukemia. 2007 Feb;21(2):207-14
[
17170731.001
]
[Cites]
AJR Am J Roentgenol. 2007 Jun;188(6):1443-5
[
17515361.001
]
[Cites]
J Am Acad Orthop Surg. 2002 Sep-Oct;10(5):312-20
[
12374482.001
]
[Cites]
Rev Chir Orthop Reparatrice Appar Mot. 2002 Sep;88(5):518-21
[
12399719.001
]
[Cites]
Leuk Lymphoma. 2002 Dec;43(12):2405-7
[
12613532.001
]
[Cites]
Skeletal Radiol. 2004 Jun;33(6):311-20
[
15127244.001
]
(PMID = 18939988.001).
[ISSN]
1477-7819
[Journal-full-title]
World journal of surgical oncology
[ISO-abbreviation]
World J Surg Oncol
[Language]
eng
[Publication-type]
Case Reports; Journal Article; Review
[Publication-country]
England
[Number-of-references]
24
29.
Gotoh M, Kitahara T, Iguchi T, Izumi M, Mukai K, Ohyashiki K:
[HIV-related multiple non-Hodgkin lymphomas].
Rinsho Ketsueki
; 2008 Nov;49(11):1552-5
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
[HIV-
related
multiple non-Hodgkin lymphomas].
He was HIV-positive, and had gastric
diffuse large
B-
cell lymphoma
and renal T-
cell
anaplastic
large cell lymphoma
(T-ALCL).
We diagnosed double lymphomas
related
to
AIDS
.
Biopsy specimen demonstrated null
cell
ALCL, and this patient demonstrated multiple lymphomas.
[MeSH-major]
Lymphoma
,
AIDS
-
Related
/ diagnosis.
Lymphoma
, B-
Cell
/ diagnosis.
Lymphoma
,
Large B
-
Cell
,
Diffuse
/ diagnosis.
Lymphoma
,
Large
-
Cell
, Anaplastic / diagnosis.
Lymphoma
, T-
Cell
/ diagnosis. Neoplasms, Multiple Primary. Stomach Neoplasms / diagnosis
Genetic Alliance.
consumer health - HIV
.
MedlinePlus Health Information.
consumer health - Stomach Cancer
.
Hazardous Substances Data Bank.
DOXORUBICIN
.
Hazardous Substances Data Bank.
CYCLOPHOSPHAMIDE
.
Hazardous Substances Data Bank.
PREDNISOLONE
.
Hazardous Substances Data Bank.
VINCRISTINE
.
NCI CPTC Antibody Characterization Program.
NCI CPTC Antibody Characterization Program
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 19047787.001).
[ISSN]
0485-1439
[Journal-full-title]
[Rinshō ketsueki] The Japanese journal of clinical hematology
[ISO-abbreviation]
Rinsho Ketsueki
[Language]
jpn
[Publication-type]
Case Reports; English Abstract; Journal Article
[Publication-country]
Japan
[Chemical-registry-number]
5J49Q6B70F / Vincristine; 80168379AG / Doxorubicin; 8N3DW7272P / Cyclophosphamide; 9PHQ9Y1OLM / Prednisolone; VAP-cyclo protocol
30.
NAGAI Y, MORI M, INOUE D, KIMURA T, SHIMOJI S, TOGAMI K, TABATA S, MATSUSHITA A, NAGAI K, Imai Y, Takafuta T, Takahashi T:
Successful treatment with autologous peripheral blood stem cell transplantation for acquired immunodeficiency syndrome (AIDS)-related malignant lymphoma.
Rinsho Ketsueki
; 2009 Nov;50(11):1641-6
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Successful treatment with autologous peripheral blood stem
cell
transplantation for acquired immunodeficiency syndrome (
AIDS
)-
related
malignant
lymphoma
.
Histologic diagnosis of a biopsied lymph node was
diffuse
,
large
,
B cell
-type malignant
lymphoma
.
The karyotype of the
lymphoma
cells was t(8;14)(q24;q32), which was confirmed by G-banding and fluorescent in situ hybridization.
The clinical stage of the
lymphoma
was IVB and the international prognosis index was categorized as high.
Complete remission (CR) of the
lymphoma
was obtained after 2 courses of CHOP (cyclophosphamide, adriamycin, vincristine, prednisolone) chemotherapy and 4 subsequent courses of rituximab-combined CHOP (R-CHOP).
Because of the poor prognosis of
AIDS
-
related lymphoma
, he received autologous peripheral blood stem
cell
transplantation with the MEAM protocol (ranimustine, etoposide, cytarabine, melphalan) as a conditioning procedure without a severe infectious episode.
[MeSH-major]
Lymphoma
,
AIDS
-
Related
/ therapy.
Lymphoma
,
Large B
-
Cell
,
Diffuse
/ therapy. Peripheral Blood Stem
Cell
Transplantation
Genetic Alliance.
consumer health - AIDS-HIV
.
Genetic Alliance.
consumer health - Transplantation
.
Hazardous Substances Data Bank.
RITUXIMAB
.
Hazardous Substances Data Bank.
DOXORUBICIN
.
Hazardous Substances Data Bank.
CYCLOPHOSPHAMIDE
.
Hazardous Substances Data Bank.
PREDNISOLONE
.
Hazardous Substances Data Bank.
VINCRISTINE
.
NCI CPTC Antibody Characterization Program.
NCI CPTC Antibody Characterization Program
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 20009441.001).
[ISSN]
0485-1439
[Journal-full-title]
[Rinshō ketsueki] The Japanese journal of clinical hematology
[ISO-abbreviation]
Rinsho Ketsueki
[Language]
eng
[Publication-type]
Case Reports; Journal Article
[Publication-country]
Japan
[Chemical-registry-number]
0 / Antibodies, Monoclonal; 0 / Antibodies, Monoclonal, Murine-Derived; 4F4X42SYQ6 / Rituximab; 5J49Q6B70F / Vincristine; 80168379AG / Doxorubicin; 8N3DW7272P / Cyclophosphamide; 9PHQ9Y1OLM / Prednisolone; VAP-cyclo protocol
31.
Rafaniello Raviele P, Pruneri G, Maiorano E:
Plasmablastic lymphoma: a review.
Oral Dis
; 2009 Jan;15(1):38-45
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Plasmablastic
lymphoma
: a review.
Plasmablastic
lymphoma
(PBL) has been recently characterised as an aggressive subtype of non-Hodgkin's
lymphoma
, most frequently arising in the oral cavity of HIV-infected patients.
PBLs are composed of
large
cells with eccentrically located nuclei and deeply basophilic cytoplasm with a paranuclear hof.
The tumour cells are invariably immunoreactive for the plasma
cell
marker CD138, and show monoclonal rearrangement of the immunoglobulin heavy chain gene (IgH) and/or clonal restriction of the Ig light chain (IgL) gene expression in most of the cases.
Similar to other types of
AIDS
-
related
lymphomas, there is evidence that Epstein-Barr virus and Kaposi-sarcoma associated Human Herpes Virus 8 may play a relevant role in the pathogenesis of PBL.
[MeSH-major]
Lymphoma
,
AIDS
-
Related
/ pathology.
Lymphoma
,
Large B
-
Cell
,
Diffuse
/ pathology. Mouth Neoplasms / pathology
MedlinePlus Health Information.
consumer health - Oral Cancer
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 18939960.001).
[ISSN]
1601-0825
[Journal-full-title]
Oral diseases
[ISO-abbreviation]
Oral Dis
[Language]
eng
[Publication-type]
Journal Article; Review
[Publication-country]
Denmark
[Chemical-registry-number]
0 / SDC1 protein, human; 0 / Syndecan-1
[Number-of-references]
54
32.
Dunleavy K, Wilson WH:
Role of molecular subtype in predicting outcome of AIDS-related diffuse large B-cell lymphoma.
J Clin Oncol
; 2010 Jun 1;28(16):e260; author reply e261-2
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Role of molecular subtype in predicting outcome of
AIDS
-
related diffuse large B
-
cell lymphoma
.
[MeSH-major]
Lymphoma
,
AIDS
-
Related
/ genetics.
Lymphoma
,
AIDS
-
Related
/ pathology.
Lymphoma
,
Large B
-
Cell
,
Diffuse
/ genetics.
Lymphoma
,
Large B
-
Cell
,
Diffuse
/ pathology
Genetic Alliance.
consumer health - AIDS-HIV
.
Genetic Alliance.
consumer health - Large B cell diffuse lymphoma
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[CommentOn]
J Clin Oncol. 2009 Oct 20;27(30):5039-48
[
19752343.001
]
(PMID = 20421532.001).
[ISSN]
1527-7755
[Journal-full-title]
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
[ISO-abbreviation]
J. Clin. Oncol.
[Language]
eng
[Publication-type]
Comment; Letter
[Publication-country]
United States
33.
Ma Y, He RK:
[Pathology of AIDS-related lymphadenopathy: a study of 18 biopsy cases].
Zhonghua Bing Li Xue Za Zhi
; 2005 Dec;34(12):776-9
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
[Pathology of
AIDS
-
related
lymphadenopathy: a study of 18 biopsy cases].
OBJECTIVE: To study the clinicopathologic features of acquired immunodeficiency syndrome (
AIDS
)-
related
lymphadenopathy and to elucidate the salient features helpful in achieving a correct pathologic differentiated diagnosis.
METHODS: Eighteen cases of
AIDS
-
related
lymphadenopathy were retrieved from the files of the First Affiliated Hospital of Guangxi Medical University from 2001 to 2004.
The remaining patient was complicated with
diffuse large
B-
cell lymphoma
.
CONCLUSIONS: When presented in early stages,
AIDS
-
related
lymphadenopathy may be overlooked, especially in routine pathology practice.
Florid infection with Penicillium marneffei is also considered as an important predictor for underlying
AIDS
.
Thorough understanding of morphologic features of
AIDS
-
related
lymphadenopathy, including possible co-infection, is essential in arriving at the correct diagnosis.
[MeSH-major]
AIDS
-
Related
Complex / pathology.
AIDS
-
Related
Opportunistic Infections / pathology. Lymph Nodes / pathology
[MeSH-minor]
Adult. Diagnosis, Differential. Female. Humans.
Lymphoma
,
AIDS
-
Related
/ pathology.
Lymphoma
,
Large B
-
Cell
,
Diffuse
/ pathology. Male. Middle Aged. Mycobacterium / isolation & purification. Mycobacterium Infections / microbiology. Mycobacterium Infections / pathology. Mycoses / microbiology. Mycoses / pathology. Penicillium / isolation & purification. Retrospective Studies
Genetic Alliance.
consumer health - AIDS-HIV
.
MedlinePlus Health Information.
consumer health - HIV/AIDS and Infections
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 16545184.001).
[ISSN]
0529-5807
[Journal-full-title]
Zhonghua bing li xue za zhi = Chinese journal of pathology
[ISO-abbreviation]
Zhonghua Bing Li Xue Za Zhi
[Language]
chi
[Publication-type]
English Abstract; Journal Article
[Publication-country]
China
34.
Deffenbacher KE, Iqbal J, Liu Z, Fu K, Chan WC:
Recurrent chromosomal alterations in molecularly classified AIDS-related lymphomas: an integrated analysis of DNA copy number and gene expression.
J Acquir Immune Defic Syndr
; 2010 May 1;54(1):18-26
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Recurrent chromosomal alterations in molecularly classified
AIDS
-
related
lymphomas: an integrated analysis of DNA copy number and gene expression.
HIV-infected individuals have a significantly increased risk of developing an aggressive B-
cell
Non-Hodgkin
Lymphoma
relative to HIV(-) persons.
Due to their aggressive nature,
AIDS
-
related
lymphomas (ARL) can also be more difficult to classify.
To aid in case classification and identify key pathogenetic events in ARL, we analyzed gene expression data and somatic DNA copy number changes by high-resolution array comparative genomic hybridization in tumors from 20 B-
cell
derived ARL (B-ARL) patients.
Gene expression-based predictors robustly classified the B-ARL cases, distinguishing Burkitt
lymphoma
and
diffuse large
B-
cell lymphoma
, and identifying activated B-
cell
like and germinal center B-
cell
like molecular subtypes of
diffuse large
B-
cell lymphoma
.
[MeSH-major]
Chromosome Aberrations. Gene Dosage. Gene Expression. HIV Infections / complications.
Lymphoma
,
AIDS
-
Related
/ diagnosis.
Lymphoma
,
AIDS
-
Related
/ pathology
[MeSH-minor]
Adult. Burkitt
Lymphoma
/ diagnosis. Burkitt
Lymphoma
/ pathology. Comparative Genomic Hybridization. Diagnosis, Differential. Female. Humans.
Lymphoma
,
Large B
-
Cell
,
Diffuse
/ diagnosis.
Lymphoma
,
Large B
-
Cell
,
Diffuse
/ pathology. Male. Middle Aged. Young Adult
Genetic Alliance.
consumer health - AIDS-HIV
.
MedlinePlus Health Information.
consumer health - HIV/AIDS
.
MedlinePlus Health Information.
consumer health - HIV/AIDS in Women
.
SciCrunch.
ArrayExpress: Data: Microarray
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 20216076.001).
[ISSN]
1944-7884
[Journal-full-title]
Journal of acquired immune deficiency syndromes (1999)
[ISO-abbreviation]
J. Acquir. Immune Defic. Syndr.
[Language]
eng
[Grant]
United States / NCI NIH HHS / CA / 5U01/CA114778; United States / NCI NIH HHS / CA / 5U01/CA114778-02S1; United States / NCRR NIH HHS / RR / P20 RR016469; United States / NCI NIH HHS / CA / U01/CA84967
[Publication-type]
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
[Publication-country]
United States
35.
Caimi PF, Barr PM, Berger NA, Lazarus HM:
Non-Hodgkin's lymphoma in the elderly.
Drugs Aging
; 2010 Mar 01;27(3):211-38
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Non-Hodgkin's
lymphoma
in the elderly.
The expansion of older population segments and the continuous increase in the incidence of non-Hodgkin's
lymphoma
(NHL) makes this group of neoplasms an important and growing problem.
Older NHL patients have increased risk of therapy-
related
toxicity as a result of age-
related
physiological changes and frequent co-morbidities.
The comprehensive geriatric assessment (CGA) is one multidisciplinary tool that has been applied successfully to older cancer patients and
aids
in identification of subjects who will or will not benefit from anti-neoplastic treatment.
Diffuse large
B-
cell lymphoma
is an aggressive but potentially curable disease.
Salvage chemotherapy followed by autologous haematopoietic
cell
transplant (autoHCT) has been shown to have better failure-free and overall survival in randomized trials involving younger patients.
Highly selected individuals up to age 70 years may attain long-term survival benefit from autoHCT, although transplant-
related
mortality is higher than in younger patients.
[MeSH-major]
Aging / physiology. Antineoplastic Agents / therapeutic use.
Lymphoma
, Non-Hodgkin / physiopathology.
Lymphoma
, Non-Hodgkin / therapy
MedlinePlus Health Information.
consumer health - Cancer Chemotherapy
.
MedlinePlus Health Information.
consumer health - Seniors' Health
.
Hazardous Substances Data Bank.
RITUXIMAB
.
NCI CPTC Antibody Characterization Program.
NCI CPTC Antibody Characterization Program
.
NCI CPTC Antibody Characterization Program.
NCI CPTC Antibody Characterization Program
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Cites]
J Clin Oncol. 2005 Aug 1;23(22):5019-26
[
15983392.001
]
[Cites]
Blood. 2008 Jun 15;111(12 ):5486-95
[
18390837.001
]
[Cites]
Clin Pharmacokinet. 2003;42(9):779-91
[
12882586.001
]
[Cites]
Semin Oncol. 2002 Feb;29(1S2):25-29
[
28140088.001
]
[Cites]
Oncology (Williston Park). 2007 Aug;21(9):1104-10
[
17910313.001
]
[Cites]
Clin Pharmacokinet. 1996 Jul;31(1):47-64
[
8827399.001
]
[Cites]
N Engl J Med. 1993 Apr 8;328(14):1002-6
[
7680764.001
]
[Cites]
J Clin Oncol. 2007 Mar 1;25(7):787-92
[
17228021.001
]
[Cites]
J Clin Oncol. 2001 Jan 15;19(2):389-97
[
11208830.001
]
[Cites]
J Clin Oncol. 2004 Aug 1;22(15):3032-8
[
15210738.001
]
[Cites]
Best Pract Res Clin Haematol. 2005 Mar;18(1):81-95
[
15694186.001
]
[Cites]
Blood. 1990 Oct 1;76(7):1293-8
[
2207307.001
]
[Cites]
J Clin Oncol. 2005 Jun 20;23(18):4117-26
[
15867204.001
]
[Cites]
Blood. 2004 Aug 1;104(3):634-41
[
15016643.001
]
[Cites]
Cancer. 2008 May 15;112(10):2228-32
[
18338745.001
]
[Cites]
Eur J Haematol. 2008 Feb;80(2):127-32
[
18005385.001
]
[Cites]
Crit Rev Oncol Hematol. 2008 Oct;68 Suppl 1:S1-8
[
18752969.001
]
[Cites]
J Clin Oncol. 2006 Jul 1;24(19):3187-205
[
16682719.001
]
[Cites]
Eur J Cancer. 2003 May;39(7):870-80
[
12706355.001
]
[Cites]
J Clin Oncol. 2009 Jun 20;27(18):3036-43
[
19414675.001
]
[Cites]
J Clin Oncol. 1995 Jul;13(7):1726-33
[
7602362.001
]
[Cites]
J Clin Oncol. 2009 Aug 10;27(23):3822-9
[
19581539.001
]
[Cites]
Blood. 2002 Sep 1;100(5):1559-65
[
12176870.001
]
[Cites]
Curr Treat Options Oncol. 2006 Jul;7(4):285-94
[
16916489.001
]
[Cites]
Lancet Oncol. 2006 May;7(5):357-9
[
16648037.001
]
[Cites]
J Clin Oncol. 2004 Apr 15;22(8):1454-9
[
15024027.001
]
[Cites]
Blood. 2005 Feb 15;105(4):1417-23
[
15494430.001
]
[Cites]
Oncology (Williston Park). 2007 Sep;21(10):1191-8; discussion 1198-1208, 1210
[
17926798.001
]
[Cites]
Blood. 2005 May 15;105(10):3817-23
[
15687232.001
]
[Cites]
Crit Rev Oncol Hematol. 2000 Feb;33(2):119-28
[
10737373.001
]
[Cites]
Am J Geriatr Pharmacother. 2008 Aug;6(3):153-60
[
18775390.001
]
[Cites]
Cancer Control. 2007 Jan;14(1):44-56
[
17242670.001
]
[Cites]
Crit Rev Oncol Hematol. 2005 Sep;55(3):241-52
[
16084735.001
]
[Cites]
Ann Oncol. 2007 Jul;18(7):1216-23
[
17470451.001
]
[Cites]
J Clin Oncol. 2004 Nov 1;22(21):4302-11
[
15381684.001
]
[Cites]
Blood. 2006 Jan 1;107(1):265-76
[
16150940.001
]
[Cites]
Ann Oncol. 2009 Mar;20(3):520-5
[
19074748.001
]
[Cites]
Semin Hematol. 1999 Apr;36(2):115-27
[
10319380.001
]
[Cites]
J Clin Oncol. 2003 Nov 1;21(21):3918-27
[
14517188.001
]
[Cites]
Br J Haematol. 2005 May;129(3):366-72
[
15842660.001
]
[Cites]
Leuk Lymphoma. 2008;49 Suppl 1:43-51
[
18821432.001
]
[Cites]
J Clin Oncol. 2007 Jul 20;25(21):3158-67
[
17634496.001
]
[Cites]
Br J Haematol. 2009 May;145(3):344-9
[
19245430.001
]
[Cites]
J Clin Oncol. 2004 Aug 1;22(15):2982-4
[
15210737.001
]
[Cites]
Clin Lymphoma Myeloma. 2007 Dec;8 Suppl 2:S43-9
[
18284715.001
]
[Cites]
Bull Cancer. 2008 May 28;95 FMC Onco:F79-83
[
18511372.001
]
[Cites]
N Engl J Med. 1995 Dec 7;333(23):1540-5
[
7477169.001
]
[Cites]
Leuk Lymphoma. 1999 Jul;34(3-4):273-85
[
10439364.001
]
[Cites]
J Clin Oncol. 2008 Jan 10;26(2):204-10
[
18182663.001
]
[Cites]
Am J Health Syst Pharm. 2007 Mar 15;64(6):652-60
[
17353576.001
]
[Cites]
J Clin Oncol. 2002 May 15;20(10 ):2453-63
[
12011122.001
]
[Cites]
N Engl J Med. 1992 Oct 22;327(17):1209-15
[
1406793.001
]
[Cites]
Blood. 2004 Sep 1;104(5):1258-65
[
15126323.001
]
[Cites]
J Clin Oncol. 2009 Mar 10;27(8):1209-13
[
19188674.001
]
[Cites]
J Clin Oncol. 2005 Jul 1;23(19):4390-8
[
15994148.001
]
[Cites]
J Clin Oncol. 2000 Apr;18(7):1412-22
[
10735888.001
]
[Cites]
Aging Clin Exp Res. 2005 Jun;17(3):181-5
[
16110729.001
]
[Cites]
J Clin Oncol. 2008 Sep 20;26(27):4473-9
[
18626004.001
]
[Cites]
Leukemia. 2007 Nov;21(11):2324-31
[
17637813.001
]
[Cites]
Bone Marrow Transplant. 2000 May;25(9):957-64
[
10800063.001
]
[Cites]
J Immunol. 2009 Jul 1;183(1):749-58
[
19535640.001
]
[Cites]
J Clin Oncol. 2006 May 1;24(13):2105-12
[
16606971.001
]
[Cites]
J Clin Oncol. 2008 Oct 1;26(28):4579-86
[
18662969.001
]
[Cites]
Cancer. 1983 Aug 1;52(3):393-8
[
6344979.001
]
[Cites]
J Clin Oncol. 2009 Apr 1;27(10):1607-14
[
19255334.001
]
[Cites]
Clin Geriatr Med. 1997 May;13(2):251-63
[
9115450.001
]
[Cites]
J Clin Oncol. 1997 Aug;15(8):2945-53
[
9256139.001
]
[Cites]
N Engl J Med. 1993 Sep 30;329(14):1046
[
8366915.001
]
[Cites]
Biol Blood Marrow Transplant. 2008 Dec;14(12):1323-33
[
19041053.001
]
[Cites]
Cochrane Database Syst Rev. 2008 Oct 08;(4):CD003189
[
18843642.001
]
[Cites]
J Clin Oncol. 2006 Aug 20;24(24):3880-6
[
16864854.001
]
[Cites]
J Clin Oncol. 2005 Mar 20;23(9):1984-92
[
15668467.001
]
[Cites]
Blood. 2006 Dec 15;108(13):4003-8
[
16946304.001
]
[Cites]
Haematologica. 2002 Jan;87(1):33-43
[
11801463.001
]
[Cites]
Blood. 2005 Apr 1;105(7):2677-84
[
15591112.001
]
[Cites]
Br J Haematol. 2008 Jun;142(2):149-65
[
18410453.001
]
[Cites]
J Clin Oncol. 2005 Aug 10;23(23):5347-56
[
15983389.001
]
[Cites]
J Clin Oncol. 2003 Sep 1;21(17):3214-9
[
12874269.001
]
[Cites]
Cancer. 1976 Oct;38(4):1484-93
[
791473.001
]
[Cites]
J Clin Oncol. 1986 Mar;4(3):295-305
[
3512783.001
]
[Cites]
Hematol Oncol. 1989 Sep-Oct;7(5):365-80
[
2670728.001
]
[Cites]
Ann Hematol. 2001 Jul;80(7):398-405
[
11529465.001
]
[Cites]
Blood. 2003 May 15;101(10):3840-8
[
12531794.001
]
[Cites]
J Am Geriatr Soc. 2001 Dec;49(12):1691-9
[
11844005.001
]
[Cites]
Br J Haematol. 2007 Jan;136(2):191-202
[
17073892.001
]
[Cites]
J Clin Oncol. 2005 Nov 20;23(33):8447-52
[
16230674.001
]
[Cites]
N Engl J Med. 2005 Mar 24;352(12):1197-205
[
15788496.001
]
[Cites]
J Clin Oncol. 2007 Jun 20;25(18):2554-9
[
17515573.001
]
[Cites]
Radiother Oncol. 1995 Sep;36(3):167-71
[
8532901.001
]
[Cites]
Blood. 2004 May 15;103(10):3684-8
[
14739217.001
]
[Cites]
Eur J Cancer. 2006 Oct;42(15):2433-53
[
16750358.001
]
[Cites]
Clin Lymphoma. 2001 Jun;2(1):47-56
[
11707870.001
]
[Cites]
Leuk Lymphoma. 2008;49 Suppl 1:59-66
[
18821434.001
]
[Cites]
Blood. 2004 Oct 15;104(8):2269-71
[
15166030.001
]
[Cites]
Blood. 1994 Oct 15;84(8):2726-32
[
7919385.001
]
[Cites]
Semin Oncol. 1993 Feb;20(1):43-9
[
8475409.001
]
[Cites]
Cancer. 2004 Oct 15;101(8):1835-42
[
15386331.001
]
[Cites]
Ann Oncol. 2007 Jan;18(1):116-21
[
16971665.001
]
[Cites]
Br J Haematol. 2003 Aug;122(3):413-23
[
12877668.001
]
[Cites]
J Clin Oncol. 1994 Jun;12(6):1169-76
[
8201379.001
]
[Cites]
Blood. 2004 Aug 1;104(3):626-33
[
14982884.001
]
[Cites]
Blood. 1999 Jul 1;94(1):33-8
[
10381495.001
]
[Cites]
J Clin Oncol. 2006 Jul 1;24(19):3121-7
[
16754935.001
]
[Cites]
Ann Oncol. 2006 Sep;17 (9):1418-23
[
16766582.001
]
[Cites]
Semin Hematol. 1988 Apr;25(2 Suppl 2):11-6
[
2456618.001
]
[Cites]
N Engl J Med. 1998 Sep 24;339(13):900-5
[
9744975.001
]
[Cites]
Int J Radiat Oncol Biol Phys. 2001 Dec 1;51(5):1219-27
[
11728680.001
]
[Cites]
Expert Rev Anticancer Ther. 2008 Oct;8(10):1651-8
[
18925856.001
]
[Cites]
Blood. 2005 Dec 1;106(12):3725-32
[
16123223.001
]
[Cites]
Ann Oncol. 2008 Jul;19(7):1327-30
[
18349031.001
]
[Cites]
J Clin Oncol. 2005 Feb 1;23(4):667-75
[
15613697.001
]
[Cites]
Lancet. 2003 Aug 16;362(9383):516-22
[
12932382.001
]
[Cites]
Ann Intern Med. 2002 Jan 15;136(2):144-52
[
11790067.001
]
[Cites]
Int J Radiat Oncol Biol Phys. 2006 Mar 1;64(3):928-34
[
16243446.001
]
[Cites]
Eur J Cancer. 2008 Mar;44(4):579-87
[
18242077.001
]
[Cites]
J Clin Oncol. 2007 May 20;25(15):1986-92
[
17420513.001
]
[Cites]
J Natl Cancer Inst. 2006 Sep 20;98(18):1292-301
[
16985248.001
]
[Cites]
Cancer. 2003 Dec 15;98(12):2630-5
[
14669282.001
]
[Cites]
Cancer Invest. 2007 Dec;25(8):766-75
[
18058474.001
]
[Cites]
J Clin Oncol. 2008 Jul 1;26(19):3159-65
[
18591554.001
]
[Cites]
Ann Oncol. 2008 Jun;19 Suppl 4:iv60-2
[
18519407.001
]
[Cites]
Cancer Control. 2003 Nov-Dec;10(6):487-99
[
14652525.001
]
[Cites]
J Clin Oncol. 2003 Jun 15;21(12):2407-14
[
12805341.001
]
[Cites]
N Engl J Med. 1998 Jul 2;339(1):21-6
[
9647875.001
]
[Cites]
Cancer Control. 1996 Oct;3(5 Suppl 1):5-14
[
10765230.001
]
[Cites]
J Clin Oncol. 1997 Mar;15(3):1110-7
[
9060552.001
]
[Cites]
Blood. 2004 Nov 1;104(9):2667-74
[
15238420.001
]
[Cites]
J Natl Cancer Inst. 2007 May 2;99(9):706-14
[
17470738.001
]
[Cites]
Bone Marrow Transplant. 2001 Mar;27(6):593-9
[
11319588.001
]
[Cites]
J Clin Oncol. 2005 Feb 1;23(4):676-84
[
15613699.001
]
[Cites]
Nephron. 1976;16(1):31-41
[
1244564.001
]
[Cites]
J Clin Oncol. 2005 Feb 20;23(6):1088-95
[
15657401.001
]
[Cites]
J Clin Oncol. 2002 Dec 15;20(24):4643-8
[
12488408.001
]
[Cites]
J Clin Oncol. 2006 Apr 1;24(10):1582-9
[
16575009.001
]
[Cites]
Lancet. 2009 Oct 31;374(9700):1512-20
[
19767089.001
]
[Cites]
J Clin Oncol. 2002 Oct 15;20(20):4261-7
[
12377971.001
]
[Cites]
J Clin Oncol. 1998 Jan;16(1):13-8
[
9440717.001
]
[Cites]
J Clin Oncol. 2005 Oct 1;23(28):7013-23
[
16145068.001
]
[Cites]
J Clin Oncol. 2005 May 20;23(15):3383-9
[
15908650.001
]
[Cites]
Ann Oncol. 1995 Mar;6(3):257-62
[
7612491.001
]
[Cites]
J Clin Oncol. 1996 Apr;14(4):1282-90
[
8648385.001
]
[Cites]
Clin Cancer Res. 2008 Jan 1;14(1):309-17
[
18172283.001
]
[Cites]
Hematol Oncol Clin North Am. 2008 Oct;22(5):941-52, ix
[
18954744.001
]
[Cites]
Hematol Oncol Clin North Am. 2008 Oct;22(5):1037-49, x-xi
[
18954750.001
]
[Cites]
Blood. 1997 May 1;89(9):3129-35
[
9129015.001
]
[Cites]
J Clin Oncol. 1995 Oct;13(10):2530-9
[
7595704.001
]
[Cites]
Semin Oncol. 2003 Feb;30(1S2):9-15
[
28140221.001
]
[Cites]
J Clin Oncol. 2009 Mar 10;27(8):1202-8
[
19204203.001
]
[Cites]
Blood. 2004 Nov 15;104(10):3064-71
[
15284112.001
]
[Cites]
Cancer Control. 2007 Jan;14(1):7-12
[
17242666.001
]
[Cites]
J Clin Oncol. 1998 Jul;16(7):2352-8
[
9667250.001
]
[Cites]
Leuk Lymphoma. 2009 Jan;50(1):47-53
[
19152172.001
]
[Cites]
Cancer. 2005 Nov 1;104(9):1998-2005
[
16206252.001
]
[Cites]
Ann Hematol. 2007 Feb;86(2):95-100
[
17031689.001
]
[Cites]
Nat Rev Cancer. 2009 Sep;9(9):675-81
[
19701243.001
]
[Cites]
Curr Opin Oncol. 2008 Sep;20(5):502-8
[
19106651.001
]
[Cites]
Bone Marrow Transplant. 2007 Nov;40(10):973-8
[
17873917.001
]
[Cites]
Cancer. 1997 Oct 1;80(7):1302-10
[
9317183.001
]
[Cites]
Blood. 2008 Feb 1;111(3):1094-100
[
18003886.001
]
[Cites]
Haematologica. 2008 Dec;93(12):1837-42
[
18838474.001
]
[Cites]
Blood. 2007 Mar 1;109(5):1857-61
[
17105812.001
]
[Cites]
Ann Intern Med. 1990 May 1;112(9):699-706
[
2334082.001
]
[Cites]
Drugs Aging. 2003;20(10):737-59
[
12875610.001
]
[Cites]
J Clin Oncol. 1989 Nov;7(11):1748-56
[
2681557.001
]
[Cites]
J Clin Oncol. 2002 Jan 15;20(2):494-502
[
11786579.001
]
[Cites]
Eur J Cancer. 1998 Feb;34(3):329-36
[
9640217.001
]
[Cites]
Gerontology. 1999 Sep-Oct;45(5):243-53
[
10460985.001
]
[Cites]
Blood. 1997 Jun 1;89(11):3909-18
[
9166827.001
]
[Cites]
Haematologica. 2006 Jan;91(1):11-6
[
16434365.001
]
[Cites]
J Clin Oncol. 2003 Aug 15;21(16):3051-9
[
12837807.001
]
[Cites]
J Clin Oncol. 1998 Mar;16(3):859-63
[
9508166.001
]
[Cites]
Ann Oncol. 1994;5 Suppl 2:67-71
[
7515649.001
]
[Cites]
Blood. 2006 Nov 15;108(10):3295-301
[
16873669.001
]
[Cites]
N Engl J Med. 1984 Dec 6;311(23):1471-5
[
6548796.001
]
[Cites]
Hematol Oncol Clin North Am. 2008 Oct;22(5):863-82, viii
[
18954741.001
]
[Cites]
N Engl J Med. 2002 Jan 24;346(4):235-42
[
11807147.001
]
[Cites]
J Clin Oncol. 1998 Jan;16(1):27-34
[
9440719.001
]
[Cites]
Semin Radiat Oncol. 2007 Jul;17(3):169-75
[
17591563.001
]
[Cites]
N Engl J Med. 2008 Aug 7;359(6):613-26
[
18687642.001
]
[Cites]
Blood. 2006 Oct 15;108(8):2540-4
[
16835383.001
]
[Cites]
J Clin Oncol. 2009 Mar 20;27(9):1492-501
[
19224851.001
]
[Cites]
J Clin Oncol. 2003 Jan 1;21(1):5-15
[
12506163.001
]
[Cites]
J Clin Oncol. 2004 Apr 15;22(8):1469-79
[
15084620.001
]
[Cites]
Ann Oncol. 1997 Jul;8(7):675-80
[
9296221.001
]
[Cites]
J Clin Oncol. 2006 Oct 20;24(30):4867-74
[
17001068.001
]
[Cites]
J Natl Cancer Inst. 2009 Feb 18;101(4):248-55
[
19211444.001
]
[Cites]
Blood. 2008 Oct 1;112(7):2687-93
[
18625886.001
]
[Cites]
Blood. 2001 Jan 1;97(1):101-6
[
11133748.001
]
[Cites]
Blood. 2002 Jun 15;99(12 ):4336-42
[
12036859.001
]
[Cites]
Lancet Neurol. 2009 Jun;8(6):581-92
[
19446277.001
]
[Cites]
Blood Rev. 2009 May;23(3):137-42
[
18951668.001
]
[Cites]
Cancer Invest. 2006 Oct;24(6):593-600
[
16982464.001
]
[Cites]
Cancer. 2006 Oct 1;107(7):1530-41
[
16933332.001
]
[Cites]
Cancer Control. 2002 May-Jun;9(3):203-11
[
12060818.001
]
[Cites]
Blood. 2001 Jan 15;97(2):404-9
[
11154216.001
]
[Cites]
J Clin Oncol. 2003 Aug 15;21(16):3041-50
[
12915593.001
]
[Cites]
J Clin Oncol. 1998 Aug;16(8):2825-33
[
9704735.001
]
[Cites]
Lancet Oncol. 2006 May;7(5):379-91
[
16648042.001
]
[Cites]
J Natl Cancer Inst. 2000 Aug 2;92(15):1240-51
[
10922409.001
]
[Cites]
Cancer. 2002 Apr 1;94(7):2015-23
[
11932904.001
]
[Cites]
J Clin Oncol. 2008 Mar 20;26(9):1544-52
[
18285605.001
]
[Cites]
J Clin Oncol. 2002 Feb 1;20(3):770-5
[
11821460.001
]
[Cites]
Lancet Oncol. 2008 Feb;9(2):105-16
[
18226581.001
]
[Cites]
J Clin Oncol. 1998 Dec;16(12):3803-9
[
9850025.001
]
[Cites]
Blood. 2009 Apr 23;113(17):3896-902
[
19144985.001
]
[Cites]
J Clin Oncol. 2009 Feb 1;27(4):511-8
[
19075279.001
]
[Cites]
J Clin Oncol. 2008 Oct 20;26(30):4952-7
[
18606983.001
]
[Cites]
Blood. 2009 Apr 30;113(18):4144-52
[
19168784.001
]
[Cites]
J Clin Oncol. 2002 Aug 1;20(15):3262-9
[
12149300.001
]
(PMID = 20210368.001).
[ISSN]
1179-1969
[Journal-full-title]
Drugs & aging
[ISO-abbreviation]
Drugs Aging
[Language]
eng
[Publication-type]
Journal Article; Research Support, Non-U.S. Gov't
[Publication-country]
New Zealand
[Chemical-registry-number]
0 / Antibodies, Monoclonal; 0 / Antibodies, Monoclonal, Murine-Derived; 0 / Antineoplastic Agents; 4F4X42SYQ6 / Rituximab
36.
Hill QA, Owen RG:
CNS prophylaxis in lymphoma: who to target and what therapy to use.
Blood Rev
; 2006 Nov;20(6):319-32
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
CNS prophylaxis in
lymphoma
: who to target and what therapy to use.
The purpose of this article is to review the current data on the risk of CNS relapse in patients with
lymphoma
and the efficacy of CNS directed prophylactic therapy.
CNS relapse occurred in 30-50% of those with Burkitt
lymphoma
and acute lymphoblastic leukaemia/
lymphoma
prior to the introduction of intensified regimens that include CNS prophylaxis.
Most patients with
AIDS
-
related
-
lymphoma
receive a short course of intrathecal prophylaxis but a re-evaluation of type and targeting of CNS prophylaxis is needed.
Patients with
diffuse large
B-
cell lymphoma
(DLBCL) have a 5% overall risk of CNS relapse but a high risk sub-population can be identified on the basis of raised LDH and >1 extranodal site, testicular or primary breast involvement.
[MeSH-major]
Central Nervous System Neoplasms / complications. Central Nervous System Neoplasms / prevention & control.
Lymphoma
/ complications.
Lymphoma
/ prevention & control
MedlinePlus Health Information.
consumer health - Lymphoma
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 16884838.001).
[ISSN]
0268-960X
[Journal-full-title]
Blood reviews
[ISO-abbreviation]
Blood Rev.
[Language]
eng
[Publication-type]
Journal Article; Review
[Publication-country]
Scotland
[Chemical-registry-number]
0 / Antineoplastic Agents
[Number-of-references]
151
37.
Radhakrishnan R, Suhas S, Kumar RV, Krishnanand G, Srinivasan R, Rao NN:
Plasmablastic lymphoma of the oral cavity in an HIV-positive child.
Oral Surg Oral Med Oral Pathol Oral Radiol Endod
; 2005 Dec;100(6):725-31
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Plasmablastic
lymphoma
of the oral cavity in an HIV-positive child.
A provisional diagnosis of non-Hodgkin's
lymphoma
or embryonal rhabdomyosarcoma was made.
Fine-needle aspiration cytology findings were inconclusive, and incisional biopsy tissue on routine stains gave an impression of small round
cell
tumor with plasmacytoid features.
The salient immunostaining was negativity with all routine small round
cell
tumor markers and positivity with CD138 and lambda light chain restriction.
The heterogeneous presentation of plasmablastic
lymphoma
as a variant of
diffuse large
B-
cell lymphoma
and its histogenesis is documented.
Potential pitfalls and differential characterization of
AIDS
-plasmablastic
lymphoma
from other closely
related
tumors are addressed.
The importance of excluding other common pediatric small round
cell
tumors by immunohistochemistry is highlighted.
[MeSH-major]
HIV Seropositivity / complications.
Lymphoma
,
AIDS
-
Related
/ etiology.
Lymphoma
,
Large B
-
Cell
,
Diffuse
/ etiology. Maxillary Neoplasms / etiology
Genetic Alliance.
consumer health - HIV
.
HIV InSite.
treatment guidelines - Human Herpesvirus-8
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 16301154.001).
[ISSN]
1528-395X
[Journal-full-title]
Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics
[ISO-abbreviation]
Oral Surg Oral Med Oral Pathol Oral Radiol Endod
[Language]
eng
[Publication-type]
Case Reports; Journal Article
[Publication-country]
United States
[Chemical-registry-number]
0 / Immunoglobulin lambda-Chains; 0 / Membrane Glycoproteins; 0 / Proteoglycans; 0 / SDC1 protein, human; 0 / Syndecan-1; 0 / Syndecans
38.
Park S, Jeen YT, Kwon YD, Keum B, Seo YS, Kim YS, Chun HJ, Um SH, Kim CD, Ryu HS:
Successfully cured primary esophageal lymphoma in a patient with acquired immune deficiency syndrome (AIDS).
Endoscopy
; 2009;41 Suppl 2:E148-9
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Successfully cured primary esophageal
lymphoma
in a patient with acquired immune deficiency syndrome (
AIDS
).
[MeSH-major]
Esophageal Neoplasms / drug therapy.
Lymphoma
,
AIDS
-
Related
/ drug therapy.
Lymphoma
,
Large B
-
Cell
,
Diffuse
/ drug therapy
Genetic Alliance.
consumer health - AIDS-HIV
.
MedlinePlus Health Information.
consumer health - Esophageal Cancer
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 19544273.001).
[ISSN]
1438-8812
[Journal-full-title]
Endoscopy
[ISO-abbreviation]
Endoscopy
[Language]
eng
[Publication-type]
Case Reports; Journal Article
[Publication-country]
Germany
39.
Licci S, Brenna A, Abbate I, Ascani S:
The association between non-Hodgkin lymphoma and renal cell carcinoma in an HIV-positive patient: clinico-pathological features and pathogenic implications.
Am J Hematol
; 2008 Sep;83(9):759
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
The association between non-Hodgkin
lymphoma
and renal
cell
carcinoma in an HIV-positive patient: clinico-pathological features and pathogenic implications.
[MeSH-major]
Carcinoma, Renal
Cell
/ etiology. Epstein-Barr Virus Infections / complications. HIV Infections / complications. Kidney Neoplasms / etiology.
Lymphoma
,
AIDS
-
Related
/ etiology.
Lymphoma
,
Large B
-
Cell
,
Diffuse
/ etiology. Neoplasms, Multiple Primary / etiology
Genetic Alliance.
consumer health - Hodgkin lymphoma
.
Genetic Alliance.
consumer health - Non-Hodgkin Lymphoma
.
Genetic Alliance.
consumer health - HIV
.
Genetic Alliance.
consumer health - Renal cell carcinoma
.
MedlinePlus Health Information.
consumer health - HIV/AIDS
.
MedlinePlus Health Information.
consumer health - Kidney Cancer
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 18615452.001).
[ISSN]
1096-8652
[Journal-full-title]
American journal of hematology
[ISO-abbreviation]
Am. J. Hematol.
[Language]
eng
[Publication-type]
Case Reports; Letter
[Publication-country]
United States
40.
Chao C, Jacobson LP, Tashkin D, Martínez-Maza O, Roth MD, Margolick JB, Chmiel JS, Holloway MN, Zhang ZF, Detels R:
Recreational amphetamine use and risk of HIV-related non-Hodgkin lymphoma.
Cancer Causes Control
; 2009 Jul;20(5):509-16
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Recreational amphetamine use and risk of HIV-
related
non-Hodgkin
lymphoma
.
The results of many laboratory studies suggest that amphetamine use may lead to altered immune function and cytokine expression, both of which are implicated in HIV-
related
lymphomagenesis.
We examined the hypothesis that use of amphetamines modifies risk of non-Hodgkin
lymphoma
(NHL) in HIV-infected men in the Multicenter
AIDS
Cohort Study.
Similar associations were observed when we separately examined systemic NHL and
diffuse large
B-
cell lymphoma
.
Genetic Alliance.
consumer health - Hodgkin lymphoma
.
Genetic Alliance.
consumer health - Non-Hodgkin Lymphoma
.
Genetic Alliance.
consumer health - HIV
.
MedlinePlus Health Information.
consumer health - HIV/AIDS
.
COS Scholar Universe.
author profiles
.
Hazardous Substances Data Bank.
AMPHETAMINE
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Cites]
Eur J Epidemiol. 2004;19(6):585-7
[
15330132.001
]
[Cites]
Immunology. 2004 Apr;111(4):357-67
[
15056370.001
]
[Cites]
Am J Epidemiol. 1987 Aug;126(2):310-8
[
3300281.001
]
[Cites]
J Acquir Immune Defic Syndr. 1989;2(1):77-83
[
2918462.001
]
[Cites]
Life Sci. 1991;49(16):PL107-12
[
1910138.001
]
[Cites]
Immunopharmacol Immunotoxicol. 1994 Feb;16(1):1-21
[
8169319.001
]
[Cites]
Life Sci. 1996;58(2):PL 29-33
[
8606616.001
]
[Cites]
Am J Epidemiol. 1996 Feb 15;143(4):374-9
[
8633621.001
]
[Cites]
Epidemiology. 1996 Mar;7(2):131-9
[
8834551.001
]
[Cites]
J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Jul 1;15(3):211-22
[
9257656.001
]
[Cites]
Br J Cancer. 1997;76(11):1532-7
[
9400954.001
]
[Cites]
Immunopharmacology. 1998 Jan;38(3):253-60
[
9506825.001
]
[Cites]
J Neuroimmunol. 1998 Mar 15;83(1-2):133-8
[
9610681.001
]
[Cites]
J Neuroimmunol. 1998 Mar 15;83(1-2):139-47
[
9610682.001
]
[Cites]
Mem Inst Oswaldo Cruz. 1998 May-Jun;93(3):373-81
[
9698872.001
]
[Cites]
AIDS Educ Prev. 1999 Jun;11(3):232-42
[
10407457.001
]
[Cites]
AIDS Read. 2004 Nov;14(11):605-17
[
15570672.001
]
[Cites]
J Natl Cancer Inst. 2005 Mar 16;97(6):425-32
[
15770006.001
]
[Cites]
Scand J Infect Dis. 2005;37(6-7):493-6
[
16012010.001
]
[Cites]
Int J Obes (Lond). 2005 Oct;29(10):1267-74
[
15997248.001
]
[Cites]
AIDS. 2005 Oct 14;19(15):1711-2
[
16184051.001
]
[Cites]
Tumour Biol. 2006;27(4):187-94
[
16651853.001
]
[Cites]
AIDS. 2006 Aug 1;20(12):1645-54
[
16868446.001
]
[Cites]
PLoS Med. 2006 Nov;3(11):e438
[
17121449.001
]
[Cites]
Cancer Epidemiol Biomarkers Prev. 2007 Mar;16(3):392-5
[
17337642.001
]
[Cites]
Int J Cancer. 2007 Oct 1;121(7):1564-70
[
17443495.001
]
[Cites]
Subst Use Misuse. 2007;42(10):1613-28
[
17918031.001
]
[Cites]
AIDS Care. 2007 Oct;19(9):1134-40
[
18058397.001
]
[Cites]
AIDS. 2008 Jan 30;22(3):357-65
[
18195562.001
]
[Cites]
Lancet. 2008 Feb 16;371(9612):569-78
[
18280327.001
]
[Cites]
J Immunol. 2000 Jun 15;164(12):6461-6
[
10843702.001
]
[Cites]
Semin Oncol. 2000 Aug;27(4):390-401
[
10950365.001
]
[Cites]
Lancet. 2000 Jul 22;356(9226):291-6
[
11071184.001
]
[Cites]
J Pharmacol Exp Ther. 2001 Jan;296(1):207-15
[
11123382.001
]
[Cites]
J Natl Cancer Inst. 2000 Nov 15;92(22):1823-30
[
11078759.001
]
[Cites]
Life Sci. 2001 Nov 2;69(24):2931-41
[
11720096.001
]
[Cites]
Ann N Y Acad Sci. 2002 Jun;965:421-33
[
12105117.001
]
[Cites]
Curr Opin Oncol. 2002 Sep;14(5):528-32
[
12192272.001
]
[Cites]
J Infect Dis. 2003 Feb 15;187(4):700-4
[
12599091.001
]
[Cites]
J Leukoc Biol. 2003 Oct;74(4):486-96
[
12960289.001
]
[Cites]
Clin Immunol. 2003 Nov;109(2):119-29
[
14597210.001
]
[Cites]
J Pharmacol Exp Ther. 2004 Apr;309(1):285-92
[
14722327.001
]
[Cites]
AIDS Care. 2004 Nov;16(8):1036-47
[
15511735.001
]
(PMID = 19011979.001).
[ISSN]
1573-7225
[Journal-full-title]
Cancer causes & control : CCC
[ISO-abbreviation]
Cancer Causes Control
[Language]
ENG
[Grant]
United States / NIAID NIH HHS / AI / U01 AI035042; United States / NIDA NIH HHS / DA / R01 DA008254-12; United States / NIAID NIH HHS / AI / U01 AI037984; United States / NCI NIH HHS / CA / P50 CA096888-05; United States / NIDA NIH HHS / DA / R01 DA08254; United States / NIDA NIH HHS / DA / DA003018-18; United States / NIDA NIH HHS / DA / DA008254-12; United States / NIDA NIH HHS / DA / R37 DA003018; United States / NIDA NIH HHS / DA / R37 DA03018; United States / NIDA NIH HHS / DA / R37 DA003018-21; United States / NIAID NIH HHS / AI / U01 AI037613; United States / NCI NIH HHS / CA / P50 CA096888-01; United States / NCRR NIH HHS / RR / M01 RR000722; United States / NIAID NIH HHS / AI / U01 AI035041; United States / NCI NIH HHS / CA / P50CA096888; United States / NIAID NIH HHS / AI / UM1 AI035043; United States / NIDA NIH HHS / DA / R37 DA003018-18; United States / NIDA NIH HHS / DA / DA008254-06; United States / NIAID NIH HHS / AI / U01 AI035043; United States / NIDA NIH HHS / DA / DA003018-21; United States / NIAID NIH HHS / AI / U01 AI035040; United States / NIDA NIH HHS / DA / R01 DA008254; United States / NCI NIH HHS / CA / CA096888-01; United States / NIDA NIH HHS / DA / R01 DA008254-06; United States / NIAID NIH HHS / AI / U01 AI035039; United States / NCI NIH HHS / CA / P50 CA096888
[Publication-type]
Journal Article; Multicenter Study; Research Support, N.I.H., Extramural
[Publication-country]
Netherlands
[Chemical-registry-number]
0 / Street Drugs; CK833KGX7E / Amphetamine
[Other-IDs]
NLM/ NIHMS192303; NLM/ PMC2862618
41.
Mani D, Dorer RK, Aboulafia DM:
Therapy-related acute myeloid leukemia following HIV-associated lymphoma.
Clin Lymphoma Myeloma
; 2009 Aug;9(4):316-9
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Therapy-
related
acute myeloid leukemia following HIV-associated
lymphoma
.
In the highly active antiretroviral therapy era, an increasingly
large
number of HIV-infected patients are developing non-
AIDS
-defining cancers (NADCs).
As patients survive longer, long-term therapy-
related
complications take on greater importance.
Herein, we describe a patient with
AIDS
who presented to medical attention with pancytopenia 48 months postchemotherapy with etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab (R-EPOCH) for
diffuse large
B-
cell lymphoma
.
With the diagnosis of therapy-
related
acute myeloid leukemia (AML) secured, he began induction chemotherapy with idarubicin and cytarabine.
Through a literature search, we were able to identify 4 additional cases of therapy-
related
AML in
AIDS
patients following chemotherapy for lymphomas.
The median age of these patients at the time of AML diagnosis was 39 years (range, 33-59 years), the median time from the treatment of
lymphoma
to AML was 18 months (range, 11-48 months), and the median survival following induction chemotherapy was 4 weeks (range, 2-16 weeks).
With many HIV-infected patients surviving alkylator and topoisomerase inhibitor-based treatment and radiation therapy for
AIDS
-defining cancers and NADCs, long-term follow-up for therapy-
related
complications assumes greater importance.
[MeSH-major]
Antineoplastic Combined Chemotherapy Protocols / adverse effects. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Leukemia, Myeloid, Acute / chemically induced.
Lymphoma
,
AIDS
-
Related
/ drug therapy
Genetic Alliance.
consumer health - Leukemia, Myeloid
.
Genetic Alliance.
consumer health - HIV
.
MedlinePlus Health Information.
consumer health - Acute Myeloid Leukemia
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 19717383.001).
[ISSN]
1938-0712
[Journal-full-title]
Clinical lymphoma & myeloma
[ISO-abbreviation]
Clin Lymphoma Myeloma
[Language]
eng
[Publication-type]
Case Reports; Journal Article
[Publication-country]
United States
[Chemical-registry-number]
0 / MLL protein, human; 149025-06-9 / Myeloid-Lymphoid Leukemia Protein; EC 2.1.1.43 / Histone-Lysine N-Methyltransferase
42.
Madan R, Gormley R, Dulau A, Xu D, Walsh D, Ramesh KH, Cannizaro L, Tamas EF, Kumar P, Sparano J, LeValley A, Xue X, Bhattacharyya PK, Ioachim HL, Ratech H:
AIDS and non-AIDS diffuse large B-cell lymphomas express different antigen profiles.
Mod Pathol
; 2006 Mar;19(3):438-46
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
AIDS
and non-
AIDS diffuse large B
-
cell
lymphomas express different antigen profiles.
Based on gene expression profiling,
diffuse large
B-
cell
lymphomas arising in immunocompetent patients can be divided into germinal center and activated B-
cell
types.
Since little is known about acquired immunodeficiency syndrome associated
diffuse large
B-
cell
lymphomas, we tested whether the protein expression of germinal center and activated B-
cell
markers differed between acquired immunodeficiency syndrome (
AIDS
) vs non-
AIDS diffuse large B
-
cell
lymphomas.
We immunohistochemically stained tissue microarrays of 39 de novo
diffuse large
B-
cell
lymphomas: 12
AIDS
associated and 27 non-
AIDS
, with germinal center (BCL6, CD10, CyclinH) and activated B-
cell
markers (MUM1, CD138, PAK1, CD44, BCL2).
The activated B-
cell
and germinal center summation scores of each case were used as (x, y) coordinate data points to construct two-dimensional contour-frequency plots.
The contour plot of non-
AIDS diffuse large B
-
cell
lymphomas showed two distinct clusters: a cluster with a high germinal center phenotype (cluster 1) and a cluster with a high activated B-
cell
phenotype (cluster 3).
In contrast, the
AIDS
-
related diffuse large B
-
cell
lymphomas formed a single aggregate (cluster 2) (P=0.02, Fisher exact test).
When the contour plots of the
AIDS
-
related
and the non-
AIDS
cases were superimposed, cluster 2 of the
AIDS
cases expressed an intermediate germinal center/activated B-
cell
phenotype compared to clusters 1 and 3 of the non-
AIDS diffuse large B
-
cell
lymphomas.
Our results confirm that non-
AIDS diffuse large B
-
cell
lymphomas segregate into two groups with either germinal center or activated B-
cell
phenotype.
We report the new finding that the
AIDS
status of the patient predicts the immunophenotype of the
diffuse large
B-
cell
lymphomas.
[MeSH-major]
Lymphoma
,
AIDS
-
Related
/ pathology.
Lymphoma
, B-
Cell
/ pathology.
Lymphoma
,
Large B
-
Cell
,
Diffuse
/ pathology
Genetic Alliance.
consumer health - AIDS-HIV
.
Genetic Alliance.
consumer health - B-Cell Lymphomas
.
COS Scholar Universe.
author profiles
.
NCI CPTAC Assay Portal.
NCI CPTAC Assay Portal
.
NCI CPTC Antibody Characterization Program.
NCI CPTC Antibody Characterization Program
.
NCI CPTC Antibody Characterization Program.
NCI CPTC Antibody Characterization Program
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 16444194.001).
[ISSN]
0893-3952
[Journal-full-title]
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
[ISO-abbreviation]
Mod. Pathol.
[Language]
eng
[Publication-type]
Comparative Study; Journal Article
[Publication-country]
United States
[Chemical-registry-number]
0 / BCL6 protein, human; 0 / DNA-Binding Proteins; 0 / Interferon Regulatory Factors; 0 / Ki-67 Antigen; 0 / Proto-Oncogene Proteins c-myc; 0 / interferon regulatory factor-4; EC 3.4.24.11 / Neprilysin
43.
Kizer N, Martinez E, Powell M:
Report of two cases of rasburicase-induced methemoglobinemia.
Leuk Lymphoma
; 2006 Dec;47(12):2648-50
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[MeSH-minor]
Acquired Immunodeficiency Syndrome / complications. Humans. Hyperuricemia / drug therapy.
Lymphoma
,
AIDS
-
Related
/ drug therapy.
Lymphoma
,
Large B
-
Cell
,
Diffuse
/ drug therapy. Male. Mycosis Fungoides / drug therapy. Product Surveillance, Postmarketing. Sarcoidosis, Pulmonary / drug therapy. Treatment Outcome. Tumor Lysis Syndrome / drug therapy. Uric Acid / metabolism
HIV InSite.
treatment guidelines - Human Herpesvirus-8
.
Pharmacogenomics Knowledge Base.
meta-databases - Pharmacogenomic Annotation 1183685241 for PMID:17169811 [PharmGKB]
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 17169811.001).
[ISSN]
1042-8194
[Journal-full-title]
Leukemia & lymphoma
[ISO-abbreviation]
Leuk. Lymphoma
[Language]
eng
[Publication-type]
Case Reports; Letter
[Publication-country]
England
[Chemical-registry-number]
268B43MJ25 / Uric Acid; EC 1.7.3.3 / Urate Oxidase; EC 1.7.3.3. / rasburicase
44.
Balsalobre P, Díez-Martín JL, Re A, Michieli M, Ribera JM, Canals C, Rosselet A, Conde E, Varela R, Cwynarski K, Gabriel I, Genet P, Guillerm G, Allione B, Ferrant A, Biron P, Espigado I, Serrano D, Sureda A:
Autologous stem-cell transplantation in patients with HIV-related lymphoma.
J Clin Oncol
; 2009 May 1;27(13):2192-8
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Autologous stem-
cell
transplantation in patients with HIV-
related lymphoma
.
PURPOSE: Peripheral-blood autologous stem-
cell
transplantation (ASCT) in patients with HIV-
related lymphoma
(HIV-Ly) has been reported as a safe and useful procedure.
RESULTS: Since 1999, 68 patients from 20 institutions (median age, 41 years; range, 29 to 62 years) were included, diagnosed with non-Hodgkin's
lymphoma
(NHL; n = 50) or Hodgkin's
lymphoma
(n = 18).
CI of relapse was 30.4% at 24 months, statistically
related
with not being in CR at ASCT (relative risk [RR] = 3.6), NHL histology other than
diffuse large
B-
cell lymphoma
(RR = 3.4), and use of more than two previous treatment lines (RR = 3).
CONCLUSION: Similarly to HIV-negative patients with
lymphoma
, ASCT is a useful treatment for patients with HIV-Ly and is associated with low NRM, mainly when performed in early stages and chemo-S disease.
[MeSH-major]
Hematopoietic Stem
Cell
Transplantation.
Lymphoma
,
AIDS
-
Related
/ therapy
Genetic Alliance.
consumer health - Transplantation
.
Genetic Alliance.
consumer health - HIV
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[ErratumIn]
J Clin Oncol. 2009 Jul 1;27(19):3263
(PMID = 19332732.001).
[ISSN]
1527-7755
[Journal-full-title]
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
[ISO-abbreviation]
J. Clin. Oncol.
[Language]
eng
[Publication-type]
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
[Publication-country]
United States
45.
Armstrong R, Bradrick J, Liu YC:
Spontaneous regression of an HIV-associated plasmablastic lymphoma in the oral cavity: a case report.
J Oral Maxillofac Surg
; 2007 Jul;65(7):1361-4
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Spontaneous regression of an HIV-associated plasmablastic
lymphoma
in the oral cavity: a case report.
[MeSH-major]
HIV Infections / drug therapy.
Lymphoma
,
AIDS
-
Related
/ physiopathology.
Lymphoma
, B-
Cell
/ physiopathology.
Lymphoma
,
Large B
-
Cell
,
Diffuse
/ physiopathology. Maxillary Neoplasms / physiopathology. Neoplasm Regression, Spontaneous
Genetic Alliance.
consumer health - HIV
.
MedlinePlus Health Information.
consumer health - HIV/AIDS
.
MedlinePlus Health Information.
consumer health - HIV/AIDS Medicines
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 17577503.001).
[ISSN]
0278-2391
[Journal-full-title]
Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons
[ISO-abbreviation]
J. Oral Maxillofac. Surg.
[Language]
eng
[Publication-type]
Case Reports; Journal Article
[Publication-country]
United States
[Chemical-registry-number]
0 / Antigens, CD79; 0 / Ki-67 Antigen; 0 / Syndecan-1
46.
Levine AM:
Management of AIDS-related lymphoma.
Curr Opin Oncol
; 2008 Sep;20(5):522-8
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Management of
AIDS
-
related lymphoma
.
PURPOSE OF REVIEW: With the advent of highly active antiretroviral therapy, the epidemiology of
AIDS
-
lymphoma
has changed, and prognosis has improved.
Although the incidence of
AIDS
-
lymphoma
has decreased, the incidence of HIV-associated Hodgkin's
lymphoma
has increased; mechanisms for these changes in epidemiology will be discussed.
High-dose chemotherapy with autologous stem
cell
transplant is associated with long-term, disease-free survival in approximately 50-80% of patients with relapsed/refractory
AIDS
-
lymphoma
.
Infusional etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin is associated with excellent results among patients with either
diffuse large B cell lymphoma
or Burkitt's
lymphoma
.
Optimal therapy for patients with HIV-Hodgkin's
lymphoma
has not yet been defined.
[MeSH-major]
Antineoplastic Agents / therapeutic use.
Lymphoma
,
AIDS
-
Related
/ drug therapy
Genetic Alliance.
consumer health - AIDS-HIV
.
MedlinePlus Health Information.
consumer health - Cancer Chemotherapy
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 19106654.001).
[ISSN]
1531-703X
[Journal-full-title]
Current opinion in oncology
[ISO-abbreviation]
Curr Opin Oncol
[Language]
eng
[Publication-type]
Journal Article; Review
[Publication-country]
United States
[Chemical-registry-number]
0 / Antineoplastic Agents
[Number-of-references]
48
47.
Desai RS, Vanaki SS, Puranik RS, Giraddi G, Pujari RV:
Plasmablastic lymphoma presenting as a gingival growth in a previously undiagnosed HIV-positive patient: a case report.
J Oral Maxillofac Surg
; 2007 Jul;65(7):1358-61
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Plasmablastic
lymphoma
presenting as a gingival growth in a previously undiagnosed HIV-positive patient: a case report.
[MeSH-major]
Gingival Neoplasms / pathology. HIV Infections / diagnosis.
Lymphoma
,
AIDS
-
Related
/ pathology.
Lymphoma
, B-
Cell
/ pathology.
Lymphoma
,
Large B
-
Cell
,
Diffuse
/ pathology
Genetic Alliance.
consumer health - HIV
.
MedlinePlus Health Information.
consumer health - HIV/AIDS
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 17577502.001).
[ISSN]
0278-2391
[Journal-full-title]
Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons
[ISO-abbreviation]
J. Oral Maxillofac. Surg.
[Language]
eng
[Publication-type]
Case Reports; Journal Article
[Publication-country]
United States
[Chemical-registry-number]
0 / Immunoglobulin lambda-Chains; 0 / Mucin-1; 0 / Syndecan-1
48.
Metta H, Corti M, Maranzana A, Schtirbu R, Narbaitz M, De Dios Soler M:
Unusual case of plasmablastic non-Hodgkin's lymphoma located in the liver. First case reported in an AIDS patient.
Ann Hepatol
; 2009 Jul-Sep;8(3):242-5
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Unusual case of plasmablastic non-Hodgkin's
lymphoma
located in the liver. First case reported in an
AIDS
patient.
Plasmablastic
lymphoma
is a rare and a relatively new entity that was first described in the jaws and the oral cavity of HIV-
AIDS
patients.
We report a case of plasmablastic
lymphoma
involving the liver in an
AIDS
patient.
Plasmablastic
lymphoma
is considered a
diffuse large
B-
cell lymphoma
with a unique phenotype and predilection for the oral cavity.
The smears showed a dense infiltrate composed by atypical lymphocytes with numerous plasmocytes expressing the plasma
cell
markers MUM-1 and CD138 and negative for the B-
cell
markers CD3, CD20 and CD45.
[MeSH-major]
Acquired Immunodeficiency Syndrome / complications. Liver Neoplasms / diagnosis.
Lymphoma
,
AIDS
-
Related
/ diagnosis.
Lymphoma
,
Large B
-
Cell
,
Diffuse
/ diagnosis.
Lymphoma
, Non-Hodgkin / diagnosis
Genetic Alliance.
consumer health - AIDS-HIV
.
MedlinePlus Health Information.
consumer health - HIV/AIDS
.
MedlinePlus Health Information.
consumer health - Liver Cancer
.
HIV InSite.
treatment guidelines - Human Herpesvirus-8
.
NCI CPTAC Assay Portal.
NCI CPTAC Assay Portal
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 19841505.001).
[ISSN]
1665-2681
[Journal-full-title]
Annals of hepatology
[ISO-abbreviation]
Ann Hepatol
[Language]
eng
[Publication-type]
Case Reports; Journal Article
[Publication-country]
Mexico
[Chemical-registry-number]
0 / Interferon Regulatory Factors; 0 / Syndecan-1; 0 / interferon regulatory factor-4
49.
Cornejo-Juárez P, Volkow-Fernández P, Avilés-Salas A, Calderón-Flores E:
AIDS and non-Hodgkin's lymphoma. Experience at an oncological center in Mexico.
Rev Invest Clin
; 2008 Sep-Oct;60(5):375-81
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
AIDS
and non-Hodgkin's
lymphoma
. Experience at an oncological center in Mexico.
BACKGROUND: Non-Hodgkin
lymphoma
(NHL) associated with HIV became an
AIDS
-defining condition early in the epidemic and remains the second most common malignancy in patients with
AIDS
.
With the advent of highly active antiretroviral therapy (HAART), the incidence and mortality of
AIDS
-
related
opportunistic infections and Kaposi's sarcoma has fallen dramatically, this trend is not observed so clearly for NHL.
Our objective was to review the clinical spectrum of patients with
AIDS
-associated NHL and to analyze the impact of HAART on survival at an oncological tertiary center.
RESULTS: Eighty seven HIV-positive patients were diagnosed with NHL (
diffuse large
B-
cell lymphoma
n=69; Burkitt-like n=8; pleomorphic
large cell
n=7; low-grade n=2, and angiocentric n=1).
[MeSH-major]
Cancer Care Facilities / statistics & numerical data.
Lymphoma
,
AIDS
-
Related
/ epidemiology.
Lymphoma
,
Large B
-
Cell
,
Diffuse
/ epidemiology.
Lymphoma
, Non-Hodgkin / epidemiology
Genetic Alliance.
consumer health - AIDS-HIV
.
HIV InSite.
treatment guidelines - Human Herpesvirus-8
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 19227434.001).
[ISSN]
0034-8376
[Journal-full-title]
Revista de investigación clínica; organo del Hospital de Enfermedades de la Nutrición
[ISO-abbreviation]
Rev. Invest. Clin.
[Language]
eng
[Publication-type]
Journal Article
[Publication-country]
Mexico
50.
Gormley RP, Madan R, Dulau AE, Xu D, Tamas EF, Bhattacharyya PK, LeValley A, Xue X, Kumar P, Sparano J, Ramesh KH, Pulijaal V, Cannizzaro L, Walsh D, Ioachim HL, Ratech H:
Germinal center and activated b-cell profiles separate Burkitt lymphoma and diffuse large B-cell lymphoma in AIDS and non-AIDS cases.
Am J Clin Pathol
; 2005 Nov;124(5):790-8
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Germinal center and activated b-
cell
profiles separate Burkitt
lymphoma
and
diffuse large
B-
cell lymphoma
in
AIDS
and non-
AIDS
cases.
Morphologic features of Burkitt
lymphoma
(BL) and
diffuse large
B-
cell lymphoma
(DLBCL) overlap.
We tested a panel of 8 germinal center (GC) and activated B-
cell
(ABC) markers for their ability to separate BL and DLBCL.
We diagnosed 16 BL and 39 DLBCL cases from 21 patients with
AIDS
and 34 without
AIDS
based on traditional morphologic criteria, Ki-67 proliferative index, and c-myc rearrangement (fluorescence in situ hybridization).
[MeSH-major]
B-Lymphocytes / immunology. Burkitt
Lymphoma
/ pathology. Germinal Center / immunology.
Lymphoma
,
AIDS
-
Related
/ pathology.
Lymphoma
, B-
Cell
/ pathology.
Lymphoma
,
Large B
-
Cell
,
Diffuse
/ pathology
Genetic Alliance.
consumer health - AIDS-HIV
.
Genetic Alliance.
consumer health - Large B cell diffuse lymphoma
.
COS Scholar Universe.
author profiles
.
NCI CPTAC Assay Portal.
NCI CPTAC Assay Portal
.
NCI CPTC Antibody Characterization Program.
NCI CPTC Antibody Characterization Program
.
NCI CPTC Antibody Characterization Program.
NCI CPTC Antibody Characterization Program
.
NCI CPTC Antibody Characterization Program.
NCI CPTC Antibody Characterization Program
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 16203284.001).
[ISSN]
0002-9173
[Journal-full-title]
American journal of clinical pathology
[ISO-abbreviation]
Am. J. Clin. Pathol.
[Language]
eng
[Publication-type]
Journal Article
[Publication-country]
United States
51.
Morton LM, Curtis RE, Linet MS, Bluhm EC, Tucker MA, Caporaso N, Ries LA, Fraumeni JF Jr:
Second malignancy risks after non-Hodgkin's lymphoma and chronic lymphocytic leukemia: differences by lymphoma subtype.
J Clin Oncol
; 2010 Nov 20;28(33):4935-44
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Second malignancy risks after non-Hodgkin's
lymphoma
and chronic lymphocytic leukemia: differences by
lymphoma
subtype.
PURPOSE: Previous studies have shown increased risks of second malignancies after non-Hodgkin's
lymphoma
(NHL) and chronic lymphocytic leukemia (CLL); however, no earlier investigation has quantified differences in risk of new malignancy by
lymphoma
subtype.
PATIENTS AND METHODS: We evaluated second cancer and leukemia risks among 43,145 1-year survivors of CLL/small lymphocytic
lymphoma
(SLL),
diffuse large
B-
cell lymphoma
(DLBCL), or follicular
lymphoma
(FL) from 11 Surveillance, Epidemiology, and End Results (SEER) population-based registries during 1992 to 2006.
RESULTS: Among patients without HIV/
AIDS
-
related lymphoma
, lung cancer risks were significantly elevated after CLL/SLL and FL but not after DLBCL (standardized incidence ratio [SIR], CLL/SLL = 1.42, FL = 1.28, DLBCL = 1.00; Poisson regression P for difference among subtypes, P(Diff) = .001).
Patients with HIV/
AIDS
-
related lymphoma
(n = 932) were predominantly diagnosed with DLBCL and had significantly and substantially elevated risks for second anal cancer (SIR = 120.50) and Kaposi's sarcoma (SIR = 138.90).
CONCLUSION: Our findings suggest that differing immunologic alterations, treatments (eg, alkylating agent chemotherapy), genetic susceptibilities, and other risk factors (eg, viral infections, tobacco use) among
lymphoma
subtypes contribute to the patterns of second malignancy risk.
Elucidating these patterns may provide etiologic clues to
lymphoma
as well as to the second malignancies.
Genetic Alliance.
consumer health - Chronic Lymphocytic Leukemia
.
COS Scholar Universe.
author profiles
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Cites]
Cancer Epidemiol Biomarkers Prev. 2005 Apr;14(4):925-33
[
15824165.001
]
[Cites]
Am J Epidemiol. 2010 Feb 1;171(3):267-76
[
20047977.001
]
[Cites]
Br J Cancer. 2005 Jul 11;93(1):159-66
[
15970927.001
]
[Cites]
Cancer Epidemiol Biomarkers Prev. 2005 Oct;14(10):2402-6
[
16214923.001
]
[Cites]
N Engl J Med. 2005 Nov 17;353(20):2135-47
[
16291983.001
]
[Cites]
Lung Cancer. 2005 Dec;50(3):419-20
[
16125820.001
]
[Cites]
J Clin Oncol. 2006 Apr 1;24(10):1568-74
[
16520465.001
]
[Cites]
Cancer. 2006 Jul 1;107(1):108-15
[
16708354.001
]
[Cites]
Haematologica. 2006 Nov;91(11):1481-8
[
17043014.001
]
[Cites]
Leuk Lymphoma. 2006 Nov;47(11):2314-20
[
17107903.001
]
[Cites]
AIDS. 2007 Jan 11;21(2):207-13
[
17197812.001
]
[Cites]
Int J Cancer. 2007 Mar 1;120(5):1099-102
[
17131330.001
]
[Cites]
Cancer Causes Control. 2007 Mar;18(2):135-42
[
17235495.001
]
[Cites]
Int J Cancer. 2007 Jul 1;121(1):151-6
[
17351903.001
]
[Cites]
Blood. 2007 Jun 1;109(11):4617-26
[
17311989.001
]
[Cites]
Blood. 2007 Jul 15;110(2):695-708
[
17389762.001
]
[Cites]
Lancet. 2007 Jul 7;370(9581):59-67
[
17617273.001
]
[Cites]
Int J Cancer. 2008 Jan 1;122(1):144-54
[
17708556.001
]
[Cites]
Cancer Causes Control. 2008 Feb;19(1):43-50
[
17906957.001
]
[Cites]
Haematologica. 2008 Mar;93(3):398-404
[
18268277.001
]
[Cites]
Clin Gastroenterol Hepatol. 2008 Apr;6(4):451-8
[
18387498.001
]
[Cites]
Blood. 2008 Apr 15;111(8):4029-38
[
18263783.001
]
[Cites]
J Clin Oncol. 2008 Apr 10;26(11):1850-7
[
18347006.001
]
[Cites]
Expert Rev Anticancer Ther. 2008 Apr;8(4):605-15
[
18402527.001
]
[Cites]
Int J Cancer. 2008 Jul 1;123(1):187-94
[
18435450.001
]
[Cites]
Expert Opin Pharmacother. 2008 Jun;9(9):1481-94
[
18518779.001
]
[Cites]
Hematol Oncol Clin North Am. 2008 Oct;22(5):941-52, ix
[
18954744.001
]
[Cites]
Blood. 2008 Dec 15;112(13):5150-60
[
18796628.001
]
[Cites]
Blood. 2009 Jan 29;113(5):1175-83
[
18971419.001
]
[Cites]
J Clin Oncol. 1999 Aug;17(8):2454-60
[
10561309.001
]
[Cites]
Cancer. 2001 Feb 15;91(4):874-80
[
11241258.001
]
[Cites]
J Clin Oncol. 2001 Mar 15;19(6):1610-8
[
11250989.001
]
[Cites]
J Natl Cancer Inst. 2002 Feb 6;94(3):182-92
[
11830608.001
]
[Cites]
Semin Oncol. 2002 Feb;29(1 Suppl 2):10-24
[
11842384.001
]
[Cites]
J Clin Oncol. 2002 Sep 15;20(18):3878-84
[
12228208.001
]
[Cites]
Br J Cancer. 2003 Jan 13;88(1):74-8
[
12556962.001
]
[Cites]
Med Oncol. 2003;20(3):211-20
[
14514970.001
]
[Cites]
Eur J Cancer. 2004 Feb;40(3):383-9
[
14746857.001
]
[Cites]
Blood. 2004 Feb 15;103(4):1222-8
[
14576060.001
]
[Cites]
Cancer. 2004 May 1;100(9):1902-8
[
15112271.001
]
[Cites]
J Acquir Immune Defic Syndr. 2004 Aug 15;36(5):1083-91
[
15247562.001
]
[Cites]
J Natl Cancer Inst. 1992 Sep 16;84(18):1422-7
[
1512794.001
]
[Cites]
Eur J Haematol. 1994 Oct;53(4):218-22
[
7957806.001
]
[Cites]
J Natl Cancer Inst. 1995 Apr 5;87(7):524-30
[
7707439.001
]
[Cites]
J Clin Oncol. 1996 Feb;14(2):565-71
[
8636772.001
]
[Cites]
Int J Cancer. 1997 Nov 27;73(5):645-50
[
9398040.001
]
[Cites]
Cancer. 2005 Jan 15;103(2):216-28
[
15578683.001
]
[Cites]
N Engl J Med. 2009 Feb 12;360(7):659-67
[
19213679.001
]
[Cites]
J Natl Cancer Inst. 2009 Feb 18;101(4):248-55
[
19211444.001
]
[Cites]
J Clin Oncol. 2009 Feb 20;27(6):904-10
[
19114699.001
]
[Cites]
Nat Genet. 2009 Aug;41(8):873-5
[
19620980.001
]
[Cites]
J Natl Cancer Inst. 2009 Aug 19;101(16):1120-30
[
19648510.001
]
[Cites]
Blood. 2005 Jun 15;105(12):4573-5
[
15741224.001
]
(PMID = 20940199.001).
[ISSN]
1527-7755
[Journal-full-title]
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
[ISO-abbreviation]
J. Clin. Oncol.
[Language]
ENG
[Grant]
United States / Intramural NIH HHS / /
[Publication-type]
Journal Article; Research Support, N.I.H., Intramural
[Publication-country]
United States
[Other-IDs]
NLM/ PMC3020697
52.
Nagajothi N, Dham SK, Gelfand Y, Sanmugarajah J:
Treatment of AIDS-associated anaplastic large-cell lymphoma with dose-adjusted EPOCH chemotherapy.
J Natl Med Assoc
; 2007 Jul;99(7):799-801
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Treatment of
AIDS
-associated anaplastic
large
-
cell lymphoma
with dose-adjusted EPOCH chemotherapy.
Anaplastic
large
-
cell lymphoma
(ALCL) has rarely been described in patients with acquired immunodeficiency syndrome (
AIDS
).
Reports of treatment of ALCL in the setting of
AIDS
are rare as well.
Dose-adjusted EPOCH (DA-EPOCH; etoposide, prednisone, vincristine, cyclophosphamide and doxorubicin) has been shown to be well tolerated and effective in the treatment of
AIDS
-
related
aggressive B-
cell
lymphomas.
Treatment of
AIDS
-associated ALCL with DA-EPOCH has not been reported.
This report describes two patients with
AIDS
-associated ALCL treated with DA-EPOCH chemotherapy.
Our experience suggests that DA-EPOCH is an effective treatment for
AIDS
-associated ALCL.
[MeSH-major]
Antineoplastic Combined Chemotherapy Protocols.
Lymphoma
,
AIDS
-
Related
/ drug therapy.
Lymphoma
,
Large B
-
Cell
,
Diffuse
/ drug therapy
Genetic Alliance.
consumer health - AIDS-HIV
.
Genetic Alliance.
consumer health - Anaplastic Large Cell Lymphoma
.
Genetic Alliance.
consumer health - Lymphoma, large-cell
.
Hazardous Substances Data Bank.
DOXORUBICIN
.
Hazardous Substances Data Bank.
ETOPOSIDE
.
Hazardous Substances Data Bank.
CYCLOPHOSPHAMIDE
.
Hazardous Substances Data Bank.
PREDNISONE
.
Hazardous Substances Data Bank.
VINCRISTINE
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Cites]
Ann Intern Med. 2005 Aug 16;143(4):265-73
[
16103470.001
]
[Cites]
Blood. 2006 Jan 1;107(1):265-76
[
16150940.001
]
[Cites]
Blood. 1999 Jun 1;93(11):3913-21
[
10339500.001
]
[Cites]
Blood. 1995 Sep 1;86(5):1954-60
[
7655022.001
]
[Cites]
Blood. 1995 Sep 1;86(5):1694-700
[
7655001.001
]
[Cites]
Cancer. 1993 Nov 15;72(10):3078-90
[
8221575.001
]
[Cites]
Am J Surg Pathol. 1988 Apr;12(4):264-74
[
3354752.001
]
[Cites]
Blood. 2000 Dec 1;96(12):3681-95
[
11090048.001
]
[Cites]
Blood. 2003 Jun 15;101(12):4653-9
[
12609827.001
]
[Cites]
Ai Zheng. 2004 Aug;23(8):943-6
[
15301720.001
]
(PMID = 17668647.001).
[ISSN]
1943-4693
[Journal-full-title]
Journal of the National Medical Association
[ISO-abbreviation]
J Natl Med Assoc
[Language]
eng
[Publication-type]
Case Reports; Journal Article
[Publication-country]
United States
[Chemical-registry-number]
5J49Q6B70F / Vincristine; 6PLQ3CP4P3 / Etoposide; 80168379AG / Doxorubicin; 8N3DW7272P / Cyclophosphamide; VB0R961HZT / Prednisone; EPOCH protocol
[Other-IDs]
NLM/ PMC2574342
53.
Gucalp A, Noy A:
Spectrum of HIV lymphoma 2009.
Curr Opin Hematol
; 2010 Jul;17(4):362-7
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Spectrum of HIV
lymphoma
2009.
Lymphomas comprise a
large
proportion of the malignancies that affect the HIV-infected population in developed countries.
This review summarizes the recent progress made in HIV
lymphoma
research published in 2009 through January 2010.
RECENT FINDINGS: The majority of investigation in this field has been in
diffuse large
B-
cell lymphoma
, with infusional therapy remaining promising.
Rituximab likely improves complete response and possibly overall survival, but may be associated with increased infections in a subset of patients with very low CD4
cell
counts.
Risk factors associated with the development of
lymphoma
include low CD4
cell
count and likely cumulative HIV viremia.
SUMMARY: Overall, the outcome for HIV
lymphoma
continues to improve as insights into the pathophysiology and treatment advance.
[MeSH-major]
Antiretroviral Therapy, Highly Active / methods. HIV Infections / therapy.
Lymphoma
,
AIDS
-
Related
/ therapy. Stem
Cell
Transplantation / methods
[MeSH-minor]
Antibodies, Monoclonal / administration & dosage. Antibodies, Monoclonal, Murine-Derived. CD4 Lymphocyte Count. Combined Modality Therapy. HIV / drug effects. Humans.
Lymphoma
,
Large B
-
Cell
,
Diffuse
/ complications.
Lymphoma
,
Large B
-
Cell
,
Diffuse
/ therapy. Rituximab
Genetic Alliance.
consumer health - HIV
.
MedlinePlus Health Information.
consumer health - HIV/AIDS
.
MedlinePlus Health Information.
consumer health - HIV/AIDS Medicines
.
HIV InSite.
treatment guidelines - Human Herpesvirus-8
.
Hazardous Substances Data Bank.
RITUXIMAB
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 20442655.001).
[ISSN]
1531-7048
[Journal-full-title]
Current opinion in hematology
[ISO-abbreviation]
Curr. Opin. Hematol.
[Language]
eng
[Publication-type]
Journal Article; Review
[Publication-country]
United States
[Chemical-registry-number]
0 / Antibodies, Monoclonal; 0 / Antibodies, Monoclonal, Murine-Derived; 4F4X42SYQ6 / Rituximab
[Number-of-references]
36
54.
Foschi D, Rizzi A, Corsi F, Trabucchi E, Corbellino M:
Chylous ascites secondary to B-cell non Hodgkin's lymphoma in a patient with the acquired immune deficiency syndrome (AIDS).
Dig Liver Dis
; 2008 Jun;40(6):481-2
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Chylous ascites secondary to B-
cell
non Hodgkin's
lymphoma
in a patient with the acquired immune deficiency syndrome (
AIDS
).
In the present article we describe a patient with
AIDS
and chylous ascites secondary to B-
cell
non Hodgkin's
lymphoma
.
The final pathology report was of
diffuse
, CD20-positive, CD3-negative, Epstein Barr Virus-negative,
large B
-
Cell
non Hodgkin's
lymphoma
.
Five months after the initial diagnosis of
lymphoma
, the patient relapsed and was treated with high-dose BEAM (carmustine, etoposide, cytosine, arabinoside, melphalan) chemotherapy followed by CD34 stem-
cell
transplantations salvage therapy.
[MeSH-major]
Acquired Immunodeficiency Syndrome / complications. Chylous Ascites / etiology.
Lymphoma
,
AIDS
-
Related
/ complications.
Lymphoma
, B-
Cell
/ complications
Genetic Alliance.
consumer health - Chylous Ascites
.
Genetic Alliance.
consumer health - AIDS-HIV
.
MedlinePlus Health Information.
consumer health - HIV/AIDS
.
HIV InSite.
treatment guidelines - Human Herpesvirus-8
.
NCI CPTC Antibody Characterization Program.
NCI CPTC Antibody Characterization Program
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 17997372.001).
[ISSN]
1878-3562
[Journal-full-title]
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
[ISO-abbreviation]
Dig Liver Dis
[Language]
eng
[Publication-type]
Case Reports; Journal Article
[Publication-country]
Netherlands
55.
Gilaberte M, Gallardo F, Bellosillo B, Saballs P, Barranco C, Serrano S, Pujol RM:
Recurrent and self-healing cutaneous monoclonal plasmablastic infiltrates in a patient with AIDS and Kaposi sarcoma.
Br J Dermatol
; 2005 Oct;153(4):828-32
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Recurrent and self-healing cutaneous monoclonal plasmablastic infiltrates in a patient with
AIDS
and Kaposi sarcoma.
Infection with human immunodeficiency virus (HIV) increases the risk of developing non-Hodgkin
lymphoma
.
Plasmablastic
lymphoma
(PBL) is a rare variant of
diffuse large cell lymphoma
that often involves the oral cavity of HIV+ patients.
It is characterized by immunoblastic morphology and plasma
cell
phenotype.
We report a 44-year-old man with
AIDS
and Kaposi sarcoma (KS) previously treated with doxorubicin who, following treatment with highly active antiretroviral therapy, developed an erythematous infiltrated nodule on the right arm.
Histology showed subcutaneous fat necrosis and clusters of atypical
large
plasma cells (plasmablastic cells).
PBL may be seen in patients with transplants or receiving chemotherapy, but is usually observed in patients with advanced
AIDS
.
The observation of recurrent self-healing EBV- and HHV-8-associated cutaneous monoclonal plasmablastic infiltrates, in a patient with
AIDS
and KS, expands the clinical spectrum of
AIDS
-associated plasmablastic lymphoproliferative disorders.
[MeSH-major]
Acquired Immunodeficiency Syndrome / complications. Epstein-Barr Virus Infections / complications. Herpesvirus 8, Human.
Lymphoma
,
AIDS
-
Related
/ virology. Sarcoma, Kaposi / complications
[MeSH-minor]
Adult. Humans.
Lymphoma
,
Large B
-
Cell
,
Diffuse
/ pathology.
Lymphoma
,
Large B
-
Cell
,
Diffuse
/ virology. Male. Neoplasm Regression, Spontaneous. Recurrence
Genetic Alliance.
consumer health - AIDS-HIV
.
MedlinePlus Health Information.
consumer health - HIV/AIDS
.
MedlinePlus Health Information.
consumer health - Kaposi's Sarcoma
.
HIV InSite.
treatment guidelines - Human Herpesvirus-8
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 16181470.001).
[ISSN]
0007-0963
[Journal-full-title]
The British journal of dermatology
[ISO-abbreviation]
Br. J. Dermatol.
[Language]
eng
[Publication-type]
Case Reports; Journal Article
[Publication-country]
England
56.
Ojha J, Gupta A, Aziz N:
Intraoral diffuse large B-cell lymphoma with Burkitt-like morphology in an HIV-positive patient--a diagnostic dilemma.
J Oral Maxillofac Surg
; 2010 Oct;68(10):2632-8
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Intraoral
diffuse large
B-
cell lymphoma
with Burkitt-like morphology in an HIV-positive patient--a diagnostic dilemma.
[MeSH-major]
Burkitt
Lymphoma
/ pathology.
Lymphoma
,
AIDS
-
Related
/ pathology.
Lymphoma
,
Large B
-
Cell
,
Diffuse
/ pathology. Maxillary Neoplasms / pathology
Genetic Alliance.
consumer health - Large B cell diffuse lymphoma
.
Genetic Alliance.
consumer health - HIV
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 20591554.001).
[ISSN]
1531-5053
[Journal-full-title]
Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons
[ISO-abbreviation]
J. Oral Maxillofac. Surg.
[Language]
eng
[Publication-type]
Case Reports; Journal Article
[Publication-country]
United States
57.
Hishima T, Oyaizu N, Fujii T, Tachikawa N, Ajisawa A, Negishi M, Nakamura T, Iwamoto A, Hayashi Y, Matsubara D, Sasao Y, Kimura S, Kikuchi Y, Teruya K, Yasuoka A, Oka S, Saito K, Mori S, Funata N, Sata T, Katano H:
Decrease in Epstein-Barr virus-positive AIDS-related lymphoma in the era of highly active antiretroviral therapy.
Microbes Infect
; 2006 Apr;8(5):1301-7
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Decrease in Epstein-Barr virus-positive
AIDS
-
related lymphoma
in the era of highly active antiretroviral therapy.
Recent introduction of highly active antiretroviral therapy (HAART) is reported to have reduced the incidence of
lymphoma
among HIV-infected individuals.
A clinicopathological study was performed on 86
AIDS
-
related lymphoma
patients who were treated in Tokyo area from 1987 to 2005.
The incidence of
lymphoma
detected by autopsy was 27% (53 cases/198 autopsies).
Diffuse large B cell lymphoma
was the most predominant histological subtype throughout the period (78%).
Burkitt's
lymphoma
(BL) increased from 2% in the pre-HAART era (before end-1997) to 13% in the HAART era, whereas incidence of BL did not vary between HAART users and non-users.
Epstein-Barr virus (EBV)-positive
lymphoma
decreased from 88% in the pre-HAART era to 58% in the HAART era, but did not differ significantly between HAART users (73%) and non-users (74%).
Nodal involvement of
lymphoma
increased from 14% in the pre-HAART era to 50% in the HAART era; however, central nervous system involvement decreased from 62 to 38%.
These data suggest that HAART might play a partial role in these changes, and the alteration in immunological backgrounds, such as EBV prevalence, is suggested as another leading cause of these changes in Japanese
AIDS
-
related lymphoma
.
Genetic Alliance.
consumer health - AIDS-HIV
.
MedlinePlus Health Information.
consumer health - HIV/AIDS
.
MedlinePlus Health Information.
consumer health - HIV/AIDS in Women
.
MedlinePlus Health Information.
consumer health - HIV/AIDS Medicines
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 16697236.001).
[ISSN]
1286-4579
[Journal-full-title]
Microbes and infection
[ISO-abbreviation]
Microbes Infect.
[Language]
ENG
[Publication-type]
Journal Article; Research Support, Non-U.S. Gov't
[Publication-country]
France
58.
Corti M, de Dios Soler M, Bare P, Villafañe MF, De Tezanos Pinto M, Perez Bianco R, Narbaitz M:
[AIDS related lymphomas: Histopathological subtypes and association with Epstein Barr virus and Human Herpes virus type-8].
Medicina (B Aires)
; 2010;70(2):151-8
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
[
AIDS related
lymphomas: Histopathological subtypes and association with Epstein Barr virus and Human Herpes virus type-8].
Non-Hodgkin lymphomas (NHL) of the B-
cell
type are the second most common neoplasm among patients with human immunodeficiency virus (HIV) infection and
AIDS
.
Here, we evaluated 48 cases of
AIDS
-
related
lymphomas (ARL) diagnosed at the Histopathological Division of the Instituto de Investigaciones Hematológicas of the National Academy of Medicine.
All were fenotype
B cell
lymphomas with an aggressive course and advanced neoplasm disease at the time of diagnosis.
Virological findings showed the strong association between EBV and
AIDS
-
related
NHL.
According to the histopathological subtype, the EBV genome was detected in 16/21 (76%)
diffuse large B cell
lymphomas, 1/3 Burkitt
lymphoma
and 3/4 (75%) of primary central nervous system lymphomas.
Hodgkin
lymphoma
were more frequent in males 18/20 (90%), with an aggressive clinical course and a significant predominance of the subtypes associated with worse prognosis (90% of cases).
We consider that all cases of
AIDS related
lymphomas should be assessed for the presence of EBV because its presence may play a role in the prognosis.
[MeSH-major]
DNA, Viral / analysis. Herpesvirus 4, Human / genetics. Hodgkin Disease / virology.
Lymphoma
,
AIDS
-
Related
/ virology.
Lymphoma
, Non-Hodgkin / virology
Genetic Alliance.
consumer health - AIDS-HIV
.
MedlinePlus Health Information.
consumer health - Hodgkin Disease
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 20447898.001).
[ISSN]
0025-7680
[Journal-full-title]
Medicina
[ISO-abbreviation]
Medicina (B Aires)
[Language]
spa
[Publication-type]
English Abstract; Journal Article
[Publication-country]
Argentina
[Chemical-registry-number]
0 / DNA, Viral
59.
Boué F, Gabarre J, Gisselbrecht C, Reynes J, Cheret A, Bonnet F, Billaud E, Raphael M, Lancar R, Costagliola D:
Phase II trial of CHOP plus rituximab in patients with HIV-associated non-Hodgkin's lymphoma.
J Clin Oncol
; 2006 Sep 1;24(25):4123-8
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Phase II trial of CHOP plus rituximab in patients with HIV-associated non-Hodgkin's
lymphoma
.
PURPOSE: To evaluate the safety and efficacy of rituximab adjunction to the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) regimen in patients with newly diagnosed
AIDS
-
related
non-Hodgkin's
lymphoma
.
PATIENTS AND METHODS: HIV-seropositive patients with high-grade
lymphoma
of B-
cell
origin were eligible if they had no more than one of the following characteristics: CD4
cell
count less than 100/microL, prior
AIDS
, or performance status less than 2.
Characteristics of patients were median age, 41 years; median CD4 cells, 172/microL; histology,
diffuse large
B-
cell lymphoma
(n = 42), immunoblastic (n = 2), Burkitt
lymphoma
(n = 16), and plasmablastic (n = 1); 42 patients with stage III to IV; International Prognostic Index 0 to 1 (n=31), and 2 to 3 (n = 27).
Eighteen patients died: 16 as a result of
lymphoma
, one as a result of infection, and one as a result of encephalitis.
CONCLUSION: Rituximab adjunction to CHOP produced a CR rate of 77% and a 2-year survival rate of 75% in patients with
AIDS
-
related
non-Hodgkin's
lymphoma
, without increasing the risk of life-threatening infections.
[MeSH-major]
Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Hodgkin Disease / drug therapy.
Lymphoma
,
AIDS
-
Related
/ drug therapy
Genetic Alliance.
consumer health - HIV
.
MedlinePlus Health Information.
consumer health - Hodgkin Disease
.
Hazardous Substances Data Bank.
RITUXIMAB
.
Hazardous Substances Data Bank.
DOXORUBICIN
.
Hazardous Substances Data Bank.
CYCLOPHOSPHAMIDE
.
Hazardous Substances Data Bank.
PREDNISONE
.
Hazardous Substances Data Bank.
VINCRISTINE
.
NCI CPTC Antibody Characterization Program.
NCI CPTC Antibody Characterization Program
.
The Lens.
Cited by Patents in
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[CommentIn]
J Clin Oncol. 2007 Feb 20;25(6):e6
[
17308260.001
]
[CommentIn]
J Clin Oncol. 2007 Feb 20;25(6):e7
[
17308261.001
]
(PMID = 16896005.001).
[ISSN]
1527-7755
[Journal-full-title]
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
[ISO-abbreviation]
J. Clin. Oncol.
[Language]
eng
[Publication-type]
Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
[Publication-country]
United States
[Chemical-registry-number]
0 / Antibodies, Monoclonal; 0 / Antibodies, Monoclonal, Murine-Derived; 4F4X42SYQ6 / Rituximab; 5J49Q6B70F / Vincristine; 80168379AG / Doxorubicin; 8N3DW7272P / Cyclophosphamide; VB0R961HZT / Prednisone; CHOP protocol
60.
Noy A:
Update on HIV lymphoma.
Curr Oncol Rep
; 2007 Sep;9(5):384-90
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Update on HIV
lymphoma
.
In these countries,
lymphoma
is the most common HIV-associated malignancy.
The majority of investigation has been in
diffuse large B cell lymphoma
, with infusional therapy remaining promising but cumbersome.
Biologic insights have been attained in the spectrum of HIV-associated non-Hodgkin's
lymphoma
, Hodgkin's
lymphoma
, and virologic coinfections.
Overall, the outcome for non-Hodgkin's
lymphoma
and Hodgkin's
lymphoma
in the setting of HIV continues to improve as insights into the pathophysiology and treatment advance.
[MeSH-major]
Lymphoma
,
AIDS
-
Related
Genetic Alliance.
consumer health - HIV
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Cites]
N Engl J Med. 1993 Sep 30;329(14 ):987-94
[
8141877.001
]
[Cites]
Exp Hematol. 2005 Apr;33(4):487-94
[
15781340.001
]
[Cites]
Blood. 2005 Nov 1;106(9):3166-74
[
16014568.001
]
[Cites]
Blood. 2004 Jan 1;103(1):275-82
[
14504078.001
]
[Cites]
Blood. 2006 Jan 1;107(1):13-20
[
16099881.001
]
[Cites]
Br J Cancer. 2006 Dec 4;95(11):1598-602
[
17106439.001
]
[Cites]
Clin Lymphoma Myeloma. 2006 Mar;6(5):399-402
[
16640817.001
]
[Cites]
Clin Infect Dis. 2006 Feb 15;42(4):e21-5
[
16421782.001
]
[Cites]
Ann Hematol. 2005 Oct;84(10):661-6
[
15875183.001
]
[Cites]
J Clin Oncol. 2005 Jul 1;23(19):4430-8
[
15883411.001
]
[Cites]
Blood. 1997 Feb 15;89(4):1413-20
[
9028965.001
]
[Cites]
Blood. 2005 Jan 15;105(2):496-502
[
15358629.001
]
[Cites]
Am J Surg Pathol. 2005 Dec;29(12):1633-41
[
16327436.001
]
[Cites]
Ann Intern Med. 2005 Aug 16;143(4):265-73
[
16103470.001
]
[Cites]
Clin Infect Dis. 2005 Apr 1;40(7):1022-7
[
15824995.001
]
[Cites]
AIDS Res Hum Retroviruses. 2005 Mar;21(3):214-20
[
15795527.001
]
[Cites]
AIDS. 2005 Oct 14;19(15):1711-2
[
16184051.001
]
[Cites]
Blood. 2003 Jun 15;101(12):4653-9
[
12609827.001
]
[Cites]
J Clin Oncol. 2006 Sep 1;24(25):4123-8
[
16896005.001
]
[Cites]
Cancer. 2002 Mar 1;94(5):1492-9
[
11920506.001
]
[Cites]
Cancer. 2003 Sep 15;98(6):1196-205
[
12973843.001
]
[Cites]
Blood. 2006 Apr 1;107(7):3014-5
[
16554492.001
]
[Cites]
AJNR Am J Neuroradiol. 2005 Sep;26(8):1973-9
[
16155145.001
]
[Cites]
J Clin Oncol. 2000 Oct 1;18(19):3325-30
[
11013271.001
]
[Cites]
Transplantation. 2005 Sep 15;80(5):673-82
[
16177644.001
]
[Cites]
Blood. 2001 Dec 15;98(13):3857-9
[
11739198.001
]
[Cites]
Blood. 2006 Apr 15;107(8):3412-4
[
16597601.001
]
[Cites]
J Clin Oncol. 2005 Nov 1;23(31):8116-7
[
16258111.001
]
[Cites]
Br J Dermatol. 2005 Oct;153(4):828-32
[
16181470.001
]
[Cites]
Blood. 2005 Mar 1;105(5):1891-7
[
15550484.001
]
[Cites]
Ann Oncol. 2004 Nov;15(11):1673-9
[
15520070.001
]
[Cites]
Int J Cancer. 2005 Aug 10;116(1):161-3
[
15756687.001
]
[Cites]
J Acquir Immune Defic Syndr. 2005 Jul 1;39(3):293-9
[
15980688.001
]
[Cites]
Blood. 2006 May 15;107(10):3832-40
[
16410446.001
]
[Cites]
Eur J Haematol. 2005 Jan;74(1):70-2
[
15613110.001
]
[Cites]
Nature. 2000 Feb 3;403(6769):503-11
[
10676951.001
]
[Cites]
J Clin Oncol. 2005 Jul 1;23(19):4372-80
[
15994147.001
]
[Cites]
Blood. 2007 Apr 15;109(8):3214-8
[
17209054.001
]
[Cites]
Leuk Lymphoma. 2005 Feb;46(2):207-15
[
15621803.001
]
[Cites]
Blood. 2005 Sep 1;106(5):1538-43
[
15914552.001
]
[Cites]
J Clin Oncol. 2005 Nov 1;23(31):8132-3; author reply 8133-4
[
16258119.001
]
[Cites]
Leukemia. 2005 May;19(5):851-5
[
15744337.001
]
[Cites]
HIV Med. 2005 Jan;6(1):21-6
[
15670248.001
]
[Cites]
Blood. 2005 Sep 1;106(5):1762-9
[
15905193.001
]
[Cites]
Haematologica. 2005 Jul;90(7):990-2
[
15996943.001
]
[Cites]
Blood. 2006 Dec 1;108(12):3786-91
[
16917006.001
]
[Cites]
Clin Infect Dis. 2006 Feb 1;42(3):411-7
[
16392091.001
]
[Cites]
Cell Res. 2005 Nov-Dec;15(11-12):947-52
[
16354573.001
]
[Cites]
J Cell Biol. 2003 Jun 9;161(5):839-43
[
12796473.001
]
[Cites]
Virology. 2005 Nov 10;342(1):38-46
[
16122775.001
]
[Cites]
J Clin Oncol. 2003 Dec 1;21(23):4423-7
[
14581441.001
]
[Cites]
J Clin Oncol. 2005 Nov 20;23(33):8477-82
[
16230675.001
]
(PMID = 17706167.001).
[ISSN]
1523-3790
[Journal-full-title]
Current oncology reports
[ISO-abbreviation]
Curr Oncol Rep
[Language]
eng
[Publication-type]
Journal Article; Review
[Publication-country]
United States
[Chemical-registry-number]
0 / Anti-Retroviral Agents
[Number-of-references]
52
61.
Chabay P, De Matteo E, Lorenzetti M, Gutierrez M, Narbaitz M, Aversa L, Preciado MV:
Vulvar plasmablastic lymphoma in a HIV-positive child: a novel extraoral localisation.
J Clin Pathol
; 2009 Jul;62(7):644-6
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Vulvar plasmablastic
lymphoma
in a HIV-positive child: a novel extraoral localisation.
Plasmablastic
lymphoma
(PBL) has been characterised by the World Health Organization as a new entity.
Histopathological examination of a biopsy sample showed
diffuse
submucosal infiltration by
large
cells with a cohesive growth pattern, and round and vesicular nuclei with fine chromatin centrally or eccentrically placed with one or more prominent nucleoli.
[MeSH-major]
Lymphoma
,
AIDS
-
Related
/ pathology.
Lymphoma
,
Large B
-
Cell
,
Diffuse
/ pathology. Vulvar Neoplasms / pathology
Genetic Alliance.
consumer health - HIV
.
MedlinePlus Health Information.
consumer health - Vulvar Cancer
.
NCI CPTAC Assay Portal.
NCI CPTAC Assay Portal
.
NCI CPTC Antibody Characterization Program.
NCI CPTC Antibody Characterization Program
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 19561233.001).
[ISSN]
1472-4146
[Journal-full-title]
Journal of clinical pathology
[ISO-abbreviation]
J. Clin. Pathol.
[Language]
eng
[Publication-type]
Case Reports; Journal Article; Research Support, Non-U.S. Gov't
[Publication-country]
England
62.
Pantanowitz L, Pihan G, Carbone A, Dezube BJ:
Differentiating HIV-associated non-Hodgkin's lymphomas with similar plasmacellular differentiation.
J HIV Ther
; 2009 Jun;14(2):24-33
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[MeSH-major]
Lymphoma
,
AIDS
-
Related
/ pathology.
Lymphoma
, Non-Hodgkin / pathology. Plasma Cells / pathology
[MeSH-minor]
Burkitt
Lymphoma
/ pathology.
Cell
Differentiation. Herpesvirus 4, Human / isolation & purification. Herpesvirus 8, Human / isolation & purification. Humans.
Lymphoma
,
Large B
-
Cell
,
Diffuse
/ pathology. Lymphoproliferative Disorders / pathology
Genetic Alliance.
consumer health - HIV
.
COS Scholar Universe.
author profiles
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 19839364.001).
[ISSN]
1462-0308
[Journal-full-title]
Journal of HIV therapy
[ISO-abbreviation]
J HIV Ther
[Language]
eng
[Publication-type]
Journal Article; Research Support, Non-U.S. Gov't; Review
[Publication-country]
England
[Number-of-references]
123
63.
Carbone A, Gloghini A, Vaccher E, Cerri M, Gaidano G, Dalla-Favera R, Tirelli U:
Kaposi's sarcoma-associated herpesvirus/human herpesvirus type 8-positive solid lymphomas: a tissue-based variant of primary effusion lymphoma.
J Mol Diagn
; 2005 Feb;7(1):17-27
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Kaposi's sarcoma-associated herpesvirus/human herpesvirus type 8-positive solid lymphomas: a tissue-based variant of primary effusion
lymphoma
.
Kaposi's sarcoma-associated herpesvirus (KSHV), also termed human herpesvirus type 8, is consistently identified in Kaposi's sarcoma, primary effusion
lymphoma
(PEL), and multicentric Castleman's disease.
Here we report four cases of KSHV-bearing solid lymphomas that occurred in
AIDS
patients (cases 1 to 3) and in a human immunodeficiency virus (HIV)-seronegative person (case 4).
Epstein-Barr virus was detected in two of the HIV-
related
cases.
All KSHV-positive solid lymphomas exhibited PEL-like
cell
morphology.
To investigate the relationship of these disorders to PEL and to other
AIDS
-associated
diffuse large cell
lymphomas, KSHV-positive solid lymphomas were tested for the expression of a set of genes that were previously shown by gene profiling analysis to define PEL tumor cells.
The results showed that expression of this set of genes in KSHV-positive lymphomas is similar to that of PEL but distinct from KSHV-negative
AIDS
-associated
diffuse large cell
lymphomas.
Genetic Alliance.
consumer health - Primary effusion lymphoma
.
MedlinePlus Health Information.
consumer health - Lymphoma
.
HIV InSite.
treatment guidelines - Human Herpesvirus-8
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Cites]
Mod Pathol. 2000 Jan;13(1):77-85
[
10658913.001
]
[Cites]
Am J Surg Pathol. 1999 Oct;23(10):1208-16
[
10524521.001
]
[Cites]
Leuk Lymphoma. 1999 Oct;35(3-4):379-87
[
10706463.001
]
[Cites]
AIDS. 2000 Aug 18;14(12):1675-88
[
10985303.001
]
[Cites]
Adv Cancer Res. 2001;80:115-46
[
11034542.001
]
[Cites]
Blood. 2001 Feb 1;97(3):744-51
[
11157493.001
]
[Cites]
J Mol Diagn. 2001 Feb;3(1):32-8
[
11227070.001
]
[Cites]
Methods. 2001 Dec;25(4):402-8
[
11846609.001
]
[Cites]
Blood. 2002 Apr 1;99(7):2331-6
[
11895764.001
]
[Cites]
AIDS Patient Care STDS. 2002 Apr;16(4):139-45
[
12015867.001
]
[Cites]
Hum Pathol. 2002 Aug;33(8):846-9
[
12203218.001
]
[Cites]
Am J Surg Pathol. 2002 Oct;26(10):1363-7
[
12360052.001
]
[Cites]
Blood. 2002 Nov 1;100(9):3415-8
[
12384445.001
]
[Cites]
Blood. 2003 May 15;101(10):4115-21
[
12531789.001
]
[Cites]
Mod Pathol. 2003 May;16(5):424-9
[
12748248.001
]
[Cites]
Blood. 2003 Nov 15;102(10):3775-85
[
12907442.001
]
[Cites]
J Mol Diagn. 2004 Nov;6(4):290-6
[
15507667.001
]
[Cites]
Cancer Res. 1971 Nov;31(11):1860-1
[
5121694.001
]
[Cites]
J Histochem Cytochem. 1984 Feb;32(2):219-29
[
6198355.001
]
[Cites]
J Clin Oncol. 1985 Sep;3(9):1202-16
[
4031967.001
]
[Cites]
N Engl J Med. 1993 Feb 4;328(5):327-35
[
8093551.001
]
[Cites]
Lancet. 1993 Feb 13;341(8842):441
[
8094208.001
]
[Cites]
EMBO J. 1993 Dec 15;12(13):4955-67
[
8262038.001
]
[Cites]
Science. 1994 Dec 16;266(5192):1865-9
[
7997879.001
]
[Cites]
N Engl J Med. 1995 May 4;332(18):1186-91
[
7700311.001
]
[Cites]
Blood. 1995 Aug 15;86(4):1276-80
[
7632932.001
]
[Cites]
Br J Haematol. 1996 Sep;94(3):533-43
[
8790156.001
]
[Cites]
AIDS. 1996 Aug;10(9):941-9
[
8853726.001
]
[Cites]
Am J Surg Pathol. 1997 Jun;21(6):719-24
[
9199651.001
]
[Cites]
Int J Cancer. 1997 Oct 9;73(2):303-4
[
9335459.001
]
[Cites]
Int J Cancer. 1997 Nov 14;73(4):562-9
[
9389573.001
]
[Cites]
Br J Haematol. 1998 Sep;102(4):1081-9
[
9734661.001
]
[Cites]
Semin Cancer Biol. 1999 Jun;9(3):165-74
[
10343068.001
]
[Cites]
Am J Surg Pathol. 1999 Aug;23(8):992-4
[
10435572.001
]
[Cites]
Blood. 2000 Feb 15;95(4):1406-12
[
10666218.001
]
(PMID = 15681470.001).
[ISSN]
1525-1578
[Journal-full-title]
The Journal of molecular diagnostics : JMD
[ISO-abbreviation]
J Mol Diagn
[Language]
ENG
[Grant]
United States / NCI NIH HHS / CA / R01 CA037295; United States / NCI NIH HHS / CA / R37 CA037295; United States / NCI NIH HHS / CA / CA-37295
[Publication-type]
Case Reports; Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
[Publication-country]
United States
[Other-IDs]
NLM/ PMC1876263
64.
Lim ST, Rubin N, Said J, Levine AM:
Primary effusion lymphoma: successful treatment with highly active antiretroviral therapy and rituximab.
Ann Hematol
; 2005 Aug;84(8):551-2
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Primary effusion
lymphoma
: successful treatment with highly active antiretroviral therapy and rituximab.
[MeSH-major]
Anti-Retroviral Agents / therapeutic use. Antibodies, Monoclonal / therapeutic use.
Lymphoma
/ drug therapy. Pleural Effusion, Malignant / drug therapy
[MeSH-minor]
Antibodies, Monoclonal, Murine-Derived. Herpesvirus 8, Human / isolation & purification. Humans.
Lymphoma
,
AIDS
-
Related
/ diagnosis.
Lymphoma
,
AIDS
-
Related
/ drug therapy.
Lymphoma
,
Large B
-
Cell
,
Diffuse
/ diagnosis.
Lymphoma
,
Large B
-
Cell
,
Diffuse
/ drug therapy. Male. Middle Aged. Neoplasms, Second Primary / diagnosis. Neoplasms, Second Primary / drug therapy. Pericardial Effusion / pathology. Remission Induction. Rituximab
Genetic Alliance.
consumer health - Primary effusion lymphoma
.
MedlinePlus Health Information.
consumer health - Lymphoma
.
Hazardous Substances Data Bank.
RITUXIMAB
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 15800785.001).
[ISSN]
0939-5555
[Journal-full-title]
Annals of hematology
[ISO-abbreviation]
Ann. Hematol.
[Language]
eng
[Publication-type]
Letter
[Publication-country]
Germany
[Chemical-registry-number]
0 / Anti-Retroviral Agents; 0 / Antibodies, Monoclonal; 0 / Antibodies, Monoclonal, Murine-Derived; 4F4X42SYQ6 / Rituximab
65.
Collins JA, Hernández AV, Hidalgo JA, Villena J, Sumire J, Delgado V, Salazar R, Almenara Hospital AIDS Working Group:
High proportion of T-cell systemic non-Hodgkin lymphoma in HIV-infected patients in Lima, Peru.
J Acquir Immune Defic Syndr
; 2005 Dec 15;40(5):558-64
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
High proportion of T-
cell
systemic non-Hodgkin
lymphoma
in HIV-infected patients in Lima, Peru.
OBJECTIVE: Few reports have described the clinical and pathologic characteristics of HIV-
related
systemic non-Hodgkin
lymphoma
(sNHL) in developing countries.
METHODS: A retrospective/prospective study of patients with HIV-
related
sNHL from the Guillermo Almenara General Hospital in Lima, Peru between 1993 and 2004.
Clinical characteristics at diagnosis included age, gender, risk behavior, previous
AIDS
diagnosis, opportunistic diseases, previous highly active antiretroviral therapy, Karnofsky score, origin, clinical stage and B-
cell
symptoms of sNHL, and CD4
cell
count.
Ten patients (30%) had a prior history of
AIDS
, 14 (42%) had a Karnofsky score of <or=70, and 18 (56%) had clinical stage IV sNHL.
The CD4
cell
count median value was 111 cells/microL (n = 25).
Twenty-four cases (73%) were B-
cell
sNHL, and 9 cases (27%) were T-
cell
sNHL, both from peripheral cells.
Nineteen cases of sNHL were extranodal: 15 of B-
cell
origin and 4 of T-
cell
origin.
Eighteen cases of B-
cell
sNHL had
diffuse large cell
histologic findings, and all cases of T-
cell
sNHL were unspecified.
Although there were no significant differences in clinical characteristics between phenotypes, patients with T-
cell
sNHL had less aggressive disease and a better survival rate.
CONCLUSIONS: A high proportion of T-
cell
sNHL cases was found at an HIV reference center in Peru.
Clinical characteristics were similar between B-
cell
and T-
cell lymphoma
patients.
T-
cell lymphoma
was less aggressive, and patients with T-
cell lymphoma
had a better survival rate than those with B-
cell lymphoma
.
[MeSH-major]
HIV Infections / complications.
Lymphoma
,
AIDS
-
Related
/ epidemiology.
Lymphoma
, T-
Cell
/ epidemiology
Genetic Alliance.
consumer health - Hodgkin lymphoma
.
Genetic Alliance.
consumer health - Non-Hodgkin Lymphoma
.
Genetic Alliance.
consumer health - HIV
.
MedlinePlus Health Information.
consumer health - HIV/AIDS
.
MedlinePlus Health Information.
consumer health - HIV/AIDS in Women
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 16284532.001).
[ISSN]
1525-4135
[Journal-full-title]
Journal of acquired immune deficiency syndromes (1999)
[ISO-abbreviation]
J. Acquir. Immune Defic. Syndr.
[Language]
eng
[Publication-type]
Journal Article; Research Support, Non-U.S. Gov't
[Publication-country]
United States
66.
Larson ML, Enschede SH, Gregory SA:
HIV-related lymphoma treated with maintenance thalidomide.
Clin Adv Hematol Oncol
; 2005 Mar;3(3):231-4; discussion 234-5
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
HIV-
related lymphoma
treated with maintenance thalidomide.
[MeSH-major]
Antineoplastic Agents / therapeutic use.
Lymphoma
,
AIDS
-
Related
/ drug therapy.
Lymphoma
,
Large B
-
Cell
,
Diffuse
/ drug therapy. Thalidomide / therapeutic use
Genetic Alliance.
consumer health - HIV
.
MedlinePlus Health Information.
consumer health - Cancer Chemotherapy
.
HIV InSite.
treatment guidelines - Pneumocystosis and HIV
.
Hazardous Substances Data Bank.
RITUXIMAB
.
Hazardous Substances Data Bank.
DOXORUBICIN
.
Hazardous Substances Data Bank.
ETOPOSIDE
.
Hazardous Substances Data Bank.
IFOSFAMIDE
.
Hazardous Substances Data Bank.
CARBOPLATIN
.
Hazardous Substances Data Bank.
CYCLOPHOSPHAMIDE
.
Hazardous Substances Data Bank.
THALIDOMIDE
.
Hazardous Substances Data Bank.
PREDNISONE
.
Hazardous Substances Data Bank.
VINCRISTINE
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 16166993.001).
[ISSN]
1543-0790
[Journal-full-title]
Clinical advances in hematology & oncology : H&O
[ISO-abbreviation]
Clin Adv Hematol Oncol
[Language]
eng
[Publication-type]
Case Reports; Journal Article; Review
[Publication-country]
United States
[Chemical-registry-number]
0 / Antibodies, Monoclonal; 0 / Antibodies, Monoclonal, Murine-Derived; 0 / Antineoplastic Agents; 4F4X42SYQ6 / Rituximab; 4Z8R6ORS6L / Thalidomide; 5J49Q6B70F / Vincristine; 6PLQ3CP4P3 / Etoposide; 80168379AG / Doxorubicin; 8N3DW7272P / Cyclophosphamide; BG3F62OND5 / Carboplatin; UM20QQM95Y / Ifosfamide; VB0R961HZT / Prednisone; CHOP protocol; ICE protocol 3
[Number-of-references]
22
67.
Carbone A, Cesarman E, Spina M, Gloghini A, Schulz TF:
HIV-associated lymphomas and gamma-herpesviruses.
Blood
; 2009 Feb 5;113(6):1213-24
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
Among the most common HIV-associated lymphomas are Burkitt
lymphoma
(BL) and
diffuse large
B-
cell lymphoma
(DLBCL) with immunoblastic-plasmacytoid differentiation (also involving the central nervous system).
Lymphomas occurring specifically in HIV-positive patients include primary effusion
lymphoma
(PEL) and its solid variants, plasmablastic
lymphoma
of the oral cavity type and
large B
-
cell lymphoma
arising in Kaposi sarcoma herpesvirus (KSHV)-associated multicentric Castleman disease.
These lymphomas together with BL and DLBCL with immunoblastic-plasmacytoid differentiation frequently carry EBV infection and display a phenotype
related
to plasma cells.
EBV infection occurs at different rates in different
lymphoma
types, whereas KSHV is specifically associated with PEL, which usually occurs in the setting of profound immunosuppression.
(2)
AIDS
lymphomas fall in a spectrum of B-
cell
differentiation where those associated with EBV or KSHV commonly exhibit plasmablastic differentiation; and (3) prognosis for patients with lymphomas and concomitant HIV infection could be improved using better combined chemotherapy protocols incorporating anticancer treatments and antiretroviral drugs.
[MeSH-major]
Gammaherpesvirinae / pathogenicity. HIV-1 / pathogenicity. Herpesviridae Infections / virology.
Lymphoma
,
AIDS
-
Related
/ virology
Genetic Alliance.
consumer health - HIV
.
HIV InSite.
treatment guidelines - Palliative Care of Patients with HIV
.
HIV InSite.
treatment guidelines - Human Herpesvirus-8
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 18955561.001).
[ISSN]
1528-0020
[Journal-full-title]
Blood
[ISO-abbreviation]
Blood
[Language]
eng
[Publication-type]
Journal Article; Research Support, Non-U.S. Gov't; Review
[Publication-country]
United States
[Chemical-registry-number]
0 / Antineoplastic Agents; 0 / Antiviral Agents
[Number-of-references]
162
68.
Xia T, O'Hara A, Araujo I, Barreto J, Carvalho E, Sapucaia JB, Ramos JC, Luz E, Pedroso C, Manrique M, Toomey NL, Brites C, Dittmer DP, Harrington WJ Jr:
EBV microRNAs in primary lymphomas and targeting of CXCL-11 by ebv-mir-BHRF1-3.
Cancer Res
; 2008 Mar 1;68(5):1436-42
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
We analyzed five primary "endemic" pediatric Burkitt's lymphomas (BL), two acquired immunodeficiency syndrome (
AIDS
)-
related
type I latency BL lines, a type III latency line, three EBV(+) primary effusion lymphomas (PEL), and three
AIDS
-
related diffuse large B
-
cell
lymphomas (DLBCL) for expression of EBV-encoded miRNAs.
BHRF1-3 miRNA expression inversely correlated with levels of a putative cellular target, the IFN-inducible T-
cell
attracting chemokine CXCL-11/I-TAC, and suppression of this factor was reversed by transfection of an antisense oligo to the EBV miRNA BHRF1-3.
MedlinePlus Health Information.
consumer health - Lymphoma
.
COS Scholar Universe.
author profiles
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Cites]
Annu Rev Microbiol. 2000;54:19-48
[
11018123.001
]
[Cites]
Proc Natl Acad Sci U S A. 2007 Oct 9;104(41):16164-9
[
17911266.001
]
[Cites]
Nat Med. 2002 Oct;8(10):1098-104
[
12219084.001
]
[Cites]
J Gen Virol. 2003 Apr;84(Pt 4):949-57
[
12655096.001
]
[Cites]
Nucleic Acids Res. 2004;32(4):e43
[
14985473.001
]
[Cites]
Science. 2004 Apr 30;304(5671):734-6
[
15118162.001
]
[Cites]
Virology. 2004 May 20;323(1):141-52
[
15165826.001
]
[Cites]
J Biol Chem. 2004 Jul 16;279(29):30219-27
[
15150261.001
]
[Cites]
RNA. 2004 Aug;10(8):1165-73
[
15272116.001
]
[Cites]
Methods Mol Biol. 2005;292:449-80
[
15507725.001
]
[Cites]
J Virol. 1990 May;64(5):2309-18
[
2157887.001
]
[Cites]
Proc Natl Acad Sci U S A. 1992 Sep 1;89(17):8058-62
[
1325642.001
]
[Cites]
J Virol. 1993 Jun;67(6):3182-90
[
8388496.001
]
[Cites]
J Virol. 1995 Feb;69(2):1132-41
[
7815492.001
]
[Cites]
Blood. 1995 Jul 15;86(2):659-65
[
7605996.001
]
[Cites]
Blood. 1995 Aug 15;86(4):1493-501
[
7632957.001
]
[Cites]
Blood. 1995 Oct 1;86(7):2708-14
[
7670109.001
]
[Cites]
Blood. 1996 Jun 15;87(12):5279-86
[
8652843.001
]
[Cites]
Hum Pathol. 1997 Dec;28(12):1408-14
[
9416698.001
]
[Cites]
Science. 1998 Apr 10;280(5361):248-53
[
9535648.001
]
[Cites]
J Exp Med. 1998 Jun 15;187(12):2009-21
[
9625760.001
]
[Cites]
Nucleic Acids Res. 2005;33(4):1290-7
[
15741182.001
]
[Cites]
Science. 2005 Apr 22;308(5721):557-60
[
15845854.001
]
[Cites]
Nature. 2005 Jun 2;435(7042):682-6
[
15931223.001
]
[Cites]
Blood. 2005 Jul 1;106(1):235-40
[
15790788.001
]
[Cites]
J Immunother. 2005 Jul-Aug;28(4):343-51
[
16000952.001
]
[Cites]
Science. 2005 Sep 2;309(5740):1519-24
[
16141061.001
]
[Cites]
Development. 2005 Nov;132(21):4645-52
[
16224044.001
]
[Cites]
Nucleic Acids Res. 2005;33(21):e182
[
16314296.001
]
[Cites]
Blood. 2006 Jan 1;107(1):13-20
[
16099881.001
]
[Cites]
Mamm Genome. 2006 Mar;17(3):189-202
[
16518686.001
]
[Cites]
Curr Opin Genet Dev. 2006 Apr;16(2):203-8
[
16503132.001
]
[Cites]
Vaccine. 2006 Apr 5;24(15):2966-74
[
16503368.001
]
[Cites]
RNA. 2006 May;12(5):733-50
[
16540699.001
]
[Cites]
PLoS Pathog. 2006 Mar;2(3):e23
[
16557291.001
]
[Cites]
PLoS Pathog. 2007 May 11;3(5):e65
[
17500590.001
]
[Cites]
J Virol. 2007 Sep;81(18):9967-75
[
17626073.001
]
[Cites]
Int J Cancer. 2002 Jun 10;99(5):635-43
[
12115495.001
]
(PMID = 18316607.001).
[ISSN]
1538-7445
[Journal-full-title]
Cancer research
[ISO-abbreviation]
Cancer Res.
[Language]
ENG
[Grant]
United States / NCI NIH HHS / CA / U01 CA070058; United States / NCI NIH HHS / CA / R01 CA109232; United States / NIDCR NIH HHS / DE / DE018304; United States / NIDCR NIH HHS / DE / R01 DE018304-02; United States / NCI NIH HHS / CA / CA082274; United States / NIDCR NIH HHS / DE / DE018304-01; United States / NIDCR NIH HHS / DE / R01 DE018304; United States / NIDCR NIH HHS / DE / R01 DE018304-01; United States / NCI NIH HHS / CA / CA70058; United States / NCI NIH HHS / CA / CA109232; United States / NCI NIH HHS / CA / CA121935; United States / NIDCR NIH HHS / DE / R01 DE018304-03; United States / NIDCR NIH HHS / DE / DE018304-02; United States / NCI NIH HHS / CA / R01 CA082274; United States / NCI NIH HHS / CA / R01 CA121935; United States / NIDCR NIH HHS / DE / DE018304-03
[Publication-type]
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
[Publication-country]
United States
[Chemical-registry-number]
0 / BHRF1 protein, Human herpesvirus 4; 0 / CXCL11 protein, human; 0 / Chemokine CXCL11; 0 / MicroRNAs; 0 / Oligonucleotides, Antisense; 0 / Viral Proteins; EC 3.1.- / Ribonucleases
[Other-IDs]
NLM/ NIHMS191351; NLM/ PMC2855641
69.
Bahl S, Theis B, Nishri D, Marrett LD:
Changing incidence of AIDS-related Kaposi sarcoma and non-Hodgkin lymphoma in Ontario, Canada.
Cancer Causes Control
; 2008 Dec;19(10):1251-8
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Changing incidence of
AIDS
-
related
Kaposi sarcoma and non-Hodgkin
lymphoma
in Ontario, Canada.
OBJECTIVE: To examine the influence of the
AIDS
epidemic on the incidence of Kaposi sarcoma (KS) and non-Hodgkin
lymphoma
(NHL) in Ontario.
AIDS
cases were extracted from Ontario Ministry of Health and Long-Term Care reports.
CONCLUSIONS: The
AIDS
epidemic, the introduction of antiretroviral therapies, and the decrease in HIV infection rates explain the rise and decline of KS incidence in Ontario.
NHL incidence trends are more complex, although the
AIDS
epidemic explains the trends observed in younger men (in whom
AIDS
is more common), and for the
AIDS
-
related
subtypes.
[MeSH-major]
Acquired Immunodeficiency Syndrome / epidemiology.
Lymphoma
,
AIDS
-
Related
/ epidemiology.
Lymphoma
, Non-Hodgkin / epidemiology. Population Surveillance. Sarcoma, Kaposi / epidemiology
[MeSH-minor]
Adult. Burkitt
Lymphoma
/ epidemiology. Humans. Incidence. Logistic Models.
Lymphoma
,
Large B
-
Cell
,
Diffuse
/ epidemiology.
Lymphoma
,
Large
-
Cell
, Immunoblastic / epidemiology. Male. Ontario / epidemiology. Registries / statistics & numerical data. Retrospective Studies
Genetic Alliance.
consumer health - AIDS-HIV
.
Genetic Alliance.
consumer health - Hodgkin lymphoma
.
Genetic Alliance.
consumer health - Non-Hodgkin Lymphoma
.
MedlinePlus Health Information.
consumer health - HIV/AIDS
.
MedlinePlus Health Information.
consumer health - Kaposi's Sarcoma
.
COS Scholar Universe.
author profiles
.
HIV InSite.
treatment guidelines - Human Herpesvirus-8
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 18618279.001).
[ISSN]
1573-7225
[Journal-full-title]
Cancer causes & control : CCC
[ISO-abbreviation]
Cancer Causes Control
[Language]
eng
[Publication-type]
Journal Article
[Publication-country]
Netherlands
70.
Brimo F, Michel RP, Khetani K, Auger M:
Primary effusion lymphoma: a series of 4 cases and review of the literature with emphasis on cytomorphologic and immunocytochemical differential diagnosis.
Cancer
; 2007 Aug 25;111(4):224-33
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Primary effusion
lymphoma
: a series of 4 cases and review of the literature with emphasis on cytomorphologic and immunocytochemical differential diagnosis.
BACKGROUND: Primary effusion
lymphoma
(PEL) is a human herpes virus-8 (HHV-8)-associated and very rare type of
lymphoma
usually confined to the body cavities and commonly observed in human immunodeficiency virus (HIV)-infected patients.
RESULTS: Cytologically, the most consistent features of the 4 cases and those in the literature included
large cell
size, moderate to abundant cytoplasm, a single nucleus in most cells with occasional bi- or multinucleated giant cells, single to multiple prominent nucleoli, and coarse chromatin.
Immunocytochemically, only 2 (50%) of the current cases were of the null-phenotype compared with 93% of cases in the literature; the other 2 cases had a T-
cell
phenotype.
CONCLUSIONS: Cytomorphologically, PEL exhibits features bridging
large cell
immunoblastic and anaplastic
large cell lymphoma
.
Although it is usually of null-phenotype, it may occasionally express B-
cell
or T-
cell
markers, rendering its distinction difficult from other lymphomatous effusions on a cytologic and immunocytochemical basis alone.
[MeSH-major]
Herpesviridae Infections / diagnosis. Herpesviridae Infections / pathology. Herpesvirus 8, Human / isolation & purification.
Lymphoma
, Non-Hodgkin / diagnosis.
Lymphoma
, Non-Hodgkin / pathology. Pleural Effusion, Malignant / diagnosis. Pleural Effusion, Malignant / pathology
[MeSH-minor]
Adult. Humans.
Lymphoma
,
AIDS
-
Related
/ diagnosis.
Lymphoma
,
Large B
-
Cell
,
Diffuse
/ pathology.
Lymphoma
,
Large B
-
Cell
,
Diffuse
/ virology. Male
Genetic Alliance.
consumer health - Primary effusion lymphoma
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 17554754.001).
[ISSN]
0008-543X
[Journal-full-title]
Cancer
[ISO-abbreviation]
Cancer
[Language]
eng
[Publication-type]
Comparative Study; Journal Article; Review
[Publication-country]
United States
[Number-of-references]
76
71.
Biggar RJ, Chaturvedi AK, Goedert JJ, Engels EA, HIV/AIDS Cancer Match Study:
AIDS-related cancer and severity of immunosuppression in persons with AIDS.
J Natl Cancer Inst
; 2007 Jun 20;99(12):962-72
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
AIDS
-
related
cancer and severity of immunosuppression in persons with
AIDS
.
BACKGROUND: The incidence of Kaposi sarcoma, non-Hodgkin
lymphoma
, and cervical cancer has been declining among persons with
AIDS
.
We investigated the association between cancer risk and CD4
cell
count among such persons.
METHODS: Data from US
AIDS
registries were linked to local cancer registry data.
Cancer incidence per 100,000 person-years was determined for the 4-27 months from the onset of
AIDS
from January 1, 1990, through December 31, 1995--before highly active antiretroviral therapy (HAART) became available--and from January 1, 1996, through December 31, 2002.
The relationships between CD4 count at
AIDS
onset and cancer incidence were assessed by proportional hazards models.
RESULTS: Among 325,516 adults with
AIDS
, the incidence of Kaposi sarcoma was lower in 1996-2002 (334.6 cases per 100,000 person-years) than in 1990-1995 (1838.9 cases per 100,000 person-years), and the incidence of non-Hodgkin
lymphoma
followed a similar pattern (i.e., 390.1 cases per 100,000 person-years in 1996-2002 and 1066.2 cases per 100,000 person-years in 1990-1995).
In 1996-2002, for each decline in CD4
cell
count of 50 cells per microliter of blood, increased risks were found for Kaposi sarcoma (hazard ratio [HR] = 1.40, 95% confidence interval [CI] = 1.33 to 1.50), for central nervous system non-Hodgkin
lymphoma
subtypes (HR = 1.85, 95% CI = 1.58 to 2.16), and for non-central nervous system
diffuse large
B-
cell lymphoma
(HR = 1.12, 95% CI = 1.04 to 1.20) but not for non-central nervous system Burkitt
lymphoma
(HR = 0.93, 95% CI = 0.81 to 1.06).
After adjustment for age, race, and sex or mode of HIV exposure, the risks for Kaposi sarcoma (RR = 0.22, 95% CI = 0.20 to 0.24) and for non-Hodgkin
lymphoma
(RR = 0.40, 95% CI = 0.36 to 0.44) were lower in the period of 1996-2002 than in 1990-1995.
CONCLUSIONS: Both before and after HAART was available, CD4 count was strongly associated with risks for Kaposi sarcoma and non-Hodgkin
lymphoma
but not for cervical cancer and Burkitt
lymphoma
.
The decreasing incidences of most
AIDS
-associated cancers in persons with
AIDS
during the 1990s are consistent with improving CD4 counts after HAART introduction in 1996.
[MeSH-major]
Acquired Immunodeficiency Syndrome / immunology.
Lymphoma
,
AIDS
-
Related
/ immunology.
Lymphoma
, Non-Hodgkin / immunology. Sarcoma, Kaposi / immunology
[MeSH-minor]
Adolescent. Adult. Antiretroviral Therapy, Highly Active. Burkitt
Lymphoma
/ epidemiology. Burkitt
Lymphoma
/ immunology. Burkitt
Lymphoma
/ virology. CD4 Lymphocyte Count. CD4-Positive T-Lymphocytes / immunology. Female. Humans. Male. Middle Aged. Uterine Cervical Neoplasms / epidemiology. Uterine Cervical Neoplasms / immunology. Uterine Cervical Neoplasms / virology
Genetic Alliance.
consumer health - AIDS-HIV
.
MedlinePlus Health Information.
consumer health - HIV/AIDS
.
MedlinePlus Health Information.
consumer health - Kaposi's Sarcoma
.
COS Scholar Universe.
author profiles
.
HIV InSite.
treatment guidelines - Human Herpesvirus-8
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 17565153.001).
[ISSN]
1460-2105
[Journal-full-title]
Journal of the National Cancer Institute
[ISO-abbreviation]
J. Natl. Cancer Inst.
[Language]
eng
[Grant]
United States / Intramural NIH HHS / /
[Publication-type]
Journal Article; Research Support, N.I.H., Intramural
[Publication-country]
United States
72.
Licci S, D'Antonio A, Boscaino A, Morelli L, Piscioli F, Abbate I, Donnorso RP, Del Nonno F:
Non-Hodgkin lymphomas concurrent with HHV8-associated Kaposi's sarcoma in the same lymph node in AIDS and non-AIDS patients.
Acta Haematol
; 2007;118(1):47-52
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Non-Hodgkin lymphomas concurrent with HHV8-associated Kaposi's sarcoma in the same lymph node in
AIDS
and non-
AIDS
patients.
METHODS: Two cases of concurrent non-Hodgkin
lymphoma
and Kaposi's sarcoma in the same lymph node are described: a
diffuse large B cell lymphoma
in an
AIDS
patient and a T
cell
-rich
large B cell lymphoma
in a HIV-negative patient, complete with the clinical, immunohistological and molecular features, the latter ones defined after isolation of the different neoplastic areas by laser capture microdissection.
[MeSH-major]
Herpesvirus 8, Human / isolation & purification. Lymph Nodes / pathology.
Lymphoma
,
AIDS
-
Related
/ pathology.
Lymphoma
, Non-Hodgkin / pathology. Sarcoma, Kaposi / pathology
Genetic Alliance.
consumer health - AIDS-HIV
.
MedlinePlus Health Information.
consumer health - Kaposi's Sarcoma
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Copyright]
Copyright 2007 S. Karger AG, Basel.
(PMID = 17505129.001).
[ISSN]
1421-9662
[Journal-full-title]
Acta haematologica
[ISO-abbreviation]
Acta Haematol.
[Language]
eng
[Publication-type]
Case Reports; Journal Article
[Publication-country]
Switzerland
[Chemical-registry-number]
0 / DNA, Viral
73.
Baik SJ, Shim KN, Choi HJ, Jung SA, Yoo K:
[Small bowel lymphoma detected by MiroCam capsule endoscope in a patient with acquired immune deficiency syndrome].
Korean J Gastroenterol
; 2008 Jul;52(1):37-41
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
[Small bowel
lymphoma
detected by MiroCam capsule endoscope in a patient with acquired immune deficiency syndrome].
Human immunodeficiency virus (HIV) infection is a risk factor for developing non-Hodgkin's
lymphoma
.
Most acquired immune deficiency syndrome (
AIDS
)-
related
lymphomas are high-grade
B cell
non-Hodgkin's lymphomas.
The use of highly active antiretroviral therapy has reduced the incidence of
AIDS
-
related lymphoma
.
There have been 7 reports of
AIDS
-
related
extra-nodal
lymphoma
in Korea.
We report a case of
AIDS
-
related lymphoma
detected by MiroCam capsule endoscopy.
[MeSH-major]
Acquired Immunodeficiency Syndrome / complications. Capsule Endoscopes. Jejunal Neoplasms / diagnosis.
Lymphoma
,
AIDS
-
Related
/ diagnosis
[MeSH-minor]
Anti-HIV Agents / therapeutic use. Antiretroviral Therapy, Highly Active. HIV Infections / virology. Humans.
Lymphoma
,
Large B
-
Cell
,
Diffuse
/ immunology.
Lymphoma
,
Large B
-
Cell
,
Diffuse
/ pathology. Male. Middle Aged. Tomography, X-Ray Computed
MedlinePlus Health Information.
consumer health - HIV/AIDS
.
MedlinePlus Health Information.
consumer health - Intestinal Cancer
.
HIV InSite.
treatment guidelines - Human Herpesvirus-8
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 19077490.001).
[ISSN]
1598-9992
[Journal-full-title]
The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi
[ISO-abbreviation]
Korean J Gastroenterol
[Language]
kor
[Publication-type]
Case Reports; English Abstract; Journal Article
[Publication-country]
Korea (South)
[Chemical-registry-number]
0 / Anti-HIV Agents
74.
Camilleri-Broët S, Raphaël M:
[Physiopathogenic aspects of HIV-associated primary brain lymphomas].
Rev Neurol (Paris)
; 2006 Jan;162(1):57-61
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
HIV-associated Primary brain lymphomas (PBLs) are usually
diffuse
,
large B
-
cell
lymphomas (DLBCLs).
These proteins play a major role in immortalization and transformation of infected B lymphocytes through
cell
cycle activation and apoptosis inhibition.
[MeSH-major]
Brain Neoplasms / physiopathology.
Lymphoma
,
AIDS
-
Related
/ physiopathology
[MeSH-minor]
B-Lymphocytes / pathology. B-Lymphocytes / virology. Biopsy. Brain / pathology. Brain / virology. Cerebrospinal Fluid / immunology. Epstein-Barr Virus Infections / complications. HIV / physiology. Herpesvirus 4, Human / isolation & purification. Humans.
Lymphoma
,
Large B
-
Cell
,
Diffuse
/ cerebrospinal fluid.
Lymphoma
,
Large B
-
Cell
,
Diffuse
/ etiology.
Lymphoma
,
Large B
-
Cell
,
Diffuse
/ genetics.
Lymphoma
,
Large B
-
Cell
,
Diffuse
/ pathology.
Lymphoma
,
Large B
-
Cell
,
Diffuse
/ physiopathology.
Lymphoma
,
Large B
-
Cell
,
Diffuse
/ virology
Genetic Alliance.
consumer health - HIV
.
MedlinePlus Health Information.
consumer health - Brain Tumors
.
HIV InSite.
treatment guidelines - Human Herpesvirus-8
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 16446623.001).
[ISSN]
0035-3787
[Journal-full-title]
Revue neurologique
[ISO-abbreviation]
Rev. Neurol. (Paris)
[Language]
fre
[Publication-type]
English Abstract; Journal Article; Review
[Publication-country]
France
[Number-of-references]
25
75.
Suzuki K, Nakazato T, Sanada Y, Mihara A, Tachikawa N, Kurai H, Yoshimura Y, Hayashi H, Yoshida S, Kakimoto T:
[Successful treatment with hyper-CVAD and highly active anti-retroviral therapy (HAART) for AIDS-related Burkitt lymphoma].
Rinsho Ketsueki
; 2010 Mar;51(3):207-12
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
[Successful treatment with hyper-CVAD and highly active anti-retroviral therapy (HAART) for
AIDS
-
related
Burkitt
lymphoma
].
Abdominal CT scan showed a
large
mass in the ascending colon.
Colonoscopy was performed and histological examination of the colon tumor revealed Burkitt's
lymphoma
(BL).
In the HAART era, the survival of patients with
AIDS
-
related diffuse large cell lymphoma
(DLCL) improved dramatically, whereas the survival of similarly treated patients with
AIDS
-
related
BL remained poor.
Our case suggests that intensive chemotherapy with hyper-CVAD/MTX-Ara-C combined with HAART may be well tolerated and effective in
AIDS
-
related
BL.
[MeSH-major]
Antiretroviral Therapy, Highly Active. Burkitt
Lymphoma
/ drug therapy. Colonic Neoplasms / drug therapy.
Lymphoma
,
AIDS
-
Related
/ drug therapy
Genetic Alliance.
consumer health - AIDS-HIV
.
MedlinePlus Health Information.
consumer health - HIV/AIDS Medicines
.
Hazardous Substances Data Bank.
CYTARABINE
.
Hazardous Substances Data Bank.
DOXORUBICIN
.
Hazardous Substances Data Bank.
ETOPOSIDE
.
Hazardous Substances Data Bank.
DEXAMETHASONE
.
Hazardous Substances Data Bank.
CYCLOPHOSPHAMIDE
.
Hazardous Substances Data Bank.
PREDNISONE
.
Hazardous Substances Data Bank.
VINCRISTINE
.
Hazardous Substances Data Bank.
METHOTREXATE
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 20379116.001).
[ISSN]
0485-1439
[Journal-full-title]
[Rinshō ketsueki] The Japanese journal of clinical hematology
[ISO-abbreviation]
Rinsho Ketsueki
[Language]
jpn
[Publication-type]
Case Reports; English Abstract; Journal Article
[Publication-country]
Japan
[Chemical-registry-number]
04079A1RDZ / Cytarabine; 5J49Q6B70F / Vincristine; 6PLQ3CP4P3 / Etoposide; 7S5I7G3JQL / Dexamethasone; 80168379AG / Doxorubicin; 8N3DW7272P / Cyclophosphamide; VB0R961HZT / Prednisone; YL5FZ2Y5U1 / Methotrexate; CVAD protocol; EPOCH protocol
76.
Pagès F, Galon J, Karaschuk G, Dudziak D, Camus M, Lazar V, Camilleri-Broët S, Lagorce-Pagès C, Lebel-Binay S, Laux G, Fridman WH, Henglein B:
Epstein-Barr virus nuclear antigen 2 induces interleukin-18 receptor expression in B cells.
Blood
; 2005 Feb 15;105(4):1632-9
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
We show here that the EBV nuclear antigen EBNA2 induces expression of the 2 chains of the interleukin-18 receptor (IL-18R) in Burkitt
lymphoma
(BL)
cell
lines and in nontransformed B cells.
We report that EBNA2 expression is associated with IL-18R expression in vivo in EBV-positive B-lymphomas from
AIDS
patients.
[MeSH-minor]
Burkitt
Lymphoma
/ immunology. Burkitt
Lymphoma
/ metabolism. Burkitt
Lymphoma
/ virology.
Cell
Line, Transformed.
Cell
Line, Tumor. Gene Expression Regulation, Viral / immunology. Genes, Viral. Herpesvirus 4, Human / genetics. Humans. Interleukin-18 Receptor alpha Subunit.
Lymphoma
,
AIDS
-
Related
/ immunology.
Lymphoma
,
AIDS
-
Related
/ metabolism.
Lymphoma
,
AIDS
-
Related
/ virology.
Lymphoma
,
Large B
-
Cell
,
Diffuse
/ immunology.
Lymphoma
,
Large B
-
Cell
,
Diffuse
/ metabolism.
Lymphoma
,
Large B
-
Cell
,
Diffuse
/ virology. Protein Subunits / biosynthesis. Protein Subunits / metabolism. Receptors, Interleukin-18. Viral Proteins. Viral Structural Proteins / genetics
NCI CPTC Antibody Characterization Program.
NCI CPTC Antibody Characterization Program
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 15498855.001).
[ISSN]
0006-4971
[Journal-full-title]
Blood
[ISO-abbreviation]
Blood
[Language]
eng
[Publication-type]
Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
[Publication-country]
United States
[Chemical-registry-number]
0 / EBNA-2 protein, Human herpesvirus 4; 0 / Epstein-Barr Virus Nuclear Antigens; 0 / IL18R1 protein, human; 0 / Interleukin-18 Receptor alpha Subunit; 0 / Protein Subunits; 0 / Receptors, Interleukin; 0 / Receptors, Interleukin-18; 0 / Viral Proteins; 0 / Viral Structural Proteins
77.
Dales JP, Harket A, Bagnères D, Andrac-Meyer L, Xerri L, Frances Y, Taranger-Charpin C:
[Plasmablastic lymphoma in a patient with HIV infection: an unusual case located in the skin].
Ann Pathol
; 2005 Feb;25(1):45-9
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
[Plasmablastic
lymphoma
in a patient with HIV infection: an unusual case located in the skin].
We report the case of a plasmablastic
lymphoma
involving the skin in a 45 year-old HIV-positive patient.
Plasmablastic
lymphoma
was first described in 1997 and is considered to be a
diffuse large
B-
cell lymphoma
with a unique immunophenotype and a predilection for the oral cavity.
A skin biopsy led to the diagnosis of plasmablastic
lymphoma
in view of the presence of a dense nodular infiltrate invading the dermis and subcutaneous fat composed of
large
cells that expressed neither the leucocyte common antigen nor the B- and T-
cell
antigens CD20 and CD3, but which showed a strong immunostaining with plasma
cell
marker VS38c.
HIV-associated plasmablastic
lymphoma
is a poor prognosis malignancy that may resist typing due to the lack of expression of commonly used lymphoid markers.
[MeSH-major]
HIV Seropositivity / complications.
Lymphoma
,
AIDS
-
Related
/ diagnosis. Plasma Cells. Skin Neoplasms / diagnosis
[MeSH-minor]
Fatal Outcome. Humans. Immunophenotyping.
Lymphoma
,
Large B
-
Cell
,
Diffuse
/ complications.
Lymphoma
,
Large B
-
Cell
,
Diffuse
/ diagnosis.
Lymphoma
,
Large B
-
Cell
,
Diffuse
/ pathology. Male. Middle Aged
Genetic Alliance.
consumer health - HIV
.
MedlinePlus Health Information.
consumer health - Skin Cancer
.
HIV InSite.
treatment guidelines - Human Herpesvirus-8
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 15981931.001).
[ISSN]
0242-6498
[Journal-full-title]
Annales de pathologie
[ISO-abbreviation]
Ann Pathol
[Language]
fre
[Publication-type]
Case Reports; English Abstract; Journal Article
[Publication-country]
France
78.
Vajdic CM, van Leeuwen MT, Turner JJ, McDonald AM, Webster AC, McDonald SP, Chapman JR, Kaldor JM, Grulich AE:
No excess risk of follicular lymphoma in kidney transplant and HIV-related immunodeficiency.
Int J Cancer
; 2010 Dec 1;127(11):2732-5
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
No excess risk of follicular
lymphoma
in kidney transplant and HIV-
related
immunodeficiency.
Subtype-specific incidence patterns in populations at high risk of
lymphoma
offer insight into lymphomagenesis.
The incidence profiles for the 2 most common non-Hodgkin
lymphoma
subtypes were compared for 2 immunodeficient populations, adults receiving a kidney transplant 1982-2003 (n = 7,730) or diagnosed with human immunodeficiency virus (HIV) infection 1982-2004 (n = 17,175).
National, population-based registries were linked and standardized incidence ratios (SIRs) were computed for each cohort and
lymphoma
subtype.
Risk of
diffuse large
B-
cell lymphoma
was significantly increased after transplantation (SIR 17.83, 95% CI: 13.61-22.95) and after HIV infection (SIR 58.81, 95% CI: 52.59-65.56).
Rates of follicular
lymphoma
(FL) were neither significantly increased nor decreased in transplant recipients (SIR 0.82, 95% CI: 0.10-2.96) and in people with HIV (SIR 1.25, 95% CI: 0.41-2.91).
The findings argue against an infectious or other immunodeficiency-
related
etiology for FL and clearly differentiate it from
diffuse large
B-
cell lymphoma
.
[MeSH-major]
HIV Infections / epidemiology. Kidney Transplantation / statistics & numerical data.
Lymphoma
,
AIDS
-
Related
/ epidemiology.
Lymphoma
, Follicular / epidemiology.
Lymphoma
,
Large B
-
Cell
,
Diffuse
/ epidemiology
Genetic Alliance.
consumer health - Follicular Lymphoma
.
Genetic Alliance.
consumer health - HIV
.
MedlinePlus Health Information.
consumer health - HIV/AIDS
.
MedlinePlus Health Information.
consumer health - HIV/AIDS in Women
.
MedlinePlus Health Information.
consumer health - Kidney Transplantation
.
COS Scholar Universe.
author profiles
.
HIV InSite.
treatment guidelines - Human Herpesvirus-8
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 20178100.001).
[ISSN]
1097-0215
[Journal-full-title]
International journal of cancer
[ISO-abbreviation]
Int. J. Cancer
[Language]
eng
[Grant]
United States / NIAID NIH HHS / AI / U01AI069907
[Publication-type]
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
[Publication-country]
United States
79.
Vaghefi P, Martin A, Prévot S, Charlotte F, Camilleri-Broët S, Barli E, Davi F, Gabarre J, Raphael M, Poirel HA:
Genomic imbalances in AIDS-related lymphomas: relation with tumoral Epstein-Barr virus status.
AIDS
; 2006 Nov 28;20(18):2285-91
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Genomic imbalances in
AIDS
-
related
lymphomas: relation with tumoral Epstein-Barr virus status.
BACKGROUND: The pathologic heterogeneity of
AIDS related
lymphomas (ARL) reflects several pathogenic mechanisms: chronic antigenic stimulation, Epstein-Barr virus (EBV) infection, and genomic abnormalities.
Most chromosomal regions affected in HIV-
related lymphoma
were similar to those already reported in HIV-negative lymphomas.
[MeSH-major]
Epstein-Barr Virus Infections / genetics.
Lymphoma
,
AIDS
-
Related
/ genetics
[MeSH-minor]
Adult. Aged. Burkitt
Lymphoma
/ complications. Burkitt
Lymphoma
/ genetics. Burkitt
Lymphoma
/ immunology. CD4 Lymphocyte Count. CD4-Positive T-Lymphocytes / immunology. Chromosome Aberrations. Chromosomes, Human / genetics. Clone Cells / immunology. DNA, Viral / genetics. Female. Genes, Viral / genetics. Genes, Viral / immunology. Humans.
Lymphoma
,
Large B
-
Cell
,
Diffuse
/ complications.
Lymphoma
,
Large B
-
Cell
,
Diffuse
/ genetics.
Lymphoma
,
Large B
-
Cell
,
Diffuse
/ immunology.
Lymphoma
, T-
Cell
, Peripheral / complications.
Lymphoma
, T-
Cell
, Peripheral / genetics.
Lymphoma
, T-
Cell
, Peripheral / immunology. Male. Middle Aged. Nucleic Acid Hybridization / methods
Genetic Alliance.
consumer health - AIDS-HIV
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 17117014.001).
[ISSN]
0269-9370
[Journal-full-title]
AIDS (London, England)
[ISO-abbreviation]
AIDS
[Language]
eng
[Publication-type]
Journal Article; Research Support, Non-U.S. Gov't
[Publication-country]
England
[Chemical-registry-number]
0 / DNA, Viral
80.
Chadburn A, Chiu A, Lee JY, Chen X, Hyjek E, Banham AH, Noy A, Kaplan LD, Sparano JA, Bhatia K, Cesarman E:
Immunophenotypic analysis of AIDS-related diffuse large B-cell lymphoma and clinical implications in patients from AIDS Malignancies Consortium clinical trials 010 and 034.
J Clin Oncol
; 2009 Oct 20;27(30):5039-48
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Immunophenotypic analysis of
AIDS
-
related diffuse large B
-
cell lymphoma
and clinical implications in patients from
AIDS
Malignancies Consortium clinical trials 010 and 034.
PURPOSE:
Diffuse large
B-
cell lymphoma
(DLBCL) represents a clinically heterogeneous disease.
PATIENTS AND METHODS: We examined 81 DLBCLs from patients with
AIDS
in AMC010 (cyclophosphamide, doxorubicin, vincristine, and prednisone [CHOP] v CHOP-rituximab) and AMC034 (etoposide, doxorubicin, vincristine, prednisone, and dose-adjusted cyclophosphamide plus rituximab concurrent v sequential) clinical trials and compared the immunophenotype with survival data, Epstein-Barr virus (EBV) positivity, and CD4 counts.
Expression of FOXP1, Blimp-1/PRDM1, or BCL-2 was not correlated with the outcome in patients with
AIDS
-
related
DLBCL.
CONCLUSION: These data indicate that with current treatment strategies for
lymphoma
and control of HIV infection, commonly used immunohistochemical markers may not be clinically relevant in HIV-infected patients with DLBCL.
[MeSH-major]
Immunophenotyping. Ki-67 Antigen.
Lymphoma
,
AIDS
-
Related
/ immunology.
Lymphoma
,
Large B
-
Cell
,
Diffuse
/ immunology
[MeSH-minor]
Antineoplastic Combined Chemotherapy Protocols / therapeutic use.
Cell
Proliferation. Humans. Immunohistochemistry. Prognosis. Survival Analysis
Genetic Alliance.
consumer health - AIDS-HIV
.
Genetic Alliance.
consumer health - Large B cell diffuse lymphoma
.
COS Scholar Universe.
author profiles
.
NCI CPTC Antibody Characterization Program.
NCI CPTC Antibody Characterization Program
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Cites]
N Engl J Med. 2002 Jun 20;346(25):1937-47
[
12075054.001
]
[Cites]
Oncology (Williston Park). 2002 Apr;16(4):441-51, 456, 459
[
12017534.001
]
[Cites]
Lancet Oncol. 2003 Jan;4(1):22-9
[
12517536.001
]
[Cites]
Blood. 2003 Mar 15;101(6):2363-7
[
12424193.001
]
[Cites]
Blood. 2003 Jun 15;101(12):4653-9
[
12609827.001
]
[Cites]
Blood. 2004 Jan 1;103(1):275-82
[
14504078.001
]
[Cites]
Am J Surg Pathol. 2004 Apr;28(4):464-70
[
15087665.001
]
[Cites]
Ann Hematol. 2004 Jul;83(7):414-9
[
15085385.001
]
[Cites]
Blood. 2004 Nov 1;104(9):2933-5
[
15238418.001
]
[Cites]
Blood. 1988 Apr;71(4):1157-60
[
3281723.001
]
[Cites]
Lancet. 1991 Feb 9;337(8737):320-2
[
1671232.001
]
[Cites]
N Engl J Med. 1993 Sep 30;329(14):987-94
[
8141877.001
]
[Cites]
Blood. 1994 Mar 15;83(6):1460-6
[
8123837.001
]
[Cites]
Ann Oncol. 1994;5 Suppl 1:113-6
[
8172807.001
]
[Cites]
Blood. 1997 Jan 15;89(2):601-9
[
9002964.001
]
[Cites]
Blood. 1997 Jun 1;89(11):3909-18
[
9166827.001
]
[Cites]
J Clin Oncol. 1998 May;16(5):1931-9
[
9586912.001
]
[Cites]
Leuk Lymphoma. 1998 Aug;30(5-6):515-24
[
9711914.001
]
[Cites]
Clin Cancer Res. 2005 Feb 1;11(3):1065-72
[
15709173.001
]
[Cites]
Blood. 2005 Mar 1;105(5):1851-61
[
15550490.001
]
[Cites]
Blood. 2005 Sep 1;106(5):1762-9
[
15905193.001
]
[Cites]
Blood. 2005 Sep 1;106(5):1538-43
[
15914552.001
]
[Cites]
J Clin Oncol. 2005 Dec 20;23(36):9067-72
[
16172462.001
]
[Cites]
Mod Pathol. 2006 Mar;19(3):438-46
[
16444194.001
]
[Cites]
Haematologica. 2006 Apr;91(4):467-74
[
16585013.001
]
[Cites]
Microbes Infect. 2006 Apr;8(5):1301-7
[
16697236.001
]
[Cites]
Clin Lymphoma Myeloma. 2006 May;6(6):455-7
[
16796775.001
]
[Cites]
J Clin Oncol. 2006 Sep 1;24(25):4135-42
[
16943530.001
]
[Cites]
Ann Oncol. 2007 May;18(5):931-9
[
17395602.001
]
[Cites]
Blood. 2007 Jun 1;109(11):4930-5
[
17299093.001
]
[Cites]
J Natl Cancer Inst. 2007 Jun 20;99(12):962-72
[
17565153.001
]
[Cites]
Histopathology. 2007 Jul;51(1):70-9
[
17593082.001
]
[Cites]
Curr Opin Oncol. 2007 Sep;19(5):458-63
[
17762571.001
]
[Cites]
Eur J Haematol. 2007 Dec;79(6):501-7
[
17986209.001
]
[Cites]
Blood. 2008 Mar 1;111(5):2816-24
[
18077790.001
]
[Cites]
Annu Rev Immunol. 2008;26:133-69
[
18370921.001
]
[Cites]
Int J Cancer. 2008 Jul 1;123(1):187-94
[
18435450.001
]
[Cites]
J Clin Oncol. 2008 Jun 1;26(16):2717-24
[
18378569.001
]
[Cites]
Proc Natl Acad Sci U S A. 2008 Sep 9;105(36):13520-5
[
18765795.001
]
[Cites]
Nat Rev Immunol. 2007 Dec;7(12):923-7
[
17965637.001
]
[Cites]
Nat Rev Immunol. 2002 Dec;2(12):920-32
[
12461565.001
]
[Cites]
Nature. 2000 Feb 3;403(6769):503-11
[
10676951.001
]
[Cites]
Semin Oncol. 2000 Aug;27(4):390-401
[
10950365.001
]
[Cites]
Blood. 2001 Feb 1;97(3):744-51
[
11157493.001
]
[Cites]
Nat Med. 2002 Jan;8(1):68-74
[
11786909.001
]
[CommentIn]
J Clin Oncol. 2010 Jun 1;28(16):e260; author reply e261-2
[
20421532.001
]
(PMID = 19752343.001).
[ISSN]
1527-7755
[Journal-full-title]
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
[ISO-abbreviation]
J. Clin. Oncol.
[Language]
eng
[Grant]
United States / NCI NIH HHS / CA / U01 CA121947; United States / NCI NIH HHS / CA / CA-121947
[Publication-type]
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
[Publication-country]
United States
[Chemical-registry-number]
0 / Ki-67 Antigen
[Other-IDs]
NLM/ PMC2799056
81.
Baraboutis IG, Marinos L, Lekakis LJ, Papastamopoulos V, Georgiou O, Tsagalou EP, Rondogianni P, Apostolidis J, Papadaki T, Skoutelis AT:
Long-term complete regression of nodal marginal zone lymphoma transformed into diffuse large B-cell lymphoma with highly active antiretroviral therapy alone in human immunodeficiency virus infection.
Am J Med Sci
; 2009 Dec;338(6):517-21
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Long-term complete regression of nodal marginal zone
lymphoma
transformed into
diffuse large
B-
cell lymphoma
with highly active antiretroviral therapy alone in human immunodeficiency virus infection.
Since the introduction of combination antiretroviral therapy (cART), there has been a decrease in the incidence of non-Hodgkin
lymphoma
among the HIV-infected population and also significantly improved survival rates.
We describe a remarkable case of a HIV-infected patient whose
large B
-
cell lymphoma
, most likely arising by transformation of a nodal marginal zone
lymphoma
, completely regressed with the use of cART alone.
He remained disease-free for almost 3 years and he finally died from presumed flare up of his
lymphoma
.
This is an extreme example of the significance of cART in improving survival in HIV-non-Hodgkin
lymphoma
and changing the face of the HIV epidemic in general.
[MeSH-major]
Antiretroviral Therapy, Highly Active.
Lymphoma
,
AIDS
-
Related
/ drug therapy.
Lymphoma
, B-
Cell
, Marginal Zone / complications.
Lymphoma
, B-
Cell
, Marginal Zone / drug therapy.
Lymphoma
,
Large B
-
Cell
,
Diffuse
/ complications.
Lymphoma
,
Large B
-
Cell
,
Diffuse
/ drug therapy
Genetic Alliance.
consumer health - Large B cell diffuse lymphoma
.
MedlinePlus Health Information.
consumer health - HIV/AIDS Medicines
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 20010159.001).
[ISSN]
1538-2990
[Journal-full-title]
The American journal of the medical sciences
[ISO-abbreviation]
Am. J. Med. Sci.
[Language]
eng
[Publication-type]
Case Reports; Journal Article; Review
[Publication-country]
United States
[Number-of-references]
31
82.
Leiggener CS, Kunz Ch, Lohri A, Fridrich K, Honigmann K:
[HIV-associated lymphoma -- an unusual cause of pathological mandibular fracture].
Mund Kiefer Gesichtschir
; 2005 Jan;9(1):48-52
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
[HIV-associated
lymphoma
-- an unusual cause of pathological mandibular fracture].
Despite the introduction of highly active antiretroviral therapy (HAART),
diffuse large
B-
cell lymphoma
(DLBCL) remains a common malignancy in human immunodeficiency virus (HIV)-infected patients, especially the plasmablastic variant.
A biopsy performed at the time of revision revealed the diagnosis of a primary
lymphoma
in the mandible.
After chemotherapy had induced complete remission of the
lymphoma
and autogenous iliac crest bone grafting had been performed the fracture united.
Primary
lymphoma
in the mandible is a disease that presents with a nonspecific radiological appearance which may mimic osteomyelitis or periodontal pathology.
[MeSH-major]
Fractures, Spontaneous / diagnosis.
Lymphoma
,
AIDS
-
Related
/ diagnosis. Mandibular Fractures / diagnosis. Mandibular Neoplasms / diagnosis
Genetic Alliance.
consumer health - HIV
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Cites]
J Acquir Immune Defic Syndr. 2003 Mar 1;32(3):347-8
[
12626898.001
]
[Cites]
Am J Otolaryngol. 2000 Jan-Feb;21(1):10-3
[
10668671.001
]
[Cites]
Blood. 1997 Feb 15;89(4):1413-20
[
9028965.001
]
[Cites]
J Oral Maxillofac Surg. 1997 Aug;55(8):853-6
[
9251616.001
]
[Cites]
J Craniomaxillofac Surg. 1992 Oct;20(7):297-302
[
1401107.001
]
[Cites]
AIDS. 2003 Jan 3;17(1):81-7
[
12478072.001
]
[Cites]
Lancet Oncol. 2003 Feb;4(2):110-9
[
12573353.001
]
[Cites]
J Oral Maxillofac Surg. 1995 Oct;53(10):1134-9
[
7562164.001
]
[Cites]
J Oral Maxillofac Surg. 1990 Apr;48(4):409-15
[
2179495.001
]
[Cites]
Blood. 2001 Dec 1;98(12):3406-12
[
11719381.001
]
[Cites]
Plast Reconstr Surg. 1993 Apr;91(4):577-80
[
8446709.001
]
[Cites]
Oral Surg Oral Med Oral Pathol. 1993 Sep;76(3):272-5
[
8378039.001
]
[Cites]
Br J Oral Maxillofac Surg. 2000 Aug;38(4):397
[
10922171.001
]
[Cites]
Otolaryngol Head Neck Surg. 1992 Mar;106(3):258-60
[
1589218.001
]
[Cites]
Curr Opin Oncol. 2001 Sep;13(5):354-9
[
11555712.001
]
[Cites]
Laryngoscope. 1995 Apr;105(4 Pt 2 Suppl 68):1-18
[
7715397.001
]
[Cites]
Mund Kiefer Gesichtschir. 2001 Jul;5(4):227-32
[
11550605.001
]
(PMID = 15688241.001).
[ISSN]
1432-9417
[Journal-full-title]
Mund-, Kiefer- und Gesichtschirurgie : MKG
[ISO-abbreviation]
Mund Kiefer Gesichtschir
[Language]
ger
[Publication-type]
Case Reports; English Abstract; Journal Article
[Publication-country]
Germany
[Chemical-registry-number]
0 / Biomarkers, Tumor
83.
Gujral S, Shet TM, Kane SV:
Morphological spectrum of AIDS-related plasmablastic lymphomas.
Indian J Pathol Microbiol
; 2008 Jan-Mar;51(1):121-4
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Morphological spectrum of
AIDS
-
related
plasmablastic lymphomas.
We have had a recent spurt in cases of
AIDS
-
related lymphoma
(ARL) at our centre.
Most of these cases are aggressive mature
B cell
lymphomas, mainly plasmablastic
lymphoma
(PBL) and
diffuse large
B-
cell lymphoma
(DLBCL).
[MeSH-major]
Acquired Immunodeficiency Syndrome / complications.
Lymphoma
,
AIDS
-
Related
/ pathology
[MeSH-minor]
Adolescent. Adult. Aged. Antigens, CD20 / analysis. Antigens, CD45 / analysis. Burkitt
Lymphoma
/ pathology. Child. Female. Humans. Immunoglobulin Light Chains / analysis. Leukemia, Plasma
Cell
/ pathology.
Lymphoma
,
Large
-
Cell
, Immunoblastic / pathology. Male. Middle Aged. Syndecan-1 / analysis
Genetic Alliance.
consumer health - AIDS-HIV
.
MedlinePlus Health Information.
consumer health - HIV/AIDS
.
HIV InSite.
treatment guidelines - Human Herpesvirus-8
.
NCI CPTC Antibody Characterization Program.
NCI CPTC Antibody Characterization Program
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 18417882.001).
[ISSN]
0377-4929
[Journal-full-title]
Indian journal of pathology & microbiology
[ISO-abbreviation]
Indian J Pathol Microbiol
[Language]
eng
[Publication-type]
Journal Article
[Publication-country]
India
[Chemical-registry-number]
0 / Antigens, CD20; 0 / Immunoglobulin Light Chains; 0 / SDC1 protein, human; 0 / Syndecan-1; EC 3.1.3.48 / Antigens, CD45
84.
Kane S, Khurana A, Parulkar G, Shet T, Prabhash K, Nair R, Gujral S:
Minimum diagnostic criteria for plasmablastic lymphoma of oral/sinonasal region encountered in a tertiary cancer hospital of a developing country.
J Oral Pathol Med
; 2009 Jan;38(1):138-44
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Minimum diagnostic criteria for plasmablastic
lymphoma
of oral/sinonasal region encountered in a tertiary cancer hospital of a developing country.
BACKGROUND: Haematolymphoid tumours other than plasmablastic
lymphoma
(PBL) may reveal plasmablastic differentiation with overlapping immunoreactivity causing diagnostic dilemma.
METHODS: Out of 98 total cases of primary non-Hodgkin's
lymphoma
and plasmacytoma of oral-sinonasal region recorded in our institute over 4 years, 39 cases showing varied plasmablastic differentiation were selected.
(1) predominant population of plasmablasts which are
large
monomorphic cells with high nuclear-cytoplasmic ratio, moderate amount of amphophilic cytoplasm and round nucleus with prominent central nucleolus, (2) high mitotic and/or apoptotic index and (3) absence of neoplastic plasma cells in the background.
Essential diagnostic immunophenotype consisted of CD20 negativity, LCA +/-, CD138/VS38c
diffuse
positivity, light chain restriction and high MIB-1 index (>60 %).
[MeSH-major]
Lymphoma
,
Large B
-
Cell
,
Diffuse
/ diagnosis. Mouth Neoplasms / diagnosis. Paranasal Sinus Neoplasms / diagnosis
[MeSH-minor]
Antibodies, Antinuclear / analysis. Antibodies, Monoclonal / analysis. Antigens, CD20 / analysis. Apoptosis. Cancer Care Facilities.
Cell
Nucleolus / pathology.
Cell
Nucleus / pathology. Cytoplasm / pathology. Developing Countries. Diagnosis, Differential. Epstein-Barr Virus Infections / diagnosis. Humans. India. Ki-67 Antigen / analysis.
Lymphoma
,
AIDS
-
Related
/ diagnosis.
Lymphoma
, Non-Hodgkin / diagnosis. Mitosis. Plasma Cells / pathology. Plasmacytoma / diagnosis. Syndecan-1 / analysis
Genetic Alliance.
consumer health - Oral cancer
.
MedlinePlus Health Information.
consumer health - Oral Cancer
.
The Lens.
Cited by Patents in
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 18647219.001).
[ISSN]
1600-0714
[Journal-full-title]
Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology
[ISO-abbreviation]
J. Oral Pathol. Med.
[Language]
eng
[Publication-type]
Journal Article
[Publication-country]
Denmark
[Chemical-registry-number]
0 / Antibodies, Antinuclear; 0 / Antibodies, Monoclonal; 0 / Antigens, CD20; 0 / Ki-67 Antigen; 0 / MIB-1 antibody; 0 / SDC1 protein, human; 0 / Syndecan-1; 0 / VS38 monoclonal antibody
85.
Bhatti MT, Schmalfuss IM, Eskin TA:
Isolated cranial nerve III palsy as the presenting manifestation of HIV-related large B-cell lymphoma: clinical, radiological and postmortem observations: report of a case and review of the literature.
Surv Ophthalmol
; 2005 Nov-Dec;50(6):598-606
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Isolated cranial nerve III palsy as the presenting manifestation of HIV-
related large
B-
cell lymphoma
: clinical, radiological and postmortem observations: report of a case and review of the literature.
Rarely can a neurologically isolated cranial nerve III palsy be the presenting manifestation of central nervous system
lymphoma
.
We detail the clinical, radiological, and pathological features of a previously healthy 45-year-old man presenting with an isolated, pupil-involving, right cranial nerve III palsy due to human immunodefiency virus (HIV)
related
non-Hodgkin
lymphoma
.
Morphologic and flow cytometric analysis of the cerebrospinal fluid was compatible with a
large B
-
cell lymphoma
.
Postmortem examination of the brain revealed malignant lymphomatous
cell
infiltration of both cranial nerve III,
diffuse
leptomeningeal disease and focal superficial subependymal and subpial invasion.
Based on our review of the literature, we were able to find only 10 detailed cases of cranial nerve III palsy as the presenting manifestation of central nervous system
lymphoma
.
[MeSH-major]
HIV / immunology. HIV Antibodies / immunology.
Lymphoma
,
AIDS
-
Related
/ complications. Magnetic Resonance Imaging. Oculomotor Nerve Diseases / etiology. Tomography, X-Ray Computed
Genetic Alliance.
consumer health - HIV
.
MedlinePlus Health Information.
consumer health - CT Scans
.
MedlinePlus Health Information.
consumer health - MRI Scans
.
HIV InSite.
treatment guidelines - Palliative Care of Patients with HIV
.
HIV InSite.
treatment guidelines - Human Herpesvirus-8
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 16263372.001).
[ISSN]
0039-6257
[Journal-full-title]
Survey of ophthalmology
[ISO-abbreviation]
Surv Ophthalmol
[Language]
eng
[Publication-type]
Case Reports; Journal Article; Research Support, Non-U.S. Gov't
[Publication-country]
United States
[Chemical-registry-number]
0 / HIV Antibodies
86.
Plemons JM, Benton E, Rankin KV:
Non-Hodgkin's lymphoma and acquired immune deficiency syndrome (AIDS). A case report.
Tex Dent J
; 2005 Jul;122(7):658-64
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Non-Hodgkin's
lymphoma
and acquired immune deficiency syndrome (
AIDS
). A case report.
[MeSH-major]
Facial Neoplasms / pathology. Gingival Neoplasms / pathology.
Lymphoma
,
AIDS
-
Related
/ pathology.
Lymphoma
,
Large B
-
Cell
,
Diffuse
/ pathology
Genetic Alliance.
consumer health - AIDS-HIV
.
Hazardous Substances Data Bank.
DOXORUBICIN
.
Hazardous Substances Data Bank.
CYCLOPHOSPHAMIDE
.
Hazardous Substances Data Bank.
PREDNISONE
.
Hazardous Substances Data Bank.
VINCRISTINE
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 16152890.001).
[ISSN]
0040-4284
[Journal-full-title]
Texas dental journal
[ISO-abbreviation]
Tex Dent J
[Language]
eng
[Publication-type]
Case Reports; Journal Article
[Publication-country]
United States
[Chemical-registry-number]
5J49Q6B70F / Vincristine; 80168379AG / Doxorubicin; 8N3DW7272P / Cyclophosphamide; VB0R961HZT / Prednisone; CHOP protocol
87.
Wolach O, Bairey O, Lahav M:
Late-onset neutropenia after rituximab treatment: case series and comprehensive review of the literature.
Medicine (Baltimore)
; 2010 Sep;89(5):308-18
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
Rituximab is a chimeric monoclonal antibody against CD20 that is used mainly for the treatment of CD20-positive
lymphoma
.
Four patients were treated for
diffuse large
B-
cell lymphoma
, and 2 patients for follicular
lymphoma
.
Data regarding populations at risk are not consistent, and in some instances are conflicting.Patients considered at increased risk of LON include patients after autologous stem
cell
transplantation, patients treated for acquired immunodeficiency syndrome (
AIDS
)-
related lymphoma
, and patients treated with purine analogues.
MedlinePlus Health Information.
consumer health - Cancer Chemotherapy
.
Hazardous Substances Data Bank.
RITUXIMAB
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 20827108.001).
[ISSN]
1536-5964
[Journal-full-title]
Medicine
[ISO-abbreviation]
Medicine (Baltimore)
[Language]
eng
[Publication-type]
Journal Article; Review
[Publication-country]
United States
[Chemical-registry-number]
0 / Antibodies, Monoclonal; 0 / Antibodies, Monoclonal, Murine-Derived; 0 / Antineoplastic Agents; 4F4X42SYQ6 / Rituximab
88.
Mani D, Guinee DG Jr, Aboulafia DM:
AIDS-associated plasmablastic lymphoma presenting as a poorly differentiated esophageal tumor: a diagnostic dilemma.
World J Gastroenterol
; 2008 Jul 21;14(27):4395-9
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
AIDS
-associated plasmablastic
lymphoma
presenting as a poorly differentiated esophageal tumor: a diagnostic dilemma.
Plasmablastic
lymphoma
(PBL) is a rare form of
diffuse large
B-
cell lymphoma
characterized by weak/absent expression of conventional B-
cell
markers and strong expression of plasma
cell
markers.
Herein we describe a patient with
AIDS
who presented with weight loss and dysphagia owing to a
large
gastroesophageal mass.
However, gene rearrangement studies confirmed a B-
cell
process and a more detailed immunohistochemical analysis revealed the cells stained positively for CD138 (plasma
cell
antigen).
[MeSH-major]
Esophageal Neoplasms / complications. Esophageal Neoplasms / diagnosis.
Lymphoma
,
AIDS
-
Related
/ diagnosis. Medical Oncology / methods. Plasma Cells / pathology
[MeSH-minor]
Adult. Antigens, CD20 / biosynthesis. Antigens, CD38 / biosynthesis.
Cell
Differentiation. Diagnosis, Differential. Endoscopy / methods. Gene Rearrangement. Humans.
Lymphoma
, Non-Hodgkin / complications.
Lymphoma
, Non-Hodgkin / diagnosis. Male. Stomach Neoplasms / complications. Stomach Neoplasms / diagnosis
Genetic Alliance.
consumer health - AIDS-HIV
.
MedlinePlus Health Information.
consumer health - Esophageal Cancer
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Cites]
Blood. 2000 Feb 15;95(4):1406-12
[
10666218.001
]
[Cites]
Histopathology. 2007 Dec;51(6):774-7
[
17944927.001
]
[Cites]
Blood. 2001 Feb 1;97(3):744-51
[
11157493.001
]
[Cites]
Blood. 2002 Apr 1;99(7):2331-6
[
11895764.001
]
[Cites]
Leuk Lymphoma. 2002 Feb;43(2):423-6
[
11999580.001
]
[Cites]
Histopathology. 2003 Jun;42(6):605-9
[
12786898.001
]
[Cites]
Am J Surg Pathol. 2004 Jan;28(1):41-6
[
14707862.001
]
[Cites]
Am J Surg Pathol. 2004 Jun;28(6):736-47
[
15166665.001
]
[Cites]
Leuk Lymphoma. 2004 Sep;45(9):1881-5
[
15223650.001
]
[Cites]
Am J Surg Pathol. 2004 Nov;28(11):1538-40; author reply 1540
[
15489661.001
]
[Cites]
Am J Hematol. 2004 Nov;77(3):291-5
[
15495247.001
]
[Cites]
Blood. 1997 Feb 15;89(4):1413-20
[
9028965.001
]
[Cites]
Ann Oncol. 2004 Nov;15(11):1673-9
[
15520070.001
]
[Cites]
Mod Pathol. 2005 Jun;18(6):806-15
[
15578069.001
]
[Cites]
Am J Surg Pathol. 2005 Dec;29(12):1633-41
[
16327436.001
]
[Cites]
Ann Diagn Pathol. 2006 Feb;10(1):8-12
[
16414538.001
]
[Cites]
Oncologist. 2006 Jun;11(6):666-73
[
16794245.001
]
[Cites]
Hum Pathol. 2006 Sep;37(9):1233-6
[
16938530.001
]
[Cites]
J Clin Pathol. 2007 Jan;60(1):80-1
[
17213349.001
]
[Cites]
J Oral Maxillofac Surg. 2007 Jul;65(7):1358-61
[
17577502.001
]
[Cites]
J Oral Maxillofac Surg. 2007 Jul;65(7):1361-4
[
17577503.001
]
[Cites]
Hepatology. 2007 Jul;46(1):107-12
[
17526021.001
]
[Cites]
Lancet. 2007 Jul 7;370(9581):59-67
[
17617273.001
]
[Cites]
J Clin Oncol. 2007 Jul 20;25(21):3176-8
[
17634499.001
]
[Cites]
AIDS Read. 2007 Sep;17(9):446-7
[
17902226.001
]
[Cites]
AIDS Read. 2007 Sep;17(9):448-9
[
17902227.001
]
[Cites]
Oral Dis. 2007 Nov;13(6):564-9
[
17944673.001
]
[Cites]
Rev Soc Bras Med Trop. 2007 Sep-Oct;40(5):582-4
[
17992417.001
]
[Cites]
Arch Pathol Lab Med. 2001 Feb;125(2):282-5
[
11175653.001
]
(PMID = 18666332.001).
[ISSN]
1007-9327
[Journal-full-title]
World journal of gastroenterology
[ISO-abbreviation]
World J. Gastroenterol.
[Language]
eng
[Publication-type]
Case Reports; Journal Article
[Publication-country]
China
[Chemical-registry-number]
0 / Antigens, CD20; EC 3.2.2.5 / Antigens, CD38
[Other-IDs]
NLM/ PMC2731195
89.
El-Salem M, Raghunath PN, Marzec M, Liu X, Kasprzycka M, Robertson E, Wasik MA:
Activation of mTORC1 signaling pathway in AIDS-related lymphomas.
Am J Pathol
; 2009 Aug;175(2):817-24
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Activation of mTORC1 signaling pathway in
AIDS
-
related
lymphomas.
Using immunohistochemistry with antibodies against the phosphoserine residues in both S6rp and 4E binding protein 1, we identified the activation of the mammalian target of rapamycin (mTORC)1 pathway in 29 cases of
AIDS
-
related lymphoma
.
These cases represented a diverse spectrum of histological types of non-Hodgkin
lymphoma
(24 cases) and classic Hodgkin
lymphoma
(five cases).
We also found that in B-
cell
lines that represent
diffuse large
B-
cell lymphoma
, Burkitt
lymphoma
, Epstein-Barr virus-infected lymphocytes, and human herpesvirus 8-positive primary effusion
lymphoma
, inhibitors of Syk, MEK, and, seemingly, phosphoinositide 3 kinases suppressed mTORC1 activation, in particular when these inhibitors were used in combination.
These findings indicate that
AIDS
-
related lymphoma
and other histologically similar types of lymphomas that are derived from transformed B lymphocytes may display clinical responses to inhibitors that directly target mTORC1 or, possibly, upstream activators of the mTORC1 pathway.
Genetic Alliance.
consumer health - AIDS-HIV
.
COS Scholar Universe.
author profiles
.
NCI CPTAC Assay Portal.
NCI CPTAC Assay Portal
.
NCI CPTC Antibody Characterization Program.
NCI CPTC Antibody Characterization Program
.
NCI CPTC Antibody Characterization Program.
NCI CPTC Antibody Characterization Program
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Cites]
Transpl Int. 2003 Mar;16(3):202-6
[
12664217.001
]
[Cites]
EMBO J. 2002 Aug 1;21(15):4070-80
[
12145207.001
]
[Cites]
J Biol Chem. 2003 Jun 13;278(24):21960-71
[
12668683.001
]
[Cites]
J Biol Chem. 2003 Sep 26;278(39):37288-96
[
12867426.001
]
[Cites]
Biochimie. 2003 Aug;85(8):763-9
[
14585543.001
]
[Cites]
Transplantation. 2004 Mar 15;77(5):760-2
[
15021843.001
]
[Cites]
Pediatr Transplant. 2004 Jun;8(3):243-8
[
15176961.001
]
[Cites]
J Biol Chem. 1991 Aug 15;266(23):14846-9
[
1869521.001
]
[Cites]
J Biol Chem. 1992 Apr 25;267(12):8613-9
[
1569106.001
]
[Cites]
Proc Natl Acad Sci U S A. 1992 Oct 1;89(19):9107-11
[
1409610.001
]
[Cites]
J Biol Chem. 1993 Jul 25;268(21):15900-5
[
8340414.001
]
[Cites]
J Biol Chem. 1993 Nov 15;268(32):24442-8
[
8226994.001
]
[Cites]
J Biol Chem. 1994 Feb 25;269(8):5918-25
[
8119935.001
]
[Cites]
J Immunol. 1994 Jun 1;152(11):5429-37
[
8189062.001
]
[Cites]
EMBO J. 1996 Oct 1;15(19):5256-67
[
8895571.001
]
[Cites]
Immunol Lett. 1999 Jun 1;68(2-3):301-9
[
10424436.001
]
[Cites]
N Engl J Med. 2005 Mar 31;352(13):1317-23
[
15800227.001
]
[Cites]
J Virol. 2005 May;79(9):5499-506
[
15827164.001
]
[Cites]
Cell. 2005 Apr 22;121(2):179-93
[
15851026.001
]
[Cites]
J Biol Chem. 2005 May 20;280(20):19937-47
[
15760907.001
]
[Cites]
Nephrol Dial Transplant. 2005 Aug;20(8):1748-51
[
15919698.001
]
[Cites]
Cancer Res. 2005 Sep 1;65(17):7800-8
[
16140948.001
]
[Cites]
Microsc Res Tech. 2005 Nov;68(3-4):168-75
[
16276515.001
]
[Cites]
Cell Res. 2005 Nov-Dec;15(11-12):947-52
[
16354573.001
]
[Cites]
Curr Opin Infect Dis. 2006 Feb;19(1):14-9
[
16374212.001
]
[Cites]
Cancer. 2006 Jan 1;106(1):128-35
[
16329140.001
]
[Cites]
Br J Cancer. 2006 Jan 30;94(2):195-9
[
16404421.001
]
[Cites]
Proc Natl Acad Sci U S A. 2006 Apr 4;103(14):5466-71
[
16567633.001
]
[Cites]
Am J Kidney Dis. 2006 May;47(5):e67-72
[
16632009.001
]
[Cites]
Blood. 2006 May 15;107(10):3832-40
[
16410446.001
]
[Cites]
Cancer Cell. 2006 Aug;10(2):133-43
[
16904612.001
]
[Cites]
Nat Rev Cancer. 2006 Sep;6(9):729-34
[
16915295.001
]
[Cites]
J Biol Chem. 2006 Sep 15;281(37):26904-13
[
16816403.001
]
[Cites]
Oncogene. 2006 Oct 16;25(48):6347-60
[
17041621.001
]
[Cites]
Blood. 2006 Dec 15;108(13):4156-62
[
16912221.001
]
[Cites]
Lab Invest. 2007 Jan;87(1):29-39
[
17075574.001
]
[Cites]
Transplant Proc. 2007 May;39(4):1267-71
[
17524950.001
]
[Cites]
N Engl J Med. 2007 May 31;356(22):2271-81
[
17538086.001
]
[Cites]
Blood. 2007 Jul 1;110(1):278-86
[
17363738.001
]
[Cites]
Transplant Proc. 2007 Jul-Aug;39(6):2036-7
[
17692685.001
]
[Cites]
Oncogene. 2007 Aug 16;26(38):5606-14
[
17353907.001
]
[Cites]
Blood. 2008 Feb 15;111(4):2181-9
[
18025151.001
]
[Cites]
Transpl Int. 2008 Jun;21(6):605-8
[
18282244.001
]
[Cites]
Blood. 2007 Mar 1;109(5):2165-73
[
17082322.001
]
[Cites]
Biochem J. 1999 Dec 1;344 Pt 2:427-31
[
10567225.001
]
[Cites]
Proc Natl Acad Sci U S A. 2000 Apr 11;97(8):4285-90
[
10759564.001
]
[Cites]
Cancer Res. 2000 Jul 1;60(13):3504-13
[
10910062.001
]
[Cites]
Transplantation. 2003 May 27;75(10):1710-7
[
12777861.001
]
(PMID = 19608873.001).
[ISSN]
1525-2191
[Journal-full-title]
The American journal of pathology
[ISO-abbreviation]
Am. J. Pathol.
[Language]
ENG
[Grant]
United States / NCI NIH HHS / CA / R01 CA089194; United States / NIDCR NIH HHS / DE / R01 DE017337; United States / NCI NIH HHS / CA / R01-CA89194; United States / NIDCR NIH HHS / DE / R01-DE-017337
[Publication-type]
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
[Publication-country]
United States
[Chemical-registry-number]
0 / Antibodies, Phospho-Specific; 0 / Multiprotein Complexes; 0 / Proteins; 0 / Transcription Factors; 0 / mechanistic target of rapamycin complex 1; 17885-08-4 / Phosphoserine; EC 2.7.1.1 / TOR Serine-Threonine Kinases
[Other-IDs]
NLM/ PMC2716976
90.
Keszler A, Piloni MJ, Paparella ML, Soler Mde D, Ron PC, Narbaitz M:
Extranodal oral non-Hodgkin's lymphomas. A retrospective study of 40 cases in Argentina.
Acta Odontol Latinoam
; 2008;21(1):43-8
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
The most common histological type was
Diffuse Large Cell Lymphoma
.
[MeSH-major]
Jaw Neoplasms / pathology.
Lymphoma
, B-
Cell
/ pathology.
Lymphoma
, Non-Hodgkin / pathology. Mouth Neoplasms / pathology
[MeSH-minor]
Adolescent. Adult. Age Distribution. Aged. Aged, 80 and over. Argentina. Child. Child, Preschool. Female. Humans.
Lymphoma
,
AIDS
-
Related
/ pathology. Male. Middle Aged. Retrospective Studies. Sex Distribution. Young Adult
MedlinePlus Health Information.
consumer health - Oral Cancer
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 18841745.001).
[ISSN]
0326-4815
[Journal-full-title]
Acta odontológica latinoamericana : AOL
[ISO-abbreviation]
Acta Odontol Latinoam
[Language]
eng
[Publication-type]
Journal Article; Research Support, Non-U.S. Gov't
[Publication-country]
Argentina
91.
Khan F, Bauer F, Gazi G, Bilgrami S:
Regression of large B-cell non-Hodgkin's lymphoma of stomach with HAART: case report and review.
Leuk Lymphoma
; 2006 Apr;47(4):750-4
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Regression of
large B
-
cell
non-Hodgkin's
lymphoma
of stomach with HAART: case report and review.
[MeSH-major]
Antiretroviral Therapy, Highly Active.
Lymphoma
,
AIDS
-
Related
/ drug therapy.
Lymphoma
,
Large B
-
Cell
,
Diffuse
/ drug therapy.
Lymphoma
, Non-Hodgkin / drug therapy. Stomach Neoplasms / drug therapy
MedlinePlus Health Information.
consumer health - HIV/AIDS Medicines
.
MedlinePlus Health Information.
consumer health - Stomach Cancer
.
HIV InSite.
treatment guidelines - Human Herpesvirus-8
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 16886274.001).
[ISSN]
1042-8194
[Journal-full-title]
Leukemia & lymphoma
[ISO-abbreviation]
Leuk. Lymphoma
[Language]
eng
[Publication-type]
Case Reports; Letter
[Publication-country]
England
92.
Lim ST, Karim R, Nathwani BN, Tulpule A, Espina B, Levine AM:
AIDS-related Burkitt's lymphoma versus diffuse large-cell lymphoma in the pre-highly active antiretroviral therapy (HAART) and HAART eras: significant differences in survival with standard chemotherapy.
J Clin Oncol
; 2005 Jul 1;23(19):4430-8
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
AIDS
-
related
Burkitt's
lymphoma
versus
diffuse large
-
cell lymphoma
in the pre-highly active antiretroviral therapy (HAART) and HAART eras: significant differences in survival with standard chemotherapy.
PURPOSE: To compare outcomes of patients with HIV-Burkitt's
lymphoma
(HIV-BL) and HIV-
diffuse large
-
cell lymphoma
(HIV-DLCL) after treatment with CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone) or M-BACOD (methotrexate, bleomycin, cyclophosphamide, etoposide) in pre-highly active antiretroviral therapy (HAART) versus HAART eras.
PATIENTS AND METHODS: Three hundred sixty-three patients with
AIDS
-
related lymphoma
diagnosed from 1982 to 2003 were reviewed retrospectively, including 262 in the pre-HAART (HIV-BL, 117; HIV-DLCL, 145) and 101 in the HAART era (HIV-BL, 18; HIV-DLCL, 83).
RESULTS: There were no significant differences between groups in terms of age, sex, history of injection drug use, prior
AIDS
, lactate dehydrogenase level, and disease stage at diagnosis.
[MeSH-major]
Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Antiretroviral Therapy, Highly Active. Bleomycin / therapeutic use. Burkitt
Lymphoma
/ mortality. Cyclophosphamide / therapeutic use. Dexamethasone / therapeutic use. Doxorubicin / therapeutic use. Leucovorin / therapeutic use.
Lymphoma
,
AIDS
-
Related
/ mortality.
Lymphoma
,
Large B
-
Cell
,
Diffuse
/ mortality. Methotrexate / therapeutic use. Prednisone / therapeutic use. Vincristine / therapeutic use
Genetic Alliance.
consumer health - AIDS-HIV
.
Genetic Alliance.
consumer health - Lymphoma, large-cell
.
Genetic Alliance.
consumer health - Burkitt's Lymphoma
.
MedlinePlus Health Information.
consumer health - HIV/AIDS Medicines
.
MedlinePlus Health Information.
consumer health - Steroids
.
COS Scholar Universe.
author profiles
.
Hazardous Substances Data Bank.
BLEOMYCIN
.
Hazardous Substances Data Bank.
DOXORUBICIN
.
Hazardous Substances Data Bank.
DEXAMETHASONE
.
Hazardous Substances Data Bank.
CYCLOPHOSPHAMIDE
.
Hazardous Substances Data Bank.
PREDNISONE
.
Hazardous Substances Data Bank.
VINCRISTINE
.
Hazardous Substances Data Bank.
LEUCOVORIN
.
Hazardous Substances Data Bank.
METHOTREXATE
.
NCI CPTC Antibody Characterization Program.
NCI CPTC Antibody Characterization Program
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[CommentIn]
J Clin Oncol. 2005 Nov 20;23(33):8538-40; author reply 8540-1
[
16293885.001
]
[CommentIn]
J Clin Oncol. 2005 Nov 1;23(31):8132-3; author reply 8133-4
[
16258119.001
]
(PMID = 15883411.001).
[ISSN]
0732-183X
[Journal-full-title]
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
[ISO-abbreviation]
J. Clin. Oncol.
[Language]
eng
[Publication-type]
Comparative Study; Journal Article
[Publication-country]
United States
[Chemical-registry-number]
11056-06-7 / Bleomycin; 5J49Q6B70F / Vincristine; 7S5I7G3JQL / Dexamethasone; 80168379AG / Doxorubicin; 8N3DW7272P / Cyclophosphamide; Q573I9DVLP / Leucovorin; VB0R961HZT / Prednisone; YL5FZ2Y5U1 / Methotrexate; CHOP protocol; M-BACOD protocol
93.
Horváth E, Krenács L, Bagdi E, Pávai Z, Macarie I, Nagy EE, Demian S:
Plasmoblastic lymphoma associated with human immunodeficiency virus.
Rom J Morphol Embryol
; 2008;49(3):309-14
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Plasmoblastic
lymphoma
associated with human immunodeficiency virus.
Plasmoblastic
lymphoma
(PBL) is a subtype of the
diffuse large
B-
cell lymphoma
, typically present as extranodal disease associated with human immune deficiency virus (HIV) infection.
PBLs are often the initial manifestation of
AIDS
.
The gingival biopsy showed a massive infiltration by
large
lymphoid cells with round, vesicular nuclei, prominent nucleoli, fine chromatin and an significant amount of basophilic cytoplasm which express CD79a, CD138, cytoplasmic lambda light chain and LCA, without staining for CD20, CD38, CD3 and CTK.
[MeSH-major]
HIV-1.
Lymphoma
,
AIDS
-
Related
/ diagnosis.
Lymphoma
, Non-Hodgkin / complications
HIV InSite.
treatment guidelines - Women and HIV
.
HIV InSite.
treatment guidelines - Human Herpesvirus-8
.
NCI CPTAC Assay Portal.
NCI CPTAC Assay Portal
.
NCI CPTAC Assay Portal.
NCI CPTAC Assay Portal
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 18758634.001).
[ISSN]
1220-0522
[Journal-full-title]
Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie
[ISO-abbreviation]
Rom J Morphol Embryol
[Language]
eng
[Publication-type]
Case Reports; Journal Article; Research Support, Non-U.S. Gov't
[Publication-country]
Romania
94.
Nenasheva VV, Nikolaev AI, Martynenko AV, Kaplanskaya IB, Bodemer W, Hunsmann G, Tarantul VZ:
Differential gene expression in HIV/SIV-associated and spontaneous lymphomas.
Int J Med Sci
; 2005;2(4):122-8
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
Diffuse large
B-
cell lymphoma
(DLBCL) is more prevalent and more often fatal in HIV-infected patients and SIV-infected monkeys compared to immune-competent individuals.
To find genes specifically overexpressed in HIV/SIV-associated and non-HIV/SIV-associated DLBCL we compared gene expression profiles of HIV/SIV-
related
and non-HIV-
related
lymphomas using subtractive hybridization and Northern blot analysis.
In summary, we have demonstrated that simultaneous transcriptional upregulation of at least two genes (a-myb and pub) was specific for
AIDS
-associated lymphomas.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Cites]
FEMS Immunol Med Microbiol. 1999 Dec;26(3-4):227-32
[
10575133.001
]
[Cites]
Blood. 1998 May 1;91(9):3103-11
[
9558363.001
]
[Cites]
Nature. 2000 Feb 3;403(6769):503-11
[
10676951.001
]
[Cites]
J Biol Chem. 2000 Mar 3;275(9):6499-508
[
10692454.001
]
[Cites]
Curr Opin Immunol. 2000 Apr;12(2):219-25
[
10712950.001
]
[Cites]
Clin Cancer Res. 2000 Jun;6(6):2456-63
[
10873099.001
]
[Cites]
Blood. 2000 Jul 15;96(2):398-404
[
10887098.001
]
[Cites]
Blood. 2000 Aug 1;96(3):1013-20
[
10910917.001
]
[Cites]
J Biol Chem. 2001 Jun 22;276(25):22709-14
[
11331269.001
]
[Cites]
Eur J Cancer. 2001 Jul;37(10):1236-50
[
11423256.001
]
[Cites]
Int J Cancer. 2001 Dec 20;96(6):327-33
[
11745502.001
]
[Cites]
Blood. 2002 Sep 1;100(5):1802-9
[
12176903.001
]
[Cites]
Med Hypotheses. 2002 Dec;59(6):670-3
[
12445508.001
]
[Cites]
Oncogene. 2003 Feb 6;22(5):769-74
[
12569370.001
]
[Cites]
Biochem Biophys Res Commun. 2003 Apr 11;303(3):940-6
[
12670502.001
]
[Cites]
Exp Mol Pathol. 2003 Apr;74(2):129-39
[
12710944.001
]
[Cites]
J Exp Med. 1992 Jul 1;176(1):281-6
[
1319458.001
]
[Cites]
Biochem Biophys Res Commun. 2003 Nov 14;311(2):351-60
[
14592421.001
]
[Cites]
Clin Immunol. 2003 Nov;109(2):119-29
[
14597210.001
]
[Cites]
Blood. 2005 Mar 1;105(5):1851-61
[
15550490.001
]
[Cites]
Proc Natl Acad Sci U S A. 1995 May 9;92(10):4279-83
[
7753797.001
]
[Cites]
Int J Cancer. 1995 May 16;61(4):574-9
[
7759163.0